Unnamed: 0,patient_filename,t,text,type,n,cmem_t_reasoning,cmem_t_ans_str,cmem_t_num_update
601,TCGA-A7-A56D.D564A7FB-4F0A-4589-AB32-A6CD8B547219,1,"Final Surgical Pathology Report. Procedure: Diagnosis. A. Left axillary sentinel lymph node, resection: No evidence of metastasis in one lymph node (0/1) . B. Left breast, simple mastectomy: Infiltrating ductal carcinoma, grade 3, 3.2 cm in greatest dimension. Surgical margins negative but close, less than 2 mm. C. Left axillary contents, resection: No evidence of metastasis in 7 lymph nodes (0/7). Microscopic Description: Microscopic examination performed. A. Sections of the sentinel lymph node demonstrate no evidence of. metastatic disease. The node is examined by multiple sectioning with. hematoxylin and eosin and by immunohistochemistry for pankeratin. Invasive Carcinoma: present. Histologic type: Infiltrating ductal carcinoma. Histologic grade: Overall grade: 3. Architectural score: 2. Nuclear score: 3. Mitotic score: 3. Greatest dimension (pT) : 3.2 cm,. pT2. Specimen margins: Negative but close, less than 2 mm over a. distance of 5 mm. Vessel invasion: Not identified. Calcification: Not identified. Ductal carcinoma in situ: Not identified. Description of non-tumorous breast: Proliferative fibrocystic. changes with intraductal papillomatosis. Comments: None. Prognostic markers: Previously performed. C Sections of the left axillary contents demonstrate no evidence of. metastasis in 7 lymph nodes. Specimen. A. Left sentinel node-axillary. B. Left breast-tumor at 7 o'clock. C. Axillary contents. Clinical Information. Carcinoma left breast, core biopsy positive here. Intraoperative Consultation. AFS left axillary sentinel lymph node, excision: No evidence of metastasis in one lymph node. Gross Description. A. Container a is labeled with the patient's name, medical record. number and ""sentinel lymph node"". The specimen consists of a single. piece of fatty tissue which when bisected holds a single lymph node. measuring 1.0 x 0.0 0. cm. Bisected and submitted in block AFS. B. Received fresh labeled ""left breast"" is a 25.5 cm (medial to. lateral) by 17.0 cm (superior to inferior) by 4.5 cm (anterior to. posterior) soft, lobulated tan-white-gold portion of fibroadipose. tissue oriented per placement of designated tumor as stated previously. A 19.3 x 8.5 cm wrinkled tan skin ellipse with an eccentric, 1.0 x 1.0. x 0.5 cm nipple is present along the anterior aspect. A palpable mass. is evident at 7 o'clock, corresponding to the lower inner quadrant. The antero-inferior surface of the specimen in the vicinity of the mass. is inked blue. The intact deep margin is inked black and the specimen. is sectioned. There is a well-circumscribed, 3.2 cm (medial to. lateral) by 2.4 cm (anterior to posterior) by 2.0 cm (superior to. inferior) rubbery tan-white tumor mass within the lower outer quadrant. On sectioning the tumor appears to extend to within 0.2 cm of the. inked anteroinferior surface and 1.5 cm of the inked deep margin. A. portion of tumor and a portion of normal parenchyma are submitted for. tissue procurement as requested. The cut surfaces throughout the. remainder of the specimen consist predominantly of soft, lobulated tan. gold adipose tissue with a minimal amount of interspersed dense. tan-white fibrous tissue. No additional mass lesion or abnormality is. identified. Summary: 1 - tumor to inked deep margin, 2 through 4 - tumor to inked. anteroinferior margin, 5 and 6 - tumor to adjacent parenchyma, 7 -. random upper outer quadrant, 8 - upper inner quadrant, 9 - lower inner. quadrant, 10 - lower outer quadrant, 11 - junction of the 4 quadrants,. 12 - nipple. C. Received fresh labeled ""Axillary contents"" is a 9.3 x 7.8 x 1.7 cm. portion of soft, lobulated tan gold adipose tissue. A few slightly. rubbery pale tan to tan pink tissues in keeping with lymph nodes. measuring up to 3.4 cm in greatest dimension are recovered. The. lymphoid tissues are entirely submitted. RS 4. Summary: 1 - 2 lymph nodes, 2 - 1 bisected lymph node, 3 and 4 -. bisected largest lymph node. the. Criteria. Discrepancy. Temar S. Discripancy. PIP.",BRCA,0,"The T stage for breast cancer is determined by the size of the tumor. In this report, the tumor size is given as 3.2 cm, which falls within the T2 category (tumor size of 2.1 to 5.0 cm) according to the AJCC staging system for breast cancer.",T2,0.0
609,TCGA-A8-A06N.2F0333BC-E9BB-4903-B3E2-8AE241DDDF84,3,"Diagnosis: Poorly differentiated invasive ductal carcinoma (tumor diameter: 17 cm; minimum. distance from preparation margins less than 0.1 cm) with multiple ulcerations of the. skin. Together with the preliminary finding, this gives rise to the following tumor. classification: NOS, G III, pT4bpNOLOVORO.",BRCA,0,"The report states that the tumor diameter is 17 cm, which falls under the 'T4' category of 'tumor size over 5.0 cm' or 'tumor of any size with direct extension to the chest wall or skin'. The report also mentions multiple ulcerations of the skin, which supports the 'T4' classification. Therefore, the T stage for this report is T4.",T4,1.0
594,TCGA-A7-A426.B644AEB6-7D46-4D4D-BA00-D42BCDDCB164,2,"Final Surgical Pathology Report. Procedure: Diagnosis. A. Lymph nodes, right axillary sentinel nodes, resection: 2 of 3 lymph nodes contain metastatic lobular carcinoma (2/3). B. Lymph node, left axillary sentinel node, resection: Single lymph node negative for metastatic carcinoma (0/1). C. Breast, right, simple mastectomy: Invasive lobular carcinoma. The nipple, overlying skin and deep margin of the mastectomy are free. of carcinoma. Fibrocystic changes with ductal hyperplasia and lobular carcinoma in. situ. Post-biopsy changes are present. D. Breast, left, simple mastectomy: Invasive lobular carcinoma. The nipple, overlying skin and deep margin of the mastectomy are free. of carcinoma. Fibrocystic changes with ductal hyperplasia microcalcifications. Post-biopsy changes are present. E. Lymph nodes, right axillary, resection: 11 of 17 additional lymph nodes contain metastatic lobular carcinoma. (11/17). (See template for total lymph node count). A portion of breast tissue is also present which contains a. microscopic focus. of invasive lobular carcinoma. The margins of resection of that tissue portion are. free of carcinoma. Microscopic Description: A.,C. and E.: Right Breast -. Invasive carcinoma: Histologic type: Invasive lobular carcinoma. Histologic grade: 1. Overall grade: Architectural score: 3. Nuclear score: 1. Mitotic score: 1. Greatest dimension (pT) : Tumor measures grossly a span of. approximately 6 cm (pT3). Specimen margins: Deep margin of the mastectomy is negative for. malignancy. Vessel invasion: Negative. Nipple: Negative. Invasion of skin or chest wall: Negative. Description of non-tumorous breast: Fibrocystic changes with ductal. hyperplasia and lobular carcinoma in situ. Lymph nodes: Number of positive nodes of total: 13 of 20 (including 2 of 3. positive sentinel lymph nodes). Size of largest metastasis: 1.1 cm. Extracapsular extension (present/absent) : Present. pN: pN3a. Distant metastasis (pM) : pMx. Prognostic markers: See prior core biopsy. The invasive. tumor was estrogen receptor positive, progesterone receptor positive. and showed normal expression for HER-2/neu. B. and D.: Left breast-. Invasive carcinoma: Histologic type: Invasive lobular carcinoma. Histologic grade: 1. Overall grade: Architectural score: 3. Nuclear score: 1. Mitotic score: 1. Greatest dimension: Residual tumor measures maximally 5 x 5 x 3 mm. as measured from the glass slide. Specimen margins: Deep margin mastectomy is negative for. malignancy. Vessel invasion: Negative. Nipple: Negative. Invasion of skin or chest wall: Negative. Description of non-tumorous breast: Fibrocystic changes with ductal. hyperplasia and microcalcifications. Lymph nodes: Number of positive nodes of total: 0 of 1 (sentinel lymph node). pN: pNO. Distant metastasis (pM) : pMx. Prognostic markers: See prior core biopsy (. The invasive. carcinoma was estrogen receptor positive, progesterone receptor. positive showed normal expression for HER-2/neu. Specimen. A. Right axillary sentinel node. B. Left axillary sentinel node. C. Right breast. D. Left breast. E. Right axillary contents. Clinical Information. year-old white. Bilateral invasive lobular carcinoma. Intraoperative Consultation. FSA) Right axillary sentinel nodes - Three lymph nodes present. Two of. three nodes positive for metastatic lobular carcinoma. FSB) Left axillarv sentinel node - Negative for metastatic carcinoma. Gross Description. A. Submitted fresh for frozen section labeled ""right axillary sentinel. node' or 3 nodules of partially cauterized tan yellow soft tissue. Bisecting the nodules reveal them to range from 0.7-1.8 cm in greatest. dimension. They're grossly involved by tumor. Half of each is. submitted for frozen section the remainder is kept for permanents. B. Submitted fresh for frozen section labeled ""left axillary sentinel. node is enlarged 3 x 2 x 1.5 cm mass of fatty tissue. Bisecting the. mass shows it to be possibly a large lymph node replaced with fat. Lymph node is bisected and submitted entirely for frozen section in 2. blndve. The remainder of the fat is submitted for permanent sections. C. Received fresh and subsequently fixed in formalin labeled ""right. breast ""is a 22.0 x 20.0 x 5.8 cm mastectomy which is partially covered. with a 13.0 x 7.5 cm pink-tan wrinkled skin ellipse having a 2.0 cm. everted nipple. The specimen is inked black the deep margin and. sectioned to show predominantly fibrous cut surface which is diffusely. nodular. Specimen shows an ill circumscribed fibrous mass which is. approximately 6 cm in greatest dimension. The shows a 0.8 cm previous. biopsy site, partially filled with white rice-like pellets. This comes. within 0.5 cm of the deep margin is located toward the lateral aspect. of the specimen. The specimen is diffusely nodular firm and rubbery no. additional biopsy sites are grossly identified. No lymph nodes are. grossly identified in the apex of the specimen. The specimen is. collected at. received in pathology at. and fixed in. formalin at. Representative sections of the specimen are submitted. as follows: 1 - 2 - entire nipple with representative skin, 3 - 6 -. representative sections of tumor, biopsy site and deep margin, 7 -. representative upper outer quadrant, 8 - representative lower outer. quadrant, 9 - representative lower inner quadrant, 10 - representative. upper inner quadrant. D. Received fresh and subsequently fixed in formalin labeled ""left. breast ""is a 23.0 x 20.0 x 6.5 cm mastectomy which is partially covered. with a 13 x 8 cm pink-tan wrinkled skin ellipse having a 2.0 cm everted. nipple. The specimen is inked at the deep margin to show a. predominantly white yellow nodular fibrous cut surface. There is a 1.5. x 1.2 x 0.5 cm hemorrhagic focus which is grossly consistent with a. previous biopsy. Located in the lower outer quadrant, coming within 1.2. cm of the deep margin. No other discrete biopsy sites are grossly. identified. The fibrous tissue is remarkably firm and nodular. diffusely. No lymph nodes gross identified in the apex of the specimen. The specimen is collected at. received in pathology at. and fixed in formalin at. Representative sections of the specimen. are submitted as follows: 1 - 2 - entire nipple with skin, 4 - 6. entire biopsy site representative deep margin and surrounding tissue,. 7. - representative inner upper quadrant, 8 - representative lower inner. quadrant, 9 - representative lower outer quadrant, 10 - representative. upper outer quadrant. RS 10. E. Received fresh and subsequently fixed in formalin labeled ""right. axillary content ""is a 9.5 x 8.5 x 4.5 cm aggregate of friable fatty. tissue. Less than has a suture is undesignated. This may designate the. highest node. Due to the fragment in nature, orientation of the. remainder of the tissue is indeterminate. Also received is a 6.5 cm. additional portion of possible breast tissue was which is fibrous and. nodular. Representative sections which include all the lymph nodes are. submitted as follows: 1 - representative section of breast tissue, 2. highest node, 3 - 3 possible lymph nodes, 4 - 4 possible lymph nodes, 5. - 2 possible lymph nodes, 6 - 5 possible lymph nodes, 7 - 2 possible. lymph node.",BRCA,3,"The T stage is determined by the size of the tumor. In this report, the right breast tumor measures approximately 6 cm in greatest dimension (pT3).",T3,2.0
659,TCGA-A8-A090.549E825B-F206-4FF9-835B-2FBE51C7B831,1,"Diagnosis: 1. Ablated breast sample with a moderately differentiated invasive ductal. carcinoma (tumor diameter: 2.7 cm). Tumor-free dorsal resection margin. Concluding tumor classification: NOS, G II, pT2N0LOVORO.",BRCA,0,"The report states that the tumor diameter is 2.7 cm, which falls within the range for a T2 stage tumor (2.1 to 5.0 cm).",T2,3.0
610,TCGA-A8-A06O.EB9B8904-F6CC-451F-8628-50CC71F1F7C3,0,"Diagnosis: Poorly differentiated invasive ductal carcinoma with focal intraductal spread. (maximum microscopic tumor diameter: 1.5 cm; distance from nearest resection. margin less than 0.1 cm) with multiple ulcerations of the skin. Diagnosis: 1. Ablated breast sample with a further focus of poorly differentiated invasive ductal. carcinoma (tumor diameter: 1.5 cm; distance from dorsal margin 0.8 cm and from. nearest lateral resection margin 1 cm, other margins remain free). Concluding tumor classification: NOS, G III, pT1c(m)pNO(0/13)LOVORO.",BRCA,0,"The report indicates that the maximum microscopic tumor diameter is 1.5 cm, which falls under the 'T1' category of up to 2.0 cm. The fact that there is direct extension to the skin is not considered in determining the T stage, but is instead considered in the T4 stage for chest wall or skin involvement.",T1,4.0
528,TCGA-A2-A0YH.0C344CD7-6FAB-462B-9A8E-75B720F2D626,1,"Chief of. CPNSU. Specimen. Spec Type: SURGICAL p. OPERATION. DOCTOR (8) : PROCEDURE: PARTIAL MASTECTOMY/LUMPECTOMY-AXTLLARY NODE DISSECTION. TISSUE REMOVED. A. LT PARTIAL MASTECTOMY. B. LT AXILLARY NODE. C. LT BREAST INFERIOR AND SUPERFICIAL MARGIN. GROSS DESCRIUTION. PART A RECEIVED FRESH LABELED. LEFT PARTIAL MASTECTOMY LONG. EQUALS LATERAL SHORT EQUALS SUPERIOR, IS AN OVOID PORTION OF YELLOW-PINK. FATTY TISSUE MEASURING 7 x 6 x 3.5 CM. THE SPECIMEN IS ORIENTED BY TWO. SUTURES AND MARKED AS FOLLOWS LATERAL ORANGE, MEDIAL RED, SUPERIOR. GREEN, INFERIOR BLUE, SUPERFICIAL BLACK, DEEP YELLOW. A LARGE PALPABLE. MASS IS FELT WITHIN THE SPECIMEN INFERIOR AND MEDIALLY. SECTIONING. REVEALS A ROUNDED PINK-TAN MASS MEASURING 2.4 x 2.2 x 2.7 CM IN GREATEST. DIMENSIONS. THIS APPROACHES THE SUPERFICIAL, DEEP AND INFERIOR MARGINS,. GROSSLY EXTENDING TO WITHIN 0.2 CM OF EACH OF THESE. IT IS GREATER THAN. 1 CM FROM THE OTHER MARGINS. THE SPECIMEN CONSISTS OF PINK-TAN FIBROUS. TISSUE IN THE MEDIAL ASPECT OF THE SPECIMEN AND YELLOW FATTY TISSUE MORE. LATERALLY. A RIBBON CLIP IS IDENTIFIED WITHIN THIS LESION. SECTIONS ARE. SUBMITTED AS FOLLOWS: A1 --REPRESENTATIVE PERPENDICULAR MEDIAL MARGIN,. A2 - -REPRESENTATIVE - PERPENDICULAR LATERAL MARGIN, A3 - --TUMOR (MIRROR IMAGE. TO PROTOCOL), A4--TUMOR AND INFERIOR MARGIN (MIRROR IMAGE TO PROTOCOL). A5 - -LESION AND INFERIOR MARGIN, A6--TUMOR AND SUPERFICIAL MARGIN,. A7--TUMOR AND DEEP MARGIN. NOTE THAT A5 THROUGH A6 IS ONE FULL. CROSS-SECTION OF LESION, WITH A6 MIRROR IMAGE TO TISSUE TAKEN PER. PROTOCOL. A8 --TISSUE - AND SUPERFICIAL MARGIN CORRESPONDING TO THE TUMOR. IN A3 (MIRROR IMAGE TO PROTOCOL TISSUE), A9--TISSUE TO INCLUDE THE DEEP. AND SUPERIOR MARGINS CORRESPONDING TO THE CROSS-SECTION DEPICTED IN A5. THROUGH 7, A10--THE CORRESPONDING DEEP MARGIN TO THE TUMOR TAKEN IN A3,. All --THE LATERAL ASPECT OF THE TUMOR TO INCLUDE THE INFERIOR SUPERFICIAL. MARGIN. PART B RECEIVED FRESH LABELED. LEFT AXILLARY NODE. DISSECTION, IS A PORTION OF YELLOW-RED FATTY TISSUE MEASURING 10 x 7.6 x. 4.8 CM IN GREATEST DIMENSIONS. THIS IS EXAMINED FOR LYMPH NODES WHICH. ARE THEN SUBMITTED AS FOLLOWS: 1--GROSSLY UNREMARKABLE LYMPH NODE,. B2 - - SECTION OF GROSSLY POSITIVE LYMPH NODE, B3 --SECTION - OF GROSSLY. POSITIVE LYMPH NODE WITH COIL CLIP. NOTE: SPECIMENS B1 THROUGH 3 ARE. MIRROR IMAGES TO PROTOCOL SECTIONS. B4 AND ---ONE NODE TOTAL, B6--TWO. NODES EACH BISECTED, B7--TWO NODES EACH BISECTED, B8 - THREE - NODES EACH. BISECTED, B9 - THREE NODES, B10--ONE NODE BISECTED, B11--ONE NODE. BISECTED, B12 - ONE NODE BISECTED. AFTER A SHORT TIME OF ACETIC FORMALIN FIXATION, ADDITIONAL NODES ARE. Chief of Pathology. specimen: spec Type: SURGICAL p. GROSS DESCRIPTION. IDENTIFIED AND SUBMITTED AS FOLLOWS: B13--ONE NODE BISECTED, B14 - -FIVE -. NODES, B15--THREE NODES EACH BISECTED, B16--TWO NODES EACH BISECTED. PART C RECEIVED LABELED LEFT BREAST INFERIOR AND. SUPERFICIAL MARGIN STITCH AT NEW MARGIN, IS AN OVOID PORTION OF. YELLOW-PINK FATTY TISSUE MEASURING 6.4 x 5.4 x 1.1 CM. SUTURE DENOTES A. NEW MARGIN. THIS SIDE IS MARKED WITH BLUE INK WITH A PERIMETER OF BLACK. INK. THE SPECIMEN IS SECTIONED AND ENTIRELY SUBMITTED LABELED C1 THROUGH. 10. PATH PROCEDURES. PROCEDURES: 88307/3, A BLK/11, B BLK/16, C BLK/10. FINAL DIAGHONTS. PART A LEFT PARTIAL MASTECTOMY: IN SITU AND POORLY DIFFERENTIATED. INFILTRATING DUCT CARCINOMA, NUCLEAR GRADE III/III WITH A HIGH MITOTIC. INDEX. THE INVASIVE TUMOR IS 2.- 4 CM IN MAXIMUM MICROSCOPIC DIMENSION. A 0.9 CM FOCUS OF DUCT CARCINOMA IN SITU OF THE MICROPAPILLARY AND. COMEDOCARCINOMA TYPES IS PRESENT ADMIXED WITH AND ADJACENT TO THE. INVASIVE TUMOR. DUCT CARCINOMA IN SITU IS PRESENT 1 MM FROM THE. SUPERFICIAL MARGIN, WITH INVASIVE CARCINOMA 1.5 MM FROM THE SUPERFICIAL/. MARGIN. INVASIVE CARCINOMA IS ALSO PRESENT IN A MICROSCOPIC SATELLITE. NODULE 1 MM FROM THE DEEP MARGIN. THE INFERIOR MARGIN IS CLEAR BY A. DISTANCE OF 3 MM. THE SUPERIOR, MEDIAL, AND LATERAL MARGINS ARE ALL. CLEAR OF TUMOR BY DISTANCES EXCEEDING 1 CM. THERE IS A SMALL FOCUS OF. ATYPICAL DUCT HYPERPLASIA 3 MM FROM THE MEDIAL MARGIN. PART B LEFT AXILLARY LYMPH NODE DISSECTION: METASTATIC CARCINOMA. IDENTIFIED IN 5 OF 28 AXILLARY LYMPH NODES. PART C LEFT BREAST SUPERFICIAL AND INFERIOR MARGIN, REEXCISION: FRAGMENTS OF BENIGN FATTY BREAST TISSUE AND A MICROSCOPIC FOCUS OF. INFILTRATING DUCT CARCINOMA. THIS 1 MM FOCUS OF CARCINOMA HAS A. CAUTERIZED MARGIN AND IS SEPARATE FROM THE ADJACENT ADIPOSE TISSUE. THE. AREA IS NOT INKED, BUT ITS RELATIONSHIP TO THE MARGIN CANNOT BE. ACCURATELY DETERMINED BECAUSE IT IS NOT ATTACHED TO THE INKED MARGIN. PORTION OF THE SPECIMEN. THIS FOCUS OF TUMOR IS PRESENT IN 1 OF 10. TISSUE BLOCKS (BLOCK C10). CODE. 1. (prelim.).",BRCA,2,"The report mentions that the 'invasive tumor is 2.4 cm in maximum microscopic dimension.' This corresponds to the 'T2' stage, as the tumor size is between 2.1 and 5.0 cm.",T2,5.0
626,TCGA-A8-A07G.1ED901DF-BCDC-44C8-A7DF-AB895ECA0952,0,"Diagnosis: 1. Moderately differentiated invasive ductal carcinoma with discrete intraductal. spread (tumor diameter 1.9 cm). In conjunction with the preliminary finding, this gives rise to the following tumor. classification: NOS, G II, pT1cN1aLOVORO.",BRCA,1,"The report states that the tumor diameter is 1.9 cm, which falls within the range for T1 tumors (up to 2.0 cm) as per the provided rules.",T1,6.0
623,TCGA-A8-A07C.DC5B662B-1ADD-4D6E-A6E3-3EF8B922BC71,1,"Diagnosis: 1. and 2. Bifocal poorly differentiated invasive ductal carcinoma (tumor diameters: 2.8 and. 0.8 cm). Concluding tumor classification: NOS, G III, pT2(mult)NOLOVORO.",BRCA,0,"The report provides the tumor sizes as 2.8 cm and 0.8 cm. The T stage is based on the largest dimension of the invasive tumor, which in this case is 2.8 cm. Therefore, the T stage is T2.",T2,7.0
620,TCGA-A8-A076.DD669244-34D8-4725-A52C-F3AAF59852F9,1,"Diagnosis: Poorly differentiated invasive ductal carcinoma (tumor diameter. 2.5 cm) with discrete. intraductal components. No skin infiltration. Considering the tumor-free medial follow-up resection material (sample 3), the. carcinoma was certainly excised in toto. Concluding tumor classification: NOS, G III, pT2NOLOVORO (6th edition, 2003).",BRCA,0,"The report states that the tumor diameter is 2.5 cm, which falls within the range for a T2 stage tumor (2.1 to 5.0 cm).",T2,8.0
653,TCGA-A8-A08P.7DB1F816-A55F-449A-8DF9-6724B5100CA1,1,"Diagnosis: 1. Invasive ductal breast carcinoma (maximum diameter 3 cm, conclusive malignancy grade. III) with invasion of the lymph vessels in the tumor periphery and an invasive satellite node,. as macroscopically documented. Remaining glandular body, which is rich in fatty tissue, is in. involution. No calcification here and no DCIS formation. Tumor-free nipple. Wide safety. margins. Tumor classification: pT2m pN2a (4/15), MX, R0; G3 (L1, V0).",BRCA,2,"The report states that the maximum diameter of the tumor is 3 cm, which falls within the range for a T2 stage tumor (2.1 to 5.0 cm).",T2,9.0
554,TCGA-A2-A3XV.405B9D03-6200-4DFA-A7D1-C622D3A48AEA,1,"Acct# : Unit# : Specimen. Spec Type: SURGICAL P. PREOPERATE IVE DIAGNOSIS. RIGHT BREAST CANCER - INVASIVE. OPERATION PERFORMED. DOCTOR (s) : PROCEDURE: MASTECTOMY, PARTIAL LUMPECTOMY, SENTINEL NODE BX. TISSUM REMOVED. A. RT AXILLARY SENTINEL NODE #1. B. RT AXILLARY SENTINEL NODE #2. C. RT BREAST. D. RT BREAST DEEP AND LATERAL MARGIN. GROSS DESCRIPTION. RECEIVED IN 4 PARTS. A RECEIVED LABELED. RIGHT AXILLARY SENTINEL NODE 1 HOT. COUNT 1610 IS A 3 x 2.2 x 1.2 CM PORTION OF YELLOW FATTY TISSUE WITH. FOCAL BLUE COLORATION. SECTIONING REVEALS A 2.5 CM IN DIAMETER ROUNDED. PORTION OF YELLOW FATTY TISSUE WHICH DEMONSTRATES FOCAL BLUE COLORATION. THIS IS SUBMITTED BISECTED IN A1 AND 2. ALSO IN A2 IS A SEPARATE FIRM. AREA MEASURING 0.5 CM IN DIAMETER. B RECEIVED LABELED. RIGHT AXILLARY SENTINEL NODE 2 HOT AND. BLUE COUNT 73768 IS A 4 x 2.5 x 1.2 CM PORTION OF YELLOW FATTY TISSUE. A 2.5 CM LYMPH NODE WITH MARKED BLUE COLORATION IS IDENTIFIED. THIS IS. SUBMITTED BISECTED LABELED B. C RECEIVED LABELED. RIGHT BREAST SHORT SUPERIOR LONG. LATERAL IS AN OVOID PORTION OF YELLOW-RED FATTY TISSUE MEASURING 6.8 X. 6.0 x 3.7 CM. THE SPECIMEN IS ORIENTED BY 2 SUTURES. THE MARGINS ARE. MARKED AS FOLLOWS: LATERAL ORANGE, MEDIAL RED, SUPERIOR GREEN, INFERIOR. BLUE, ANTERIOR BLACK, DEEP YELLOW. A SMALL METAL CYLINDER IS FOUND IN. THE MEDIAL ASPECT OF THE SPECIMEN WHICH IS THE EXTREME MEDIAL ASPECT OF. A CENTRAL GRAY-PINK GLISTENING MASS WHICH HAS A NODULAR APPEARANCE. THIS MEASURES 2 x 2.7 x 2 CM IN GREATEST DIMENSION. THE TISSUE INFERIOR. AND DEEP TO THIS LESION IS DENSE TAN FIBROUS TISSUE WITH FOCAL SMALL. CYSTS. THERE IS QUESTIONABLE EXTENSION OF THE LESION TO THE DEEP AND. Specimen: Spec Type: SURGICAL P. Subma Dr: GROSS DESCRIPTION. SUPERIOR ASPECT IN THE MEDIAL AREA. THIS LESION IS 0.7 CM FROM THE. ANTERIOR MARGIN AND 0.7 CM FROM THE INFERIOR MARGIN AND 1 CM OR MORE. FROM ALL OTHER MARGINS. REPRESENTATIVE SECTIONS ARE SUBMITTED AS. FOLLOWS: C1--REPRESENTATIVE PERPENDICULAR MEDIAL MARGIN,. C2--REPRESENTATIVE PERPENDICULAR LATERAL MARGIN, C3--LESION FROM MOST. MEDIAL ASPECT TO INCLUDE POSSIBLE SUPERIOR TO DEEP, C4 THROUGH 6--THE. REMAINDER OF THE CROSS SECTION TO C3, C7--ADJACENT SECTION TO C3 TO. INCLUDE POSSIBLE SUPERIOR NODULES, C8--REMAINDER OF LARGE MASS TO C7,. C9--AREA DEEP TO ca, C10--THE CLOSEST GROSS ANTERIOR AND LATERAL MARGINS. D RECEIVED LABELED. RIGHT BREAST DEEP AND LATERAL MARGIN. INK MARKS NEW MARGIN IS AN OVOID PORTION OF YELLOW-RED FATTY TISSUE. MEASURING 6 X 5 x 1.5 CM IN GREATEST DIMENSION. PURPLE-BLUE COLORATION. IS NOTED ON ONE SURFACE. THIS IS REMARKED WITH BLUE INK WITH A. PERIMETER OF BLACK INK. THIS IS SECTIONED AND SUBMITTED ENTIRELY. LABELED D1 THROUGH 8. TISSUE SECTIONS ARE PLACED IN FORMALIN AT. HOURS ON. FOR A 9-HOUR FIXATION. PATH PROCEDURES. PROCEDURES: 88307/4, IMMUNOPEROXIDAS/2, ABX X6/2, BBX x6, C BLK/10, D BLK/8. LINAL DIAGNOSTS. PARTS A AND B RIGHT AXILLA, SENTINEL LYMPH NODE BIOPSIES 1 AND 2: DERMATOPATHIC LYMPHADENITIS. NO EVIDENCE OF METASTATIC TUMOR ON H&E. STEP SECTIONS OR CYTOKERATIN STAINS IN 4 LYMPH NODES EXAMINED. PART C RIGHT BREAST, PARTIAL MASTECTOMY: 1. IN SITU AND INFILTRATING DUCT CARCINOMA. THE INVASIVE COMPONENT IS. POORLY DIFFERENTIATED HAVING APOCRINE DIFFERENTIATION, SHOWING NUCLEAR. GRADE 3/3, HIGH MITOTIC INDEX AND TUBULE FORMATION 3 WITH TOTAL. NOTTINGHAM SCORE OF 9. HIGH GRADE DCIS OF THE SOLID TYPE WHICH EXTENDS. INTO TERMINAL LOBULES SHOWS APOCRINE DIFFERENTIATION, MODERATE MITOTIC. INDEX, RARE FOCI OF LUMINAL NECROSIS AND COMPRISES APPROXIMATELY 30. PERCENT OF THE TUMOR. 2. THE TUMOR HAS A MAXIMUM GROSS DIMENSION OF 2.7 CM. Specimen: Spea Type: SURGICAL P. FINAL DIAGNOSIS. 3. THE IN SITU AND INVASIVE COMPONENTS ARE LOCATED 7 MM OR MORE FROM. THE INKED MARGINS OF RESECTION. 4. LYMPHOVASCULAR INVASION IS NOT IDENTIFIED. 5. THE BIOPSY SITE. IS PRESENT. 6. PROLIFERATIVE FIBROCYSTIC CHANGES INCLUDING SCLEROSING ADENOSIS WITH. CALCIFICATIONS, FLORID USUAL DUCT HYPERPLASIA, MICROCYST FORMATION,. APOCRINE METAPLASIA AND DENSE FIBROUS STROMA. PART D RIGHT BREAST, REEXCISION OF DEEP AND LATERAL MARGINS: FIBROGLANDULAR AND FATTY BREAST TISSUE WITH NO EVIDENCE OF RESIDUAL. TUMOR AND CLEAR MARGINS. FIBROCYSTIC CHANGES ARE PRESENT.",BRCA,0,"The report states that the largest gross dimension of the invasive tumor is 2.7 cm, which falls within the range for a T2 stage tumor (2.1 to 5.0 cm).",T2,10.0
578,TCGA-A7-A13F.D64FFDC0-38BB-456E-9621-AF89B79D0C68,2,"SPECIMEN. A. Sentinel lymph node #1, right axilla, count 422. B. Sentinel node #2, right axilla, count 2600. C. Left breast tissue, single stitch - superior, double stitch -. medial. D. Right breast. CLINICAL NOTES. PRE-OP DIAGNOSIS: Right breast Ca. FROZEN SECTION DIAGNOSIS. A. Sentinel node 1, right axillary: No tumor seen. No definite. lymph node. B. Sentinel node II right axillary, biopsy: two lymph nodes, both. positive for metatatic carcinoma. GROSS DESCRIPTION. A. The specimen is received fresh for frozen section. labeled ""sentinel node #1 right axilla"" and consists of a. 3.0 x 2.0 X 1.0 cm. piece of fatty yellow tissue. The specimen is. sectioned to reveal a possible 0.6 cm. tan lymph node. No staining. is present. The possible lymph node tissue is frozen as frozen. section AFS1. The fatty tissue is entirely submitted in block 1 for. permanent sections. B. The specimen is received fresh for frozen section. labeled ""B. sentinel node #2 right axilla"" is a 6.0 x 3.0. X 1.0 cm. piece of soft yellow fatty tissue. The specimen is. palpated and sectioned to reveal two possible lymph nodes. One. measures 1.5 cm. in greatest dimension and has a focally firm. white-tan appearance. The other measures 1.0 cm. in greatest. dimension and appears tan and soft. The larger lymph node is frozen. as frozen section BFS1 and the smaller as frozen section BFS2. Both. lymph nodes are bisected. GROSS DESCRIPTION. C. The specimen is received in formalin labeled ""left. breast tissue"" and consists of a V-shaped piece of white. skin with underlying yellow soft tissue, two additional pieces of. yellow soft tissue and an additional piece of white skin. The. entire. specimen weighs 480 grams in the partially fixed state. On cut. section the breast tissue is unremarkable. RS-8. D. The specimen is received in formalin labeled ""right. breast"" and consists of a right breast resection specimen. measuring 35 X 21 x 6 cm. There is an overlying white ellipse of. skin measuring 21 x 9 cm. The skin ellipse has a central areola. measuring 4.5 X 4 cm. with a central nipple measuring 1.3 X 1 X 0.2. cm. An arrow has been incised in the skin ellipse. The deep surface. of the specimen has been inked and the breast has been partially. sectioned prior to my examination. There is a deep central tumor a. portion of which has been resected prior to my examination,. probably. for research purposes. The tumor measures 6 X 4 X 7 cm. The. specimen. is re-incised at 1 cm. intervals from the deep surface towards the. skin. Sections are taken as dictated in the block summary: BLOCK SUMMARY: 1 and 2 - nipple; 3 - deep margin; 4-7 - tumor; 8-. 11. - upper outer, upper inner, lower outer, lower inner quadrants. Sections from the axillary portion of the specimen show 11 lymph. node-like structures. These are submitted in blocks D12-D17. MICROSCOPIC DESCRIPTION. A. Fibrofatty connective tissue is present. The specimen is. negative. for malignancy. B. Metastatic carcinoma is present in 2 of 2 lymph nodes. The. largest nodules measure 0.2 and 0.5 cm. C. There is focal benign calcification. D. MICROSCOPIC DESCRIPTION. Invasive carcinoma. Tumor type: Infiltrating ductal caricnoma with focal. lobular features. Tumor grade: 2 (Elston SBR grade; A/N/M = 3/2/1). Mitotic index: 4 mitoses/10 HPFs (1 HPF = 0.196 sq mm). Tumor size: 4 X 6 x 7 cm. Vessel invasion: Carcinoma is present in lymphatics in the. nipple. Calcification: Absent. pTNM stage: T3 pNla. Prognostic markers: See previous biopsy. Nipple: Carcinoma is present in lymphatics in the nipple. Skin over tumor: Negative for malignancy. Deep margin: Negative for malignancy. Total lymph nodes: 11 (including 2 sentinel nodes). Lymph nodes positive: 3 (including 2 sentinel nodes). Size of metastases: Up to 3.5 mm. Extranodal tumor: Absent. Matted lymph nodes: Absent. 4x2,3,5,14x2,1 15. DIAGNOSIS. A. Sentinel lymph node #1, right axilla, biopsy: Fibrofatty connective tissue. No lymph node present. B. Sentinal lymph node #2, right axilla, biopsy: Metastatic carcinoma is present in 2 of 2 lymph nodes. C. Breast, left, plastic procedure: Negative for malignancy. D. Breast, right, resection: DIAGNOSIS. Infiltrating ductal carcinoma with focal lobular features,. ( Nottingham grade 2. Note: Metatstatic carcinoma is present in 1 of 9 axillary lymph. nodes. M.D. (Electronic Signature). --- End Of Report. mud to Me it coil.",BRCA,1,"The T stage is based on the largest dimension of the invasive tumor. In this report, the tumor size is given as 4 x 6 x 7 cm, which indicates that the tumor is larger than 5 cm in its greatest dimension. Therefore, the T stage is T3.",T3,11.0
455,TCGA-A1-A0SF.1617B36B-4EFB-445E-95BC-E63B129AAAE7,1,"Working Draft. CELLULAR CHANGES WITHIN NORMAL LIMITS. Inflammation. SPECIMEN ADEQUACY: Satisfactory for evaluation. Endocervical cells present. Specimen Class: Accessioned: Specimen(s) Received: Endometrium, biopsy. Final Diagnosis. Endometrium, biopsy: Benign dyssynchronous secretory endometrium; no hyperplasia or carcinoma. identified. Specimen Class: Accessioned: Signed Out: (. Specimen(s) Received: Cervical. Endocervical, Direct. Final Diagnosis. Cervical/Endocervical, Direct. CELLULAR CHANGES WITHIN NORMAL LIMITS. Inflammation. Endocervical cells present. SPECIMEN ADEQUACY: Satisfactory for evaluation but limited by obscuring white blood cells. Specimen Class: Accessioned. Specimen(s) Received: Cervical/Endocervical, Direct. Final Diagnosis. Cervical/Endocervical, Direct. CELLULAR CHANGES WITHIN NORMAL LIMITS. SPECIMEN ADEQUACY: Satisfactory for evaluation. Endocervical cells present. Specimen Class: Accessioned. Specimen(s) Received: Bladder Washing. Final Diagnosis. Bladder Washing. BENIGN. Working Draft. Specimen Class: Accessioned: Specimen(s) Received: Urine, catheterized. Final Diagnosis. BENIGN. See Below. Specimen Class: Accessioned. {HighRisk Specimen}. Specimen(s) Received: Vaginal/Cervical/Endocervical. Final Diagnosis. CELLULAR CHANGES WITHIN NORMAL LIMITS. Squamous metaplasia. SPECIMEN ADEQUACY: Satisfactory for evaluation. Endocervical cells present. Specimen Class: Accessioned. Specimen(s) Received: BLADDER WASH. Final Diagnosis. BENIGN. Conversion. Specimen Class: Accessioned: Specimen(s) Received: BLADDER WASH. Final Diagnosis. BENIGN. Conversion. Specimen Class: Accessioned: Specimen(s) Received: BLADDER WASH. Fina) Diagnosis. BENIGN. Conversion. Working Draft. Specimen Class: Accessioned: Specimen(s) Received: VAGINALCERVICAU/ENDOCERVICAI. Final Diagnosis. BETHESDA: CELLULAR CHANGES WITHIN NORMAL LIMITS. BENIGN. Inflammation. Conversion. Specimen Class: Accessioned: Specimen(s) Received: URINE, CATHETERIZED. Final Diagnosis. BENIGN. Conversion. Specimen Class: Accessioned: Signed Out: &. Specimen(s) Received: VAGINAL/CERVICAL/ENDOCERVICAL. Final Diagnosis. DESCRIPTIVE DIAGNOSIS. Diagnosis Deferred. Conversion. Specimen Class: Accessioned: Specimen(s) Received: SITE NOT SPECIFIED. Final Diagnosis. DESCRIPTIVE DIAGNOSIS. Diagnosis Deferred. Inflammation. Conversion. Specimen Class: Accessioned. Specimen(s) Received: VAGINAL/CERVICAL/ENDOCERVICAL. Final Diagnosis. BENIGN. Conversion. FND OF REPORT. Final Pathologic Diagnosis: A. Sentinel lymph node #1, left axilla, biopsy: No carcinoma identified in one lymph. node (0/1). B. Sentinel lymph node #2, left axilla, biopsy: No carcinoma identified in one lymph. node (0/1). Working Draft. C. Left breast, mastectomy;. 1. Infiltrating ductal carcinoma, SBR grade 2, 2.4 cm; see comment. 2. Intermediate to high grade ductal carcinoma in-situ, cribriform and comedo types. 3. Non-proliferative fibrocystic changes. 4. Duct ectasia. D. Right breast, mastectomy: 1. Atypical lobular hyperplasia. 2. Non-proliferative fibrocystic changes. 3. Duct ectasia. 4. Microcalcifications associated with benign ducts and stroma. 5. No carcinoma identified. E. Soft tissue, right breast, excision: Fibroadipose tissue with skeletal muscle; no breast. parenchyma or carcinoma identified. F. Left ovary and fallopian tube, salpingooophorectomy: - Ovary: No significant pathologic abnormality. - Fallopian tube: Benign paratubal cyst. G. Right ovary and fallopian tube, salpingooophorectomy: - Ovary: No significant pathologic abnormality. - Fallopian tube: Benign paratubal cyst. H. Omentum, biopsy: Benign fibrous nodule. I. Soft tissue, left upper peritoneum, biopsy: Benign fibroadipose tissue. J. Omentum, omentectomy: No significant pathologic abnormality. Note: Breast Tumor Synoptic Comment. - Laterality: Left. - Invasive tumor type: Infiltrating ductal. - Invasive tumor size: 2.4 cm maximum diameter. - Invasive tumor grade (modified Bloom-Richardson): Nuclear grade: 3, 3 points. Mitotic count: 7 mitotic figures/1 HPF, 1 point. Tubule/papilla formation: > 10% but <75%, 2 points. Total points and SBR grade - 6 points, grade 2. - Lymphatic-vascular invasion: None identified. - Perineural invasion: None identified. - Invasive tumor necrosis: None identified. - Mononuclear cell reaction: None/minimal. - Resection margins for invasive tumor: Widely clear. - Deep margin: Widely clear; closest distance of tumor 2 cm. - Medial margin: Widely clear; closest distance of tumor > 6 cm. - Lateral margin: Widely clear; closest distance of tumor 2.8 cm. Anterior/superior margin: Widely clear; closest distance of tumor 5.5 cm. Anterior/inferior margin: Widely clear; closest distance of tumor >6 cm. - Ductal carcinoma in situ (DCIS) type: Cribriform and comedo. - Ductal carcinoma in situ size: ~2.0 cm in maximum diameter. Ductal carcinoma in situ nuclear grade: Intermediate to high grade. - Necrosis in ductal carcinoma in situ: Present. - Microcalcifications: Not identified. Working Draft. - Resection margins for ductal carcinoma in situ: Widely clear (see above for invasive tumor. - Lobular carcinoma in situ (LCIS): Not identified. - Number of lobules involved: N/A. - Nuclear type/size: N/A. - Resection margins for pleomorphic lobular carcinoma in situ: N/A. - Lymph node status: Negative. - Number of positive lymph nodes: 0. - Total number sampled: 2. - AJCC/UICC stage: pT2NOMx. - Nontumorous breast tissue: Non-proliferative fibrocystic change; duct ectasia. - Nipple: Unremarkable. - Skin/dermis: Unremarkable. Pagetoid spread of carcinoma is seen in benign ducts adjacent to the tumor. No such spread is seen away. from the tumor. Atypical lobular hyperplasia is present in the contralateral (right) breast. An immunohistochemical test for estrogen and progesterone receptors as well as for HER2 was performed. on block C3. The test for estrogen receptors is positve. There is moderate nuclear staining in >95% of tumor cells. Internal positive control is positive. The test for progesterone receptors is positive. There is moderate to strong nuclear staining in 90% of. tumor cells. Internal positive control is positive. Result of HER2/neu test: This carcinoma is negative for HER2/neu oncoprotein over-expression. An immunohistochemical assay was performed using the CB11 monoclonal antibody to HER2/neu. oncoprotein. The staining intensity of this carcinoma was 1 on a scale of 0-3 (HER2 test interpreted by. Dr. Carcinomas with staining intensity scores of o or 1 are considered negative for over-expression of HER2/neu oncoprotein. Those with a staining intensity score of 2 are considered borderline. We and others have observed that many carcinomas with staining. intensity scores of 2 do not show gene amplification. All carcinomas with staining intensity scores of 2 are therefore submitted for. FISH testing. The results of the FISH test are issued directly from the molecular cytogenetics laboratory. Carcinomas with staining intensity scores of 3 are considered positive for over-expression of HER2/neu oncoprotein. Tumors in this. category show an excellent correlation between the results of immunohistochemical and FISH testing, and almost always show gene. amplification. Intraoperative Consult Diagnosis. FS1 (A) Sentinel lymph node # 1, left axilla, biopsy: No carcinoma. FS2 (B) Sentinel lymph node #2, left axilla, biopsy: No carcinoma. FS3 (G) Right adnexa, salpingo-oophorectomy: Paratubal cyst with hemorrhage. FS4 (H) Omentum, biopsy: Dense fibrous connective tissue, no carcinoma. FS5 (I) Left upper quadrant, peritoneum, biopsy: No carcinoma. F. Left adnexa, salpingo-oophorectomy: Paratubal cyst (gross diagnosis only). Clinical History. Working Draft. The patient is a .year-old woman with left breast cancer. She undergoes bilateral mastectomies. Gross Description. The specimen is received in ten parts, each labeled with the patient's name and unit number. Parts A. through I are received fresh, and Part J is received in formalin. Part A, additionally labeled ""1. consists of one pink, unoriented,. fibroadipose tissue fragment measuring 1.5 x 0.8 x 0.8 cm. The entire specimen is frozen for frozen. section diagnosis 1, and subsequently submitted in cassette A1. Part B, additionally labeled. consists of one pink-red, unoriented,. fibroadipose tissue fragment measuring 1.3 x 0.8 x 0.7 cm. The entire specimen is frozen for frozen. section diagnosis 2, and subsequently submitted in cassette B1. Part C is additionally labeled. It consists of a mastectomy specimen, measuring. 15.8 cm from superior to inferior, 15.6 cm from medial to lateral, and 8.2 cm from anterior to posterior. The specimen weighs 442.5 gm. In the lateral aspect of the specimen is a spiculated, firm, tan mass,. measuring 2.4 x 1.2 x 1.2 cm. This mass is 2.0 cm from the deep margin, 5.5 cm from the superior. margin, >6 cm from the inferior margin, 2.8 cm from the lateral margin, and >6 cm from the medial. margin. In the anterior-inferior portion of the breast, there are dilated ducts, filled with cheesy material. This area is 0.2 cm from the deep margin. The remainder of the breast parenchyma is unremarkable. Two. pieces of tumor are banked, one for tissue banking and one for the epithelial cell study. Representative. sections are submitted as follows: Cassette C1: Nipple. Cassettes C2-C3: Spiculated mass. Cassette C4: Deep margin beneath tumor. Cassette C5: Lateral margin. Cassette C6: Lower outer quadrant. Cassette C7: Lower inner quadrant. Cassette C8: Medial margin. Cassette C9: Upper inner quadrant. Cassette C10: Anterior-inferior area with duct ectasia. Part D is additionally labeled. It consists of a mastectomy specimen, measuring. 18.2 cm from superior to inferior, 16.2 cm from medial to lateral, and 4.8 cm from anterior to posterior. The specimen weighs 688 gm. A short stitch is designated by the surgeon as superior, and a long stitch is. designated by the surgeon as lateral. In the inferior-medial portion of the specimen is a fragment of skin,. measuring 7.5 x 4.9 cm. It is white and unremarkable. There is a nipple, measuring 1.3 x 1.5 x 1.6 cm. The specimen is notable for dilated ducts with a viscous, yellow-tan material within them. This material. extends into one of the nipple ducts. No masses are noted, nor are any areas suspicious for DCIS. appreciated. The anterior-superior portion of the specimen is inked blue, the anterior-inferior portion of. the specimen is inked green, and the posterior aspect of the specimen is inked black. Multiple sections of. unremarkable breast parenchyma are taken for two studies, including a high-risk study and an epithelial. cell study. Representative sections are submitted as follows: Cassettes D1-D2: Nipple and surrounding skin. Cassette D3: Representative section of anterior-inferior breast with dilated duct. Cassette D4: Representative section of lower inner breast with dilated ducts. Cassette D5: Representative section of upper inner breast. Cassette D6: Representative section of medial breast. Cassette D7: Representative section of upper outer breast. Cassette D8: Representative section of upper inner breast. Cassette D9: Representative section of lateral breast. Part E is additionally labeled. It consists of a single irregular fragment of soft, yellow tissue, measuring 5.4 x 3.8 x 1.5 cm. A suture. has been placed on one aspect of the specimen and is designated the new margin. That aspect of the. specimen is inked black, and the specimen is serially sectioned and entirely submitted in cassettes E1. through E5. Part F is received fresh labeled,. It consists of an. Working Draft. ovary, measuring 4.3 x 2 x 0.8 cm, with attached fallopian tube, measuring 0.8 x 0.5 x 6 cm. There is a. simple paratubal cyst, measuring 1.5 x 1.5 x 0.5 cm. This is received undisrupted, with a thin 0.1 cm. translucent wall, and contains 20 CC of clear fluid. In addition, there is a second small paratubal cyst,. measuring 0.5 x 0.5 x 0.5 cm. The ovary is serially sectioned, and no abnormalities are detected, other. than a 0.5 x 0.5 x 0.5 cm small white firm area. The fallopian tube is serially sectioned, and no. abnormalities are detected. Cassettes are submitted as follows: Cassettes F1-F9: Ovary, entirely submitted (firm, white area in cassette F7). Cassettes F10-F12: Fallopian tube, entirely submitted. Cassette F13: Representative section of the paratubal cyst and smaller, 0.5-cm paratubal cyst. Cassette F14: Representative section of broad ligament. Part G is additionally labeled. It consists of an ovary with attached fallopian tube,. weighing 15.9 gm. There is a disrupted hemorrhagic, cystic mass in the broad ligament, measuring 2.3 x. 1.6 x 1.5 cm, no capsule is visualized. A representative section of the cystic mass is submitted for frozen. section diagnosis as FS3. The ovary and tube do not appear involved by the lesion. The ovary is inked. black, it contains a simple corpus luteal cyst measuring 1.5 x 1.6 x 0.8 cm. The ovary measures 3.5 x 3. x. 1 cm, and the tube measures 6.5 x 0.8 cm. The ovary and fallopian tube are serially sectioned, and no. abnormalities are detected. Cassettes are submitted as follows: Cassettes G1-G6: Ovary, entirely submitted. Cassettes G7-G10: Fallopian tube, entirely submitted. Cassettes G11-G12: Lesion in broad ligament, entirely submitted. Cassette G13: Frozen section remnant. Part H is additionally labeled. It consists of an unoriented piece of yellow,. adipose tissue, measuring 5 x 1.3 x 0.4 cm, with a white-tan, soft nodule, measuring 0.3 x 0.3 x 0.3 cm,. attached to one end. This is entirely submitted for frozen section diagnosis as FS4, with the frozen. section remnant submitted in cassette H1. The remaining omentum is entirely submitted in cassette H2. Part I is additionally labeled. It consists of multiple unoriented. fragments of tissue, measuring 1 x 0.3 x 0.1 cm in aggregate. The specimen is entirely submitted for. frozen section diagnosis as FS5, with the frozen section remnant submitted in cassette 11. Part J is additionally labeled. It consists of an aggregate of fatty tissue, measuring 4 x 2 x 0.5. cm. No abnormalities are detected. Tne specimen is entirely submitted in cassettes J1 through J3. /Pathology Resident. Fee Codes: Other Specimens. Specimen Class: Accessioned: Specimen(s) Received: Right Breast, Fine Needle Aspiration. Final Diagnosis. Right Breast, Fine Needle Aspiration: Benign scar tissue, see comment. Working Draft. Specimen Class: Accessioned: Specimen(s) Received: Vaginal/Cervical/Endocervical, Thin Prep Imaged. Final Diagnosis. Vaginal/Cervical/Endocervical, Thin Prep Imaged. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. Reactive cellular changes. Atrophic changes. SPECIMEN ADEQUACY: Satisfactory for evaluation. Transformation zone components are present. Specimen Class: Accessioned. Specimen(s) Received: Right Breast, implant capsule. Final Diagnosis. Right breast, implant capsule, capsulectomy: Peri-prosthetic capsule. Specimen Class: Accessioned. Specimen(s) Received: Cervical/Endocervical, Thin Prep Imaged. Final Diagnosis. Cervical/Endocervical, Thin Prep Imaged. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. Atrophic changes. SPECIMEN ADEQUACY: Satisfactory for evaluation. No transformation zone components are identified. Specimen Class: Accessioned: Specimen(s) Received: Endometrium, biopsy. Final Diagnosis. Endometrium, biopsy: Fragments of benign endocervical tissue and no definitive. endometrium, see comment. Working Draft. Specimen Class: Accessioned: Specimen(s) Received: Cervical/Endocervical, Thin Prep Imaged. Final Diagnosis. Cervical/Endocervical, Thin Prep Imaged. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. Atrophic changes. SPECIMEN ADEQUACY: Satisfactory for evaluation. Transformation zone components are present. Specimen Class: Accessioned. Specimen(s) Received: A: Left breast capsule, B: Right breast capsule. Final Diagnosis. A. Breast capsule, left, excision: Dense fibrous tissue with chronic inflammation. B. Breast capsule, right, excision: Dense fibrous tissue with chronic inflammation. Specimen Class: Accessioned: Specimen(s) Received: Cervical/Endocervical, Thin Prep Imaged. Final Diagnosis. Cervical/Endocervical, Thin Prep Imaged. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. Atrophic changes. SPECIMEN ADEQUACY: Satisfactory for evaluation. Transformation zone components are present. Specimen Class: Accessioned: Specimen(s) Received: A: Skin, biopsy, shave, right scalp, B: Skin, biopsy, shave, left scalp, C: Skin, biopsy, punch, left upper. arm. Final Diagnosis. (Final Report Not Signed Out}. {Not Entered}. Specimen Class: Accessioned. Specimen(s) Received: A: Pelvic Washing, B: Diaphragm Washing. Working Draft. Final Diagnosis. A: Pelvic Washing. BENIGN. Reactive mesothelial cells. B: Diaphragm Washing. BENIGN. Reactive mesothelial cells. Specimen Class: Accessioned: Specimen(s) Received: Left Breast, Fine Needle Aspiration. Final Diagnosis. Left Breast, Fine Needle Aspiration: Adenocarcinoma, morphologically consistent. with a primary breast carcinoma. Specimen Class: Accessioned. Specimen(s) Received: Cervical/Endocervical, Thin Prep Imaged. Final Diagnosis. Cervical/Endocervical, Thin Prep Imaged. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. Reactive cellular changes. SPECIMEN ADEQUACY: Satisfactory for evaluation. Transformation zone components are present. Specimen Class: Accessioned: Specimen(s) Received: Right foot foreign body. Final Diagnosis. Foot, right, excision: Fragment of hyperkeratotic squamous epithelium. Specimen Class: Accessioned. Specimen(s) Received: Cytology, GYN, Site Not Specified, Thin Prep. Final Diagnosis. Cytology, GYN, Site Not Specified, Thin Prep. Working Draft. NEGATIVE FOR INTRAEPITHELIAL. LESION OR MALIGNANCY. Reactive cellular changes. SPECIMEN ADEQUACY: Satisfactory for evaluation. Transformation zone components are present. Specimen Class: Accessioned. Specimen(s) Received: Cervical/Endocervical, Thin Prep. Fina) Diagnosis. Cervical/Endocervical, Thin Prep. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. SPECIMEN ADEQUACY: Satisfactory for evaluation. Transformation zone components are present. Specimen Class: Accessioned. Specimen(s) Received: Vaginal/Cervical/Endocervical, Direct. Final Diagnosis. Vaginal/Cervical/Endocervical,Direct. CELLULAR CHANGES WITHIN NORMAL LIMITS. Endocervical cells present. SPECIMEN ADEQUACY: Satisfactory for evaluation but limited by obscuring white blood cells. Gpecimen Class: Accessioned: Specimen(s) Received: Skin, biopsy, left chin. Final Diagnosis. {Final Report Not Signed Out}. (Not Entered}. Specimen Class: Accessioned. Specimen(s) Received: Cervical, Direct. Final Diagnosis. Cervical, Direct.",BRCA,0,"Based on the report, the largest dimension of the invasive tumor is 2.4 cm, which falls within the range for T2 (tumor size 2.1 to 5.0 cm).",T2,12.0
675,TCGA-A8-A09K.56C24ABB-CF1D-447F-A5A8-B762C4B01566,0,"Diagnosis: 4. Resected material from'l left breast segment with a 1.4 cm poorly differentiated (G3). invasive ductal breast carcinoma. Carcinoma-free resection margins, carcinoma-free skin. Fibrous mastopathy of surrounding tissue. Tumor stage: pTlc pN1mi (intranodal micrometastasis), MX, R0; G3 (L0, V0).",BRCA,1,"The report states that the tumor size is 1.4 cm, which falls under the 'T1' category of up to 2.0 cm.",T1,13.0
666,TCGA-A8-A097.5B867CB6-F94D-435D-83E3-0ADB814B8077,1,"Diagnosis: 1. Poorly differentiated invasive ductal carcinoma with a discrete. intraductal component (tumor diameter 2.8 cm). Provisional tumor classification: NOS, G III, pT2 N1mi(sn)LOVORO.",BRCA,1,"The report states that the tumor diameter is 2.8 cm, which falls within the range for a T2 stage tumor (2.1 to 5.0 cm).",T2,14.0
476,TCGA-A2-A0CK.B065FC65-CD33-4878-AE2C-7E8C04F5ECAB,2,"I. Specimen #: (Age : ) F Race : WHITE. Physician (s) : AMENDED / ADDENDUM: SPECIMEN: RIGHT BREAST TISSUE. FINAL DIAGNOSIS: BREAST, RIGHT INFERIOR LATERAL RETRO-AREOLA, EXCISION : INFILTRATING LOBULAR CARCINOMA. SURGICAL MARGINS POSITIVE FOR TUMOR. TUMOR SIZE: 0.5 CM BY MICROSCOPY. LOBULAR CARCINOMA IN SITU. PERINEURAL INVOLVEMENT BY CARCINOMA. MICROCALFICIATIONS IDENTIFIED. AJCC STAGING: STAGE I (T1, NX, MX), SEE COMMENT. COMMENT: (visiting pathology resident from. discussed the. above diagnosis with Dr. on. at. AMENDMENT. At the request of the clinician, tumor was evaluated for HER2-neu -. overexpression by immunohistochemical methods (DAKO HercepTest) with. the. following results: HER2/neu overexpression: NEGATIVE (1+). COMMENT: Membranous staining is interpreted on a scale of 0 to 3+ with. positivity defined as 2+ or qreater. Test performed at. Interpretation rendered by. -5. Specimen #: ADDENDUM: HER2/NEU BY FISH = 1.1 NOT AMPLIFIED. TEST: FISH for detection of HER2-neu gene amplification (Path Vision Her2. DNA probe by Vysis) Ratio of Her2-neu over chromosome 17 signals. RANGE FOR INTERPRETATION. Ratio less than 2.0 HER2-neu gene amplification not observed. Ratio equal to or greater than 2.0: HER2-neu gene amplification. observed. ER/PR IMMUNOSTAINS ARE NEGATIVE. C. INICAL DIAGNOSIS AND HISTORY: YO FEMALE WITH SMALL 1X.6CM COMPLEX MASS BY U/S AT INFERIOR/LATERAL. RETROAREOLAR. PRE-OPERATIVE DIAGNOSIS: FIBROUS TISSUE VS MALIGNANCY. POST-OPERATIVE DIAGNOSIS: Post-operative Diagnosis: SAA. GROSS DESCRIPTION: RIGHT BREAST TISSUE ""inferior lateral retro-areola"" consists of a single. irregularly shaped fragment of fibro fatty tissue, which previously has. been inked and sectioned. When reapproximated, the specimen measures 2 x. 1 x 1 cm. The previous sectioning reveals that the specimen is mostly fat. with admixed fibrous tissue. The specimen is placed in its entirety. in the 5 gray cassettes marked. A1-A5. The specimen was previously. inked blue before being received by this observer.",BRCA,2,"The report states that the 'TUMOR SIZE: 0.5 CM BY MICROSCOPY', and according to the rules provided, T1 corresponds to a tumor size up to 2.0 cm. Therefore, the T stage for this patient is T1.",T1,15.0
456,TCGA-A1-A0SG.89A67051-898A-4E2A-A874-E0165F274E63,1,"Final Pathologic Diagnosis: A. Right axillary sentinel lymph node #1, count = 3500, dissection: Metastatic. adenocarcinoma in one of two lymph nodes (1/2). B. Right axillary sentinel lymph node #2, count = 500, dissection: No tumor in two. lymph nodes (0/2). C. Right breast, partial mastectomy: 1. Invasive micropapillary carcinoma, 2.1 cm, associated with microcalcifications; see. comment. 2. Atypical lobular hyperplasia. 3. Fibroadenoma. 4. Microcalcifications in benign ducts. D. Sentinel lymph node #3, count = 350, dissection: No tumor in two lymph nodes. (0/2). Note: Breast Tumor Synoptic Comment. - Laterality: Right. - Invasive tumor type: Invasive micropapillary carcinoma. - Invasive tumor size: 2.1 cm maximum diameter. The tumor is present in slices 4, 5, 9, and 10; however. the tumor has been banked from slices 6, 7, and 8. Therefore, the tumor extends through seven. consecutive slices, each with a width of approximately 0.3 cm, for a total maximum diameter of 2.1 cm. - Invasive tumor grade (modified Bloom-Richardson): 2. Nuclear grade: 3, 3 points. Mitotic count: < 10 mitotic figures/1 HPF, 1 point. Tubule/papilla formation: Definite tubule formation in <10%, 3 points. Working Draft. Total points and SBR grade - 7 points, grade 2. - Lymphatic-vascular invasion: None identified. - Perineural invasion: None identified. - Resection margins for invasive tumor: - Deep margin: Negative (1 cm). - Medial margin: Negative (0.9 cm). - Lateral margin: Negative (0.6 cm). - Anterior/superio: margin: Negative (0.5 cm). - Anterior/inferior margin: Negative (greater than 1 cm). - Ductal carcnoma in situ (DCIS) type: None identified. Microcalcifications: Present involving both benign ducts and invasive carcinoma. - Lobular carcinoma in situ (LCIS): None identified. - Lymph node status: - Number of positive lymph nodes: 1. - Total number sampled: 6. - Diameter of largest metastasis: 2.1 mm. - Extranodal extension: Absent. - AJCC/UICC stage: pT2N1aMX. - Nontumorous breast tissue: Atypical lobular hyperplasia, fibroadenoma, and sclerosing adenosis. - Additional comments: We reviewed the original frozen section slides and concur with the frozen section. diagnosis rendered. The metastatic tumor in Part A was only present in the additionally submitted. sections of the lymph node (slide A2). Level sections on A2-A4 confirms the diagnosis. Select slides from. part C were shown at the. the faculty in attendance concurred. with the above diagnosis of micropapillary type of invasive carcinoma. Dr. has reviewed A2. and concurs with the diagnosis. An immunohistochemical test for estrogen and progesterone receptors was performed on block C9. The test for estrogen receptors is positive. There is 3+ nuclear staining in >95% of tumor cells. The test for progesterone receptors is positive. There is 3+ nuclear staining in >95% of tumor cells. Result of HER2/neu test: This carcinoma is negative for HER2/neu oncoprotein over-expression. An immunohistochemical assay was performed on block C9 using the CB11 monoclonal antibody to. HER2/neu oncoprotein. The staining intensity of this carcinoma was 1 on a scale of 0-3. Carcinomas with staining intensity scores of 0 or 1 are considered negative for over-expression of HER2/neu oncoprotein. Those with a staining intensity score of 2 are considered indeterminate. We and others have observed that many carcinomas with. staining intensity scores of 2 do not show gene amplification. All carcinomas with staining intensity scores of 2 are therefore. submitted for FISH testing. The results of the FISH test are issued directly from the molecular cytogenetics laboratory. Carcinomas with staining intensity scores of 3 are considered positive for over-expression of HER2/neu oncoprotein. Tumors in this. category show an excellent correlation between the results of immunohistochemical and FISH testing, and almost always show gene. amplification. Slide A2 was shown at the departmental Consensus Conference, and the faculty in attendance concurred. with the above diagnosis. Intraoperative Consult Diagnosis. FS1 (A) Right axillary SLN #1, biopsy: Negative for carcinoma. (Dr. Clinical History. The patient is a. year-old woman with right breast carcinoma. Working Draft. Gross Description. The specimen is received in four parts, each labeled with the patient's name and medical record number. Part A is received fresh and labeled. It consists of one pink-yellow,. soft, fatty tissue that measures 3.1 x 2.5 x 0.8 cm. The specimen is strained and two candidate lymph. nodes are found, the smallest is inked blue and submitted with a representative section of the largest. submitted for frozen diagnosis #1, thereafter submitted in cassette A1. The remnant of the largest lymph. node is transected and entirely submitted in cassettes A2-A3, and the remnant of the yellow fatty tissue is. submitted in cassette A4. Part B, additionally labeled. consists of a single fragment of yellow,. fibrofatty tissue measuring 2 x 1.8 x 0.4 cm. The specimen is entirely submitted in cassette B1. Part C, additionally labeled. consists of a right breast specimen oriented. with a short superior and a long stitch lateral. The specimen measures 3.2 cm from anterior to posterior,. 5 cm from medial to lateral and 6.5 cm from superior to inferior. The resection margins are inked as. follows for microscopic evaluation: anterior superior in blue, anterior inferior in green and posterior in. black. The specimen is serially sectioned from medial to lateral into twelve slices. There is gray-white,. fibrous tissue in the superior half of the specimen in slices 3-11, measuring 2.4 x 2 x 1.5 cm. White. fibrous tissue extends from this area to the anterior inferior aspect in slices 5-8. The gray-white fibrous. tissue appears extend to the inked margin in the posterior superior aspect of slices 3 and 4, and appears. to be 0.5 cm from the anterior superior inked margins in slices 5 and 9. Representative sections are. submitted as follows: Cassette C1: Representative medial margin, slice 1, bread-loafed. Cassette C2: Representative section of slice 3. Cassettes C3-C5: Slice 4. Cassette C6: Representative section of slice 5. Cassette C7: Representative section of slice 6. Cassette C8: Representative section of slice 8. Cassette C9: Representative section of slice 9. Cassettes C10-C11: Representative sections of slice 10. Cassette C12: Representative section of slice 11. Cassette C13: Representative lateral margin, slice 12, bread-loafed. Part D, additionally labeled. consists of a single, yellow, fibrofatty tissue fragment. measuring 2.5 x 1.5 x 0.4 cm. The specimen is entirely submitted in cassette D1. The immunoperoxidase stain(s) reported above were developed and their performance characteristics determined by the. They have not been cleared or approved by the U. S. Food and Drug Administration The FDA has. determined that such clearance or approval is not necessary. These tests are used for clinical purposes. They should not be regarded. as. investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (""CLIA""). as qualified to perform high-complexity clinical testing. Fee Codes: Other Specimens. pecimen Class: Accessioned: Specimen(s) Received: Right axillary contents. Final Diagnosis. Axilla, right, ""contents,"" excision: 1. Scar tissue, fat necrosis and suture with giant cell reaction. No malignancy is. identified. Working Draft. 2. No metastatic tumor identified in five lymph nodes. (0/5). Specimen Class: Accessioned: Specimen(s) Received: Final Diagnosis. Review of. from : Breast, right, 10 o'clock, core biopsies: Infiltrating ductal carcinoma, SBR Grade 2; see. comment. FND OF REPORT.",BRCA,1,"The T stage is based on the largest dimension of the invasive tumor. In this report, the invasive tumor size is given as 2.1 cm, which falls within the range for a T2 stage tumor (T2: tumor size 2.1 to 5.0 cm).",T2,16.0
558,TCGA-A2-A3XZ.A7B6FCF6-1B81-40B5-AD92-54681CBC8FE0,0,"1. y. /F. Speciment. Spec Type: SURGICAL P. PREOPERATIVE DIAGNOSIS. LEFT BREAST CANCER INVASIVE. OPERATION PERFORMED. DOCTOR (s) : PROCEDURE: MASTECTOMY COMPLETR/SIMPLE w/ SENTINED NODE BX. TISSUE REMOVED. A. LT SIMPLE MASTECTOMY. B. LT AXILLA SENTINEL NODE #1. C. LT UPPER INNER CORE BX. D. LT BREAST SUPERFICIAL MARGIN. E. LT AXILLA SENTINEL NODE #2. GROSS DESCRIPTION. PART A RECEIVED FRESH LABELED. LEFT SIMPLE MASTECTOMY. STITCH 12 O' CLOCK, IS A LEFT SIMPLE MASTECTOMY SPECIMEN MEASURING 16 x 16. x 3.5 CM. THE NIPPLE IS UNREMARKABLE WITHIN A 7.5 x 4.2 CM SKIN ELLIPSE. BLUE DYE IS NOTED IN THE SUPERIOR 12 O'CLOCK AREA OF THE BREAST. THE. SUPERFICIAL ASPECT IS MARKED WITH BLUE INK, THE DEEP WITH BLACK. AN M. CLIP IS IDENTIFIED IN THE UPPER INNER QUADRANT MEDIAL ASPECT, ASSOCIATED. WITH A PINK-TAN NODULE AT THE SUPERFICIAL MARGIN MEASURING 0.9 x 0.5 x. 1.2 CM. THIS IS 1.3 CM FROM THE DEEP MARGIN, 1 CM FROM THIS IS A 0.3 CM. FIRM GRAY-TAN AREA WHICH IS 1 CM FROM THE SUPERFICIAL MARGIN AND 1.1 CM. FROM THE DEEP MARGIN GROSSLY. IN THE 11 O'CLOCK AREA THERE IS AN. ELONGATED IRREGULAR PINK-TAN FIRM AREA WHICH ALSO EXTENDS GROSSLY TO THE. SUPERFICIAL MARGIN. THIS MEASURES 3.5 x 0.9 AND IS 1.5 CM IN GREATEST. DIMENSION. THIS LESION IS GROSSLY 3 CM FROM THE FIRST DESCRIBED LESION. THIS LESION GROSSLY EXTENDS TOWARDS THE SUPERFICIAL MARGIN AND IS 1.2 CM. FROM THE DEEP MARGIN. THE BREAST TISSUE ITSELF HAS AN OVERALL INDURATED. QUALITY TO PALPATION WITH A DIFFUSE YELLOW-GRAY APPEARANCE. THE INFERIOR. AND LATERAL ASPECTS DEMONSTRATE A MORE FATTY APPEARANCE. ALSO IN THE. AREA OF THE UPPER INNER QUADRANT, THE PARENCHYMA HAS MULTIPLE SMALL. PALPABLE LESIONS. THIS IS IN THE AREA OF THE BLUE DYE. IT IS SECTIONED. TO DEMONSTRATE THIS WHICH IS SLIGHTLY INFERIOR AND TOWARD THE NIPPLE FROM. THE SECOND DESCRIBED LESION SUBMITTED IN A10 (MIRROR IMAGE TO PROTOCOL). RANDOM TISSUE IS ALSO TAKEN FROM THE 9 O'CLOCK AREA WHICH HAS THIS. DIFFUSE INDURATED QUALITY. THE SECTIONS ARE SUBMITTED AS FOLLOWS: A1--NIPPLE AND SKIN (MIRROR IMAGE TO PROTOCOL), A2--10 O'CLOCK PERIPHERAL. LESION TO INCLUDE SUPERFICIAL AND DEEP MARGINS (MIRROR IMAGE TO. PROTOCOL), A3--10 O'CLOCK LESION (MIRROR IMAGE TO PROTOCOL), A4--MMALL. 0.3 CM NODULE WITHIN TISSUE (MIRROR IMAGE TO PROTOCOL), 15--SECTION OF 11. O'CLOCK LESION (MIRROR IMAGE TO PROTOCOL), A6 THROUGH A8--FOR. CROSS-SECTION OF 11 ''CLOCK LESION TO INCLUDE THE MOST SUPERIOR AND. SUPERFICIAL, DEEP AND SUPERFICIAL INFERIOR ASPECT OF LESIONS TO INCLUDE. SUPERFICIAL MARGIN RESPECTIVELY, A9--11 O'CLOCK LESION (MIRROR IMAGE TO. Speciment. Spec Type: SURGICAL p. GROSS DESCRIPTION. PROTOCOL), A10--TISSUE UPPER OUTER QUADRANT, A11--TISSUE 9 0'CLOCK A. REGION, A12-UPPER OUTER QUADRANT 4 CM FROM THE 11 O'CLOCK LESION (MIRROR. IMAGE TO PROTOCOL). 13--LOWER OUTER QUADRANT 8 CM FROM THE LESION. (MIRROR IMAGE TO PROTOCOL), A14--LOWER INNER QUADRANT. PART B RECEIVED FRESH LABELED. LEFT AXILLA FIRST SENTINEL. NODE HOT AND BLUE, IS A AN OVOID PORTION OF PINK-TAN SOFT TISSUE. MEASURING 2.5 x 1.3 x 1.0 CM. SECTIONING REVEALS A 1.8 CM GROSSLY. UNREMARKABLE LYMPH NODE WITHOUT OBVIOUS BLUE COLORATION. ONE HALF IS. SUBMITTED LABELED B. THE REMAINDER IS SUBMITTED PER PROTOCOL. PART C RECEIVED LABELED. LEFT UPPER INNER CORE BIOPSY. SITE, IS AN UNORIENTED ELLIPTICAL PORTION OF BROWN SKIN AND UNDERLYING. INDURATED FATTY TISSUE. THE SKIN ELLIPSE IS 1.4 x 0.5 CM. THE. UNDERLYING TISSUE MEASURES 2.1 x 0.9 x 1.8 CM. ON THE SKIN SURFACE THERE. IS A RAISED CENTRAL LESION 0.5 CM DIAMETER. THE MARGIN IS MARKED WITH. INK. THE SPECIMEN IS SECTIONED ACROSS THE NARROW MARGIN OF THE SKIN AND. THE 2 EXTREME ENDS (ELLIPTICAL END OF THE SKIN ARE SUBMITTED IN C1 WITH. THE CENTRAL TISSUE IN C2). PART D RECEIVED LABELED. LEFT BREAST SUPERFICIAL MARGIN IS. AN IRREGULAR ELONGATED FRAGMENT OF YELLOW-PINK FATTY TISSUE MEASURING 8.5. x 2.1 x 0.5 CM IN GREATEST DIMENSION. THE SPECIMEN IS NOT OTHERNISE. ORIENTED. ONE SIDE HAS A DULL APPEARANCE AND IS MARKED WITH BLUE INK. THE OPPOSITE SIDE IS MARKED YELLOW. THIS IS SECTIONED AND ENTIRELY. SUBMITTED LABELED D1 THROUGH D5. PART E RECEIVED FRESH LABELED. LEFT AXILLA SECOND SENTINEL. NODE HOT, IS AN OVOID PORTION OF YELLOW-PINK FATTY TISSUE MEASURING 2.9. x. 1.7 x 1.0 CM. SECTIONING REVEALS A 1.8 CM GROSSLY UNREMARKABLE LYMPH. NODE QUBMITTED ENTIRELY LABELED E. PATH PROCEDURES. PROCEDURES: 88307/5, IMMUNOPEROXIDAS/2, A BLK/14, BBX x6, C BLK/2, D BLK/5, EBX X6. FINAL DIAGNOSTS. PART. A LEFT SIMPLE MASTECTOMY MULTICENTRIC IN SITU AND INFILTRATING. DUCT CARCINOMA WITH AT LEAST FOUR SEPARATE FOCI OF TUMOR PRESENT. THE 10. O'CLOCK NODULE SHOWED IN SITU AND MODERATELY DIFFERENTIATED INFILTRATING. DUCT CARCINOMA, NUCLEAR GRADE III/III WITH A HIGH MITOTIC INDEX,. ASSOCIATED WITH A PREVIOUS BIOPSY SITE WITH APPROXIMATELY 1.0 CM OF IN. SITU AND 1.2 CM OF INVASIVE CARCINOMA. THIS LESION EXTENDED TO WITHIN. LESS THAN 1 MM OF THE SUPERFICIAL MARGIN. IN THE 11 O'CLOCK POSITION,. APPROXIMATELY 1.9 CM OF INVASIVE CARCINOMA WAS PRESENT ASSOCIATED WITH. 2.2 CM OF DUCT CARCINOMA IN SITU SHOWING SIMILAR NUCLEAR GRADE AND. HISTOMORPHOLOGY. THIS LESION WAS 5 MM FROM THE DEEP MARGIN AND WAS. specimens. Spec Type: SURGICAL P. FINAL DIAGNOSIS. ASSOCIATED WITH A PREVIOUS BIOPSY SITE. THE PREVIOUS BIOPSY SITE. EXTENDED TO THE SUPERFICIAL MARGIN. A SECTION OF BREAST TISSUE FROM THE. UPPER OUTER QUADRANT OF THE BREAST SHOWED APPROXIMATELY 1.1 CM OF DUCT. CARCINOMA IN SITU AND 0.5 CM OF INVASIVE CARCINOMA WITH SIMILAR. HISTOMORPHOLOGY. AN ADDITIONAL NODULE FROM THE UPPER INNER QUADRANT OF. THE BREAST SHOWED CHANGES OF A PREVIOUS BIOPSY SITE BUT NO RESIDUAL TUMOR. PARTS B AND E LEFT AXILLARY SENTINEL LYMPH NODES NUMBERS 1 AND. BIOPSIES: LYMPH NODES WITH NO EVIDENCE OF METASTATIC DISEASE, SUPPORTED. BY NEGATIVE CYTOKERATIN IMMUNOHISTOCHEMICAL STAINING. PART C LEFT UPPER INNER CORE BIOPSY SITE, REEXCISION: SKIN AND BREAST. TISSUE CONTAINING A PREVIOUS NEEDLE CORE BIOPSY SITE ASSOCIATED WITH. REACTIVE FIBROSIS AND INFLAMMATION. NO RESIDUAL TUMOR IDENTIFIED. THE. PREVIOUS BIOPSY CHANGES EXTEND INTO THE DERMIS. UIQ s-exe - tumor. PART D LEFT BREAST SUPERFICIAL MARGIN, REEXCISION: ADIPOSE TISSUE WITH. NO EVIDENCE OF MALIGNANCY. CODE. 1. (prelim.). (signature on file).",BRCA,0,"Based on the report, there are at least two separate foci of tumor with the largest one measuring approximately 2.1 cm in greatest dimension (11 o'clock position) and extending to within 5 mm of the deep margin. This meets the criteria for a T2 stage tumor (T2: tumor size 2.1 to 5.0 cm).",T2,17.0
545,TCGA-A2-A25C.1D4CA1BA-B534-4CEA-ABA5-EF9B31694204,1,"Specimen: spec Type: SURGICAL P. LEFT BREAST CANCER INVASIVE. DOCTOR (S) : PROCEDURE: SENTNEL, NODE BX/STMPLE MASTRCTOMY. A. LT BREAST SIMPLE MASTECTOMY. B. LT SENTINEL NODE #1. C. LT SENTINEL NODE #2. RECEIVED IN 3 PARTS. PART A RECEIVED LABELED. SIMPLE LEFT BREAST. MASTECTOMY STITCH AT 12 O' CLOCK, IS A SIMPLE MASTECTOMY SPECIMEN. MEASURING 17.5 x 16 x 2.8 CM. THE NIPPLE IS UNREMARKABLE WITHIN A 9 x. 2.5-CM SKIN ELLIPSE. ADDITIONALLY WITHIN THE CONTAINER ARE 2 IRREGULAR. FRAGMENTS OF FATTY TISSUE WITH NO PALPABLE MASSES TOGETHER MEASURING 4.5. x 3 x 0.5 CM. THE SUPERFICIAL ASPECT IS MARKED WITH BLUE INK, THE DEEP. WITH BLACK. SECTIONING REVEALS 2 DISCRETE GRAY FIBROUS NODULES; THE MOST. LATERAL IS AT 3 O'CLOCK MEASURING 1.5 x 1.1 x 1.5 CM. ADJACENT TO THIS. SEPARATED BY 1.5 CM IN THE 6:30 AREA IS A MASS WITH A COIL CLIP MEASURING. 2.2 x 1.8 x 2.1 CM. THESE ARE BOTH 0.5 CM FROM THE DEEP MARGIN. CENTRALLY, THE BREAST HAS DENSE TAN FIBROUS TISSUE, BUT THE PERIMETER OF. THE SPECIMEN AND THE TISSUE ADJACENT TO THE DEEP MARGIN IS YELLOW FATTY. TISSUE. THE 3 O'CLOCK LESION IS 0.7 CM FROM THE SUPERFICIAL MARGIN. THE. 6 O'CLOCK LESION EXTENDS TO WITHIN 0.6 CM OF THE SUPERFICIAL MARGIN. SECTIONS ARE SUBMITTED AS FOLLOWS: 11--NIPPLE; 12--TISSUE BETWEEN THE. TWO LESIONS; A3--3 O' CLOCK LESION TO INCLUDE DEEP MARGIN; A4--3 O'CLOCK. LESION TO INCLUDE SUPERFICIAL MARGIN; A5 AND 6--FULL CROSS-SECTION OF 6. O' CLOCK LESION TO INCLUDE THE DEEP AND SUPERFICIAL MARGIN, RESPECTIVELY;. A7--6 O'CLOCK LESION; A8--UPPER OUTER QUADRANT; A9--UPPER INNER QUADRANT;. A10 - -LOWER INNER QUADRANT; A11--LOWER OUTER QUADRANT. TISSUE FROM EACH. LESION IS SUBMITTED PER PROTOCOL. PART B RECEIVED LABELED. LEFT SENTINEL NODE #1 HOT. AND BLUE, IS AN OVOID FRAGMENT OF YELLOW-RED SOFT TISSUE MEASURING 1.7 x. 1.0 x 0.9 CM. SECTIONING REVEALS A GROSSLY UNREMARKABLE 1.3-CM LYMPH. NODE WITH CENTRAL FAT REPLACEMENT AND BLUE COLORATION. THIS IS SUBMITTED. LABELED B, BISECTED. PART C RECEIVED LABELED. LEFT SENTINEL NODE #2 HOT. 1. Specimen: Spec Type: SURGICAL P. CPA : AND BLUE, IS A 1.5 x 0.6 x 0.4-CM OVOID PORTION OF RED-TAN TISSUE. SECTIONING REVEALS THIS TO BE A GROSSLY UNREMARKABLE LYMPH NODE WITH BLUK. COLORATION SUBMITTED LABELED C, BISECTED. PROCEDURES: 88307/3, IMMUNOPEROXIDAS/2, A BLK/11, BBX X6, CBX X6. PART A LEFT BREAST, SIMPLE MASTECTOMY : 1. MODERATELY DIFFERENTIATED INFILTRATING DUCT CARCINOMA, NUCLEAR GRADE. II/III, MODERATE MITOTIC INDEX AND TUBULE FORMATION 2, WITH A TOTAL. NOTTINGHAM SCORE OF 6. RARE FOCI OF DCIS OF THE CRIBRIFORM AND SOLID. TYPES, NUCLEAR GRADE II WITH LOW MITOTIC INDEX, ARE SEEN AT THE. PERIPHERY OF THE TUMOR. 2. A 1.5-CM TUMOR IS IDENTIFIED IN THE 3 O' CLOCK LOCATION AND A 2.2-CM. LESION IS IDENTIFIED IN THE 6 D'CLOCK PORTION WHICH ARE SEPARATED BY. AT LEAST 1.5 CM OF BENIGN BREAST TISSUE. 3. THE MARGINS OF EXCISION, NIPPLE SKIN AND RANDOM SECTIONS OF REMAINING 2.2cm I Scm. QUADRANTS ARE FREE OF TUMOR. 4. LYMPHOVASCULAR INVASION IS IDENTIFIED. 5. BIOPSY CHANGES. ARE PRESENT. PART B LEFT AXILLA, SENTINEL LYMPH NODE BIOPSY #1: METASTATIC BREAST. CARCINOMA IS MULTIFOCALLY IDENTIFIED ON H&E STEP SECTIONS AND CYTOKEBATIN. STAINS IN 1 LYMPH NODE EXAMINED, THE LARGEST FOCUS OF WHICH MEASURES 3 MM. IN GREATEST MICROSCOPIC DIMENSION. NO EVIDENCE OF EXTRANODAL EXTENS FON. PART C LEFT AXILLA, SENTINEL LYMPH NODE BIOPSY #2: MULTIFOCAL. METASTATIC BREAST CARCINOMA IS IDENTIFIED ON H&E STEP SECTIONS AND. CYTOKERATIN STAINS IN 1 LYMPH NODE EXAMINED, THE LARGEST FOCUS OF WHICH. MEASURES 2 MM IN GREATEST MICROSCOPIC DIMENSION. EXTRANODAL EXTENSION IS. NOT PRESENT. Specimen: Spec Type: SURGICAL P. Her-2/neu: NEGATIVE. Score: 1+. Reference Range : Negative o - 1+. Equivocal 2+. Positive 3+. M.D. See full scanned report for details. 1. SENT TO: 2. REQUESTED BY: DR. 3. DATE SENTs. 4. KETHOD or COURIER. 5. NO. OF BLOCKS: 1 BLOCR A3. 7. MATERIAL(S) TO BE RETURNED. 14. SPECIMEN SENT (Y/X) $. x. M.D. (prelim.). M.D.",BRCA,1,"Based on the report, there are two distinct tumors identified in the left breast, one measuring 1.5 cm and the other measuring 2.2 cm. The T stage is determined by the size of the largest tumor, which in this case is 2.2 cm. Therefore, the T stage is T2.",T2,18.0
514,TCGA-A2-A0SY.8E6902A6-A673-46CC-9AEB-3A71EF11099F,2,"Lab No.: Sex: F. Date Collected: Date Received: Doctor: M.R. No.: Room No: Account No: CLINICAL HISTORY: PREOPERATIVE DIAGNOSIS: LEFT BREAST CA. POSTOPERATIVE DIAGNOSIS: LEFT BREAST CA. OPERATION: LEFT SIMPLE MASTECTOMY, SENTINEL LYMPH. NODE BIOPSY, F.S. SPECIMENS: A. LEFT SENTINEL LYMPH NODE #1, F.S. B. LEFT SENTINEL LYMPH NODE #2, F.S. C. SENTINEL LYMPH NODE #3, F.S. D. LEFT BREAST SIMPLE MASTECTOMY. FROZEN SECTION DIAGNOSIS: A. LEFT SENTINEL LYMPH NODE #1 -. NUMEROUS HISTIOCYTES WITH ATYPICAL CELLS. DEFER FOR PERMANENT SECTION. B. LEFT SENTINEL LYMPH NODE #2 -. ONE NEGATIVE LYMPH NODE (0/1). C. SENTINEL LYMPH NODE #3 -. ONE NEGATIVE LYMPH NODE (0/1). FINAL DIAGNOSIS: A. LEFT SENTINEL LYMPH NODE #1 -. POSITIVE FOR METASTATIC CARCINOMA (1/1); THE TUMOR. INVOLVES THREE-FOURTHS OF THE NODE WHICH MEASURES .6. CM. IN DIAMETER, NO PERICAPSULAR SOFT TISSUE EXTENSION. B. LEFT SENTINEL LYMPH NODE #2 -. ONE REACTIVE LYMPH NODE (0/1). Lab No.: C. SENTINEL LYMPH NODE #3 -. ONE REACTIVE LYMPH NODE (0/1). D. LEFT BREAST MASTECTOMY -. INVASIVE LOBULAR CARCINOMA (7 CM.). TUMORAL CALCIFICATION/NECROSIS: NONE IDENTIFIED. DCIS/LCIS: NONE IDENTIFIED. SURGICAL MARGINS/NIPPLE, SKIN AND AREOLA: UNINVOLVED. NON-NEOPLASTIC BREAST: FIBROCYSTIC CHANGES TO INCLUDE DUCTAL EPITHELIAL. HYPERPLASIA. PTNM CLASSIFICATION: T3 N1 MX; STAGE IIIA. COMMENT: The multiple sections from the tumor reveal patchy areas of tumor infiltration. extending up to lactiferous ducts. In addition, the tumor cells also display unfavorable. nuclear features in many areas. The ER, PR and Her-2/neu have been performed on the. previous biopsy. The PanKeratin Immunostain is performed on specimens A, B. and C. GROSS: A. The container is received fresh unfixed labele. eft sentinel lymph node #1. for frozen section"". The specimen consists of an ovoid mass of pink-tan soft rubbery. tissue mixed with fatty tissue measuring 0.6 cm. in greatest dimension. Frozen section is. obtained by. The entire specimen including frozen section in one block. B. The container is received fresh unfixed labele. left sentinel lymph node #2. for frozen section"". The specimen consists of an ovoid mass of tan-gray soft rubbery. tissue with attached fat. Frozen section is obtained by. The entire specimen. including frozen section in one block. Lab No.: C. The container is received fresh unfixed labele. sentinel lymph node #3 for. frozen section"". The specimen consist of an ovoid mass of pink-tan soft rubbery tissue. measuring 1.3 cm. in diameter in the aggregate. Frozen section is obtained by. The entire specimen including frozen section in one block. D. The container is received fresh unfixed labeled. ""left breast"". The specimen. consists of an 809 gm. apparent left breast which is 23 x 15 x 4 cm. in greatest overall. dimension. There is an inverted nipple. The attached skin ellipse is 21 x 9.5 cm. Sectioning through the breast stroma reveals dense gray-white fibrous tissue varying up. to 7.5 cm. in greatest dimension. This area has been previously marked with blue dye. There are scattered cystic spaces varying up to 0.1 cm. in greatest dimension filled with. an amber-colored fluid. Sectioning also reveals a firm tan-gray striated tumor mass. which is 7 x approximately 5.5 cm. in greatest overall dimension and is approximately. 0.7 cm. from the deep/underlying resection margin. The specimen is submitted in ten. blocks. Key Note Block Summary: 1-nipple, 2 through 4-cystic spaces, 5-random,. 6. through 10-tumor mass. MICROSCOPIC EXAMINATION: MICROSCOPIC EXAMINATION CONDUCTED BY PATHOLOGIST CONFIRMS FINAL DIAGNOSIS. SPECIAL STAINS PERFORMED: PanKeratin (specimens A,B,C).",BRCA,1,"The T stage is determined by the size of the tumor. In this report, the tumor size is given as 7 cm, which falls under the 'T3' category. The rule 'T3: tumor size over 5.0 cm without direct extension to the chest wall or skin' applies here.",T3,19.0
607,TCGA-A7-A6VX.80EDDCAC-B87B-47E6-A48C-F166D227DA6C,1,"Final Surgical Pathology Report. Procedure: Diagnosis. A. Left axillary sentinel lymph node, excision: No evidence of metastasis in 2 lymph nodes (0/2). B. Left breast, excisional biopsy: Infiltrating ductal carcinoma, grade 3, 2.5 cm, extending to within. 0.5 mm from the inferior margin of resection. Ductal carcinoma in situ, comedo and solid subtypes, nuclear grade 3. with necrosis, extending to posterior margin. Microscopic Description: Microscopic examination performed. A. Sections of the left axilla sentinel lymph node demonstrate 2 lymph. nodes with no evidence of metastasis. The nodes are examined by. multilevel sectioning with hematoxylin and eosin, as well as by. immunohistochemistry for pankeratin. B. Invasive Carcinoma: Histologic type: infiltrating ductal carcinoma. Histologic grade: Overall grade: 3. Architectural score: 3. Nuclear score: 3. Mitotic score: 2. Greatest dimension (pT) : 2.5 cm, pT2. Specimen margins: extremely close, < 0.5 mm to black ink,. (inferior margin). Vessel invasion: not identified. Calcification: present. Ductal carcinoma in situ: Histologic pattern: comedo and solid. Nuclear grade: 3. Central Necrosis: present. % DCIS of total tumor (if mixed) : < 10%. Extensive intraductal component (present/absent) : absent. Specimen margins : positive, in situ carcinoma at orange ink (. posterior margin). Prognostic markers : see outside report. Specimen. A. Left axillary sentinel node. B. Left breast biopsy long suture anterior short superior. Clinical Information. year-old black female with left breast cancer. Gross Description. A. Received fresh labeled ""left axillary sentinel node"" is a 3.4 x 3.0. X 1.5 cm portion of soft, lobulated tan gold adipose tissue which. contains two rubbery tan-pink tissues in keeping with lymph nodes. averaging 1.4 cm in greatest dimension. The lymphoid tissues are. bisected and entirely submitted independently in 2 blocks. B. Received fresh and subsequently placed in formalin at. labeled. ""left breast biopsy"" is a 6.2 cm (medial to lateral) by 5.3 cm. (anterior to posterior) by 3.0 cm (superior to inferior) soft,. lobulated tan-white-gold portion of fibroadipose tissue with 2 sutures. as stated previously. The margins are inked as follows: Superior blue,. inferior black, anterior green, and posterior orange. The specimen is. sectioned from medial to lateral. There is a 2.5 cm (medial to. lateral) by 2.0 cm (anterior to posterior) by 1.9 cm (superior to. inferior) rubbery tan-white tumor mass within the lateral half of the. specimen. The tumor focally approaches the superior margin to within. 0.2 cm. The remaining cut surfaces consist predominantly of soft,. lobulated tan gold adipose tissue with a scant amount of interspersed. delicate tan-white fibrous tissue. A representative portion of tumor. and a representative portion of normal parenchyma are submitted for. tissue procurement as requested. Summary: 1 - perpendicular sections medial margin, 2 through 9 -. sequential sections including entire lesion, 10 - perpendicular. sections lateral margin.",BRCA,0,"The T stage is determined by the size of the tumor. The report states that the greatest dimension of the invasive tumor is 2.5 cm, which falls within the range for a T2 stage tumor (2.1 to 5.0 cm). Therefore, the T stage for this patient's cancer is T2.",T2,20.0
516,TCGA-A2-A0T1.7546B7FB-1976-4994-AFB7-6270382D44D7,2,"SURGICAL REPORT. Sex: F. Date Collected: Date Received: M.R. Number. Doctor: Account Number. PRE-OPERATIVE DIAGNOSIS. RIGHT BREAST CANCER. POST-OPERATIVE DIAGNOSIS. RIGHT BREAST CANCER. PROCEDURE. RIGHT BREAST LUMPECTOMY WITH FULL AXILLARY NODE DISSECTION. TISSUES. A. BREAST EXCISION, NEEDLE LOC,SIMPLE,MARGINS,ETC.- - RIGHT BREAST. LUMPECTOMY. B. AXILLARY - CONTENTS. C. MARGINS - RIGHT BREAST. FS DIAGNOSIS. A. RIGHT BREAST LUMP (GROSS MARGINS) -. TUMOR EXTENDS TO SUPERIOR MARGIN, NEAR SKIN. (Reported to surgeon: Diagnosed by: FINAL DIAGNOSIS. A. RIGHT BREAST LUMP NEEDLE LOC -. POORLY DIFFERENTIATED INVASIVE DUCTAL CARCINOMA, 7.5 CM. IN GREATEST. DIMENSION, EXTENDING TO SUPERIOR INKED SURGICAL MARGIN. SCARFF-BLOOM-RICHARDSON BREAST CANCER HISTOLOGIC SCORE, 9. (3+3+3). HIGH NUCLEAR GRADE DUCTAL CARCINOMA IN-SITU (DCIS) COMPONENT WITH. CENTRAL NECROSIS AND CALCIFICATION EXTENDS WITHIN LESS THAN 0.1 CM. OF THE SUPERIOR SURGICAL MARGIN. REMAINING DESIGNATED SURGICAL MARGINS ARE FREE OF TUMOR. PATHOLOGIC TNM STAGE: T3 N3 MX, STAGE IIIC, G3, INVASIVE DUCTAL CARCINOMA. PQRI CATEGORY II: 3260F. B. AXILLARY CONTENTS -. TEN (10) REGIONAL LYMPH NODES POSITIVE FOR METASTATIC INVASIVE. SURGICAL REPORT. DUCTAL CARCINOMA. C. RIGHT BREAST MARGINS -. SKIN AND ATTACHED FIBROFATTY BREAST TISSUE, NEGATIVE FOR. MALIGNANCY. Diagnosed by: (. Revlawed and alecimnicallu signed out by: GROSS DESCRIPTION. The specimen is received in three separate containers labele. unated A, B,. C. A. The container is received fresh unfixed labeled ""right breast lump"" and consists of a 67 gm. ovoid. mass of apparent fatty and fibrous-encased tissue which is 7.5 : 7.5 x 3 cm. in greatest overall. dimension. The attached skin ellipse is 4 x 1 cm. There is a single short suture indicating. superior margin inked with black dye, inferior is inked orange. There is a single long suture. indicating lateral margin inked with blue dye, medial is inked green. The skin represents the. anterior margin, posterior is inked with red dye. Sectioning reveals an irregular bordered tan-gray. firm slightly whorled nodule with scattered hemorrhagic areas varying up to 3.5 cm. in greatest. overall dimension and grossly appears to be less than 0.1 cm. from the superior margin and. directly beneath the ellipse of skin. Gross margins are observed by Dr. The tumor. mass grossly appears to be approximately 1.5 cm. from the inferior, 1 cm, from the lateral, 1 cm. from the medial directly beneath the anterior, and 1 cm. from the posterior. The specimen is. submitted in tweive blocks. Key Note Block Summary: 1-superior, 2-inferior, 3-lateral, 4-medial, 5-anterior, 6-. posterior, 7 through 12-random. B. The container is received fresh unfixed labeled ""axillary contents"" and consists of an irregular. mass of apparent fat which is 13 x 12 x 4 cm. in greatest overall dimension. Sectioning reveals. firm tan-gray nodules varying up to 7 cm. in greatest dimension. The largest has scattered green-. black areas and scattered yellow-tan chalky material. The specimen is submitted in seven. blocks. C. The container is received fresh unfixed labeled ""additional right breast margin -skin represents. the anterior margin, suture on new superior margin"" and consists of an ellipse of skin with. attached underlying soft tissue which is 7 x 2.5 x 0.4 cm. in greatest overall dimension. There is. an attached suture indicating new superior margin inked with black dye. The entire specimen is. submitted in five blocks. MICROSCOPIC EXAM. MICROSCOPIC EXAMINATION CONDUCTED BY PATHOLOGIST CONFIRMS FINAL DIAGNOSIS. SURGICAL REPORT.",BRCA,3,"The report states that the largest dimension of the invasive tumor is 7.5 cm, which falls within the range for T3 (tumor size over 5.0 cm without direct extension to the chest wall or skin).",T3,21.0
630,TCGA-A8-A07O.9ECA4450-A550-44DE-B2E5-FD1CFF02A9FE,1,"Diagnosis: 1. Poorly differentiated invasive solid carcinoma, clearly consistent with. a. ductal breast carcinoma (maximum reconstructed tumor diameter: 3.0 cm; forming. a ventral margin, caudal distance 0.5 cm, lateral 1 cm, cranial 1.2 cm, medial and. dorsal 1.5 cm). The tumor-free, ink-stained resection margin of the ventral follow-up resection. material (preparation 4) gives rise to the following tumor classification: NOS, G III,. pT2 pN0(0/13)LOVORO.",BRCA,0,"The report provides the maximum reconstructed tumor diameter as 3.0 cm, which falls within the range for a T2 stage tumor (2.1 to 5.0 cm). The T stage is based on the largest dimension of the invasive tumor, and in this case, the report specifies that the maximum diameter is 3.0 cm. The T stage is not affected by the number of tumors or the involvement of the chest wall or skin, but rather the size of the largest one. Therefore, the T stage for this patient is T2.",T2,22.0
539,TCGA-A2-A1G1.E2E6CA22-AFE4-4B8F-90AC-32639687A590,1,"SURGICAL REPORT. Sex. F. Date Collected: I. Date Received: M.R. Number. Doctor: Account Numbe. PRE-OPERATIVE DIAGNOSIS. RIGHT BREAST CA. POST-OPERATIVE DIAGNOSIS. RIGHT BREAST CA. PROCEDURE. RIGHT BREAST LUMPECTOMY WITH SENTINEL LYMPH NODE BIOPSY, F.S.: POSSIBLE AXILLARY DISSECTION. TISSUES. A. BREAST EXCISION,NEEDLE LOC, SIMPLE,MARGINS,ETC - RIGHT BREAST LUMP. B. SENTINEL LYMPH NODE (S) - #1 ""FS. FS DIAGNOSIS. RIGHT BREAST LUMP (GROSS MARGINS) -. MARGINS GROSSLY NEGATIVE FOR MALIGNANCY. a. RIGHT SENTINEL LYMPH NODE #1, F.S. -. SENTINEL NODE #1, NEGATIVE FOR MALIGNANCY. (REPORTED TO SURGEON: Diagnosed by: FINAL DIAGNOSIS. A. RIGHT BREAST LUMP -. POORLY DIFFERENTIATED INFILTRATINO DUCTAL CARCINOMA WITH CENTRAL. THE TUMOR MEASURES IN MAXIMUM DIMENSION. II//II). NECROSIS (SCARFF-BLOOM-RICHARDSON GRADE. 3 CM. LYMPHOVASCULAR INVASION IDENTIFIED INSIDE THE TUMOR. ALL SURGICAL MAROINS ARE FREE OF THE TUMOR. B. RIGHT SENTINEL LYMPH NODE #1 . ONE POSITIVE LYMPH NODE (1/1). PTNM CLASSIFICATION: STAGE IIB, T2 N1 MX. PQRI CATEGORY II: 3260F. Diagnosed by: Revlewed and electronically signed out by: SURGICAL REPORT. COMMENT. Specimen ""B"" shows metastatic carcinoma which is shown in the permanent section and not In. the frozen section. This case is discussed with Dr. GROSS DESCRIPTION. The specimen is received in two separate containers labeled. designated A. and B. A. The container Is received fresh unfixed labeled ""right breast lump"" and consists of a 33 gm. ovoid. mass of apparent fatty and fibrous-encased tissue which is 5.5 x 4.5 x 2 om. In greatest overall. dimension. There are two sutures indicating superior margin inked with yellow dye, inferior Is. inked green. There Is a single short suture indicating lateral margin inked with orange dye,. medial is inked black. There is a single short suture indicating anterior margin Inked with blue. dye, posterior Is Inked red. Sectioning reveais a tumor which is 3x 2.5) 1 cm. in greatest overall. dimension and grossly appears to be 0.4 cm. from the superior/yellow, 0.9 cm. from the. inferior/green, 0.4 cm. from the medial/black, 0.3 cm. from the lateral/orange, 0.5 cm. from the. anterior/blue, 0.6 cm. from the posterior/red. The specimen is submitted In twelve blocks. Key Note Block Summary: 1-superior, 2-inferlor, 3-medial, 4-lateral, 5-anterior, 6-. posterior, 7 through - tumor, 10 through 12-random. B. The container Is received fresh unfixed labeled ""right sentinel lymph node #1 for frozen section"". and consists of an ovoid mass of apparent fat which is 1.5x x 0.6 cm. in greatest overail. dimension. Sectioning reveais a 1 cm. pink-tan firm nodule. Touch prep and frozen section are. obtained by Dr. The entire specimen including frozen section is submitted in two. blocks. MICROSCOPIC EXAM. MICROSCOPIC EXAMINATION CONDUCTED BY PATHOLOGIST CONFIRMS FINAL DIAGNOSIS. Patient Narr. SURGICAL REPORT.",BRCA,1,"The report states that the tumor measures 3 x 2.5 x 1 cm in greatest overall dimension. Based on the rules provided, T2 corresponds to a tumor size of 2.1 to 5.0 cm, which is consistent with the measured size of the tumor in this report.",T2,22.0
633,TCGA-A8-A07S.AC2E3DDC-3AF6-45F0-8269-E9DA68F4367A,1,Summary diagnosis: Left breast at 3 o'clock: invasive breast carcinoma of mixed differentiation with a tumor. classification pT2 (28 mm) pM0 (0/28) grade 1 (L0(V0) R1 (ventral). Associated extensive lobular neoplasia and DCIS grade 1 corresponding to pTis RI ventral.,BRCA,0,"The report explicitly states that the tumor size is 28mm, which falls within the range for a T2 stage tumor (2.1-5.0 cm). The T stage is based on the largest dimension of the invasive tumor, and in this case, the report provides the maximum reconstructed tumor diameter, which is 28mm.",T2,22.0
489,TCGA-A2-A0CY.CB780DE7-E98C-4F7E-9487-8F25FE80DC21,1,"Specimen #: Race: WHITE. Physician (s) : SPECIMEN: A: RIGHT BREAST B: LEFT BREAST C: SENTINEL LYMPH NODE #1. D: LEFT AXILLARY CONTENTS E: NON SENTINAL , ,LT AXILLARY L.N. FINAL DIAGNOSIS: A. BREAST, RIGHT, MASTECTOMY: - BENIGN BREAST TISSUE WITH FIBROCYSTIC CHANGES INCLUDING SCLEROSIS,. MICROCYST FORMATION, USUAL DUCTAL HYPERPLASIA, DUCT ECTASIA, AND. FOCAL MICROCALCIFICATION . B. BREAST, LEFT, MASTECTOMY: TUMOR TYPE: INVASIVE DUCTAL CARCINOMA. NOTTINGHAM GRADE: III/III. NOTTINGHAM SCORE: 9/9. (Tubules= 3, Nuclei= 3, Mitoses= 3). TUMOR SIZE (GREATEST DIMENSION OF INVASIVE COMPONENT) : 3.5 CM. (MEASURED GROSSLY). TUMOR NECROSIS: PRESENT. VENOUS / LYMPHATIC INVASION: IDENTIFIED. MARGINS : - DISTANCE OF TUMOR FROM NEAREST MARGIN IS 0.4 CM, FROM THE. SUPERFICIAL LOWER OUTER QUADRANT (BLUE INK) MARGIN. INTRADUCTAL COMPONENT: MULTIFOCAL, HIGH GRADE, SOLID AND COMEDO TYPE. EXTENDING WELL BEYOND THE INVASIVE COMPONENT. NIPPLE INVOLVEMENT: NOT IDENTIFIED. LYMPH NODES 1 OF 22 POSITIVE FOR TUMOR (PARTS C-E). SKIN INVOLVEMENT: NOT IDENTIFIED. ESTROGEN RECEPTORS : POSITIVE (STRONG, >75% OF CELLS, FROM. HER 2 NEU by IHC: NEGATIVE (1+ STAINING, FROM. PROGESTERONE RECEPTORS: NEGATIVE (WEAK, <5% OF CELLS, FROM. PATHOLOGIC STAGE: pT2 N1 MX. ADDITIONAL PATHOLOGIC CHANGES: FIBROCYSTIC CHANGES INCLUDING MICROCYST. FORMATION, FOCAL DUCT ECTASIA, SCLEROIS, USUAL DUCTAL HYPERPLASIA, AND. APOCRINE METAPLASIA. C. LYMPH NODE, LEFT SENTINEL, EXCISION: - AND ONE (1) LYMPH NODE NEGATIVE FOR METASTATIC CARCINOMA BY HEMATOXYLIN. EOSIN AND IMMUNOHISTOCHEMICAL (CYTOKERATIN) STAINS. Specimen #: FINAL DIAGNOSIS (continued) : D. LYMPH NODE, LEFT AXILLA, EXCISION: - TWENTY (20) LYMPH NODES NEGATIVE FOR METASTATIC CARCINOMA. E. LYMPH NODE, LEFT NON-SENTINEL, EXCISION: - ONE (1) LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA. COMMENT: confirmed on the permanent sections. In specimen ""E"" the frozen section diagnosis of metastic carcinoma is. CLINICAL DIAGNOSIS AND HISTORY: year old white female with history of left breast cancer. FROZEN SECTION DIAGNOSIS: SPECIMEN TYPE:LYMPH NODE (SPECIMEN ""E"") . REPORTED TO: AND. # BLOCKS : 1. # SCRAPE PREPS : 1. FROZEN SECTION DIAGNOSIS : POSITIVE FOR METASTATIC CARCINOMA. GROSS DESCRIPTION: A. Received in fresh labeled with the patient's name. of labeled a 927 ""RIGHT BREAST SHORT STITCH SUPERIOR, LONG STITCH LATERAL consists. and gram mastectomy specimen oriented with a short stitch superior. pigmented 1.0 superficial skin ellipse measures 17 x 11.5 cm and. superior to inferior, and 5 cm anterior to posterior. The lightly. long lateral. The specimen measures 24 cm medial to lateral, 19 cm. The deep cm centrally located everted nipple. No discharge or scar displays is noted. a. tan margin is inked in black. Serial sections reveal lobulated yellow. tissue. adipose tissue admixed with 10% moderately dense tan white fibrous. catted grey cysts measuring up to 0.4 cm in greatest dimension. blue The fibrous tissue is predominantly centrally located and shows. 1. Specimen #: GROSS DESCRIPTION (continued) : discrete mass or lesion identified. No lymph nodes are identified. Cassette summary : A1: skin. A2: central. A3: upper outer quadrant. A4: lower outer quadrant. A5: lower inner quadrant. A6: upper inner quadrant. A7: upper outer quadrant. A8: lower outer quadrant. A9: lower inner quadrant. A10: upper inner quadrant. All: representative section of nipple. Matched sections of A1-A6 are submitted in OCT for CBCP protocol. B. Received fresh labeled with the patient's name. designated ""LEFT BREAST SHORT STITCH SUPERIOR, LONG LATERAL"" is a 954. gram mastectomy specimen oriented with a short stitch superior and long. lateral. The specimen measures 24 cm medial to lateral, 18 cm superior. inferior, and 6 cm anterior to posterior. The lightly pigmented. to. superficial located skin ellipse measures 19 x 12.5 cm and displays a medially. deep inked margin is inked black and the superficial lower outer quadrant is. 1.5 cm everted nipple free of discharge. No scar is noted. The. located lobulated pink white indurated mass with focal hemorrhage. The mass. blue. Serial sections reveal 3.5 x 3.2 x 2.8 cm well defined. deep the margin and 0.4 cm of the inked superficial surface. The remainder. within the lower outer quadrant and comes within 3.5 cm of the is. tissue which is diffusely nodular and focally cystic. The admixed. specimen is composed of approximately 50% dense tan white fibrous. of. adipose tissue is unremarkable. No additional masses are identified. No. lymph nodes identified. Cassette summary: B1: skin. B2: lower outer quadrant mass. B3: lower outer quadrant. B4: upper outer quadrant. B5: upper inner quadrant. B6: lower inner quadrant. B7: representative section of closest deep margin. blue B8-B9: ink representative sections of mass with closest point of approach to. margin. 10: representative section of nipple. 10CF. Specimen #: GROSS DESCRIPTION (continued) : C. Received fresh labeled with the patient's name. designated. SENTINEL LYMPH NODE #1"" consists of a 2.0 x 1.7 x 1.0 cm. pink yellow fatty lymph node. The specimen is trisected. Two thirds of the. lymph node are placed in cassette C1 and C2. Matched section of C1 is. placed in. for CBCP protocol. D. Received fresh labeled with the patient's name. designated ""LEFT AXILLARY CONTENTS"" consists of an unoriented irregular. portion of adipose tissue measuring 9.0 x 9.0 x 2.0 cm. Sectioning reveals. multiple pink yellow fatty lymph nodes ranging in size from 0.4 to 2.4 cm. in greatest dimension. Cassette summary. D1-D3: one lymph node each. D4-D7: one lymph node bisected. D8: two lymph nodes bisected, one inked black. D9: four intact lymph nodes. D10: one lymph node bisected. D11: two lymph nodes. D12: four possible lymph nodes. 12CF. E. Received fresh labeled with the patient's name. designated ""NON SENTINEL CLINCALLY SUSPICOUS LEFT AXILLARY LYMPH NODE'. consists of a 1.7 x 1.5 x 1.3 cm lymph node. Cut surface is homogeneous. and firm. A portion is submitted for frozen section. 1C1.",BRCA,1,"The report states that the 'TUMOR SIZE (GREATEST DIMENSION OF INVASIVE COMPONENT) : 3.5 CM.', and based on the rules provided, T stage is determined by the size of the tumor. Specifically, T2 corresponds to a tumor size of 2.1 to 5.0 cm.",T2,23.0
651,TCGA-A8-A08L.BC0E0F93-B183-44E8-B551-EA463B2FBCE4,2,"Diagnosis. 1. Left-sided ablated breast tissue with a poorly differentiated invasive ductal breast. carcinoma measuring a maximum of 6 cm with focal invasion of the lymph vessels, extension. to the base of the nipple and the pectoral muscle and excision extending just into the healthy. tissue in the basal epidermis. No pagetoid tumor propagation or skin infiltration. Tumor classification: M-8500/3, G 3, pT3, pN2a (5/13), pMX, stage III A. R0.",BRCA,2,The report states that the 'poorly differentiated invasive ductal breast carcinoma measures a maximum of 6 cm' which falls under the 'T3: tumor size over 5.0 cm without direct extension to the chest wall or skin' category.,T3,24.0
663,TCGA-A8-A094.85288EC6-0BDC-4955-8B88-1DEECBF0E235,1,"Diagnosis: 1. Poorly differentiated invasive ductal carcinoma with focal intraductal spread (tumor. diameter 5 cm). Dorsal resection margin tumor-free. Tumor classification: NOS, G III, pT2NOLOVORO.",BRCA,0,"The report provides the size of the tumor as 5 cm, which falls within the range for a T2 stage tumor (2.1 to 5.0 cm). The T stage is based on the largest dimension of the invasive tumor, and if there are multiple foci of tumor, the T stage is based on the largest one. The T stage is not affected by the number of tumors, but rather the size of the largest one.",T2,25.0
673,TCGA-A8-A09G.2728DB14-66D5-4E67-B9B6-63D93DBF509C,2,"Diagnosis: ) Poorly differentiated invasive carcinoma (tumor diameter: 5.5 cm). Concluding tumor classification: NOS, G III, pT3N3aL0V0R0.",BRCA,3,"The report provides the tumor diameter, which is 5.5 cm. According to the rules, T3 corresponds to a tumor size over 5.0 cm without direct extension to the chest wall or skin. The given diagnosis is 'poorly differentiated invasive carcinoma' with a tumor diameter of 5.5 cm, which falls within the T3 category.",T3,26.0
536,TCGA-A2-A1FW.849E9FA7-3420-427B-A310-3346CFA9F0CC,2,"SURGICAL REPORT. Sex: F. Date Collected: Date Received: M.R. Number. Doctor: Account Number: PRE-OPERATIVE DIAGNOSIS. RIGHT BREAST CA. POST-OPERATIVE DIAGNOSIS. RIGHT BREAST CA. PROCEDURE. MODIFIEO RADICAL RIGHT MASTECTOMY, SENTINEL LYMPH NODE BIOPSY, F.S.; POSSIBLE AXILLARY DISSECTION. TISSUES. A. LYMPH NODE (S) - RIGHT SENTINEL LYMPH NODE #1FS. B. LYMPH NODE (S) - RIGHT SENTINEL LYMPH NODE #2FS. C LYMPH NODE (S) - RIGHT SENTINEL LYMPH NODE #3FS. D LYMPH NODE (S) - RIGHT SENTINEL LYMPH NODE #4FS. E LYMPH NODE (S) - RIGHT SENTINEL LYMPH NODE #5FS. F LYMPH NODE (S) - RIGHT SENTINEL LYMPH NODE #6FS. G BREAST MASTECTOMY (WAVO) NODES - RIGHT BREAST AND AXILLARY CONTENTS. FS DIAGNOSIS. A. LYMPH NODE #1, F.S. -. DEFERRED FOR PERMANENT. B. LYMPH NODE #2, F.S. -. DEFERRED FOR PERMANENT. C. LYMPH NODE #3, F.S. -. DEFERRED FOR PERMANENT. D. LYMPH NODE #4, F.S. -. POSITIVE FOR METASTATIC MALIGNANCY (1/1). E. LYMPH NODE #5, F.S. -. DEFERRED FOR PERMANENT. F. LYMPH NODE #6, F.S.. DEFERRED FOR PERMANENT. (REPORTED TO SURGEON: Diagnosed by. FINAL DIAGNOSIS. A. RIGHT SENTINEL LYMPH NODE #1 -. SURGICAL REPORT. LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA. B. RIGHT SENTINEL LYMPH NODE #2 -. LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA. c. RIGHT SENTINEL LYMPH NODE #3 -. LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA. D. RIGHT SENTINEL LYMPH NODE #4 -. LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA. E. RIGHT SENTINEL LYMPH NODE #5 -. LYMPH NODE, NEGATIVE FOR MALIGNANCY. F. RJOHT SENTINEL LYMPH NODE #6 -. LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA. G. RIGHT BREAST AND AXILLARY CONTENTS. POORLY DIFFERENTIATED INVASIVE DUCTAL CARCINOMA, 75 MM IN GREATEST. DIMENSION, EXTENDINO WITHIN 26 MM. OF THE NEAREST DEEP INKED SURGIGAL. MARGIN. ALL DESIGNATED INKED SURGICAL MARGINS ARE FREE OF TUMOR. SCARFF-BLOOM-RICHARDSON BREAST CANCER HISTOLOGIC SCORE OF 9. (3+3+3). EXTENSIVE ANGIOLYMPHATIC INVASION IS PRESENT. SCLEROSING ADENOSIS, FIBROSIS, DUCT ECTASIA, AND APOCRINE METAPLASIA,. REMAINING BREAST TISSUE DISPLAYS FIBROCYSTIC CHANGE INCLUDING. INCIDENTAL FIBROADENOMA, 10 MM. IN GREATEST DIMENSION. STIPPLED MICROCALCIFICATIONS AND MONCKEBERG'S MEDIAL CALCIFICATIONS ARE. PRESENT IN THE NON-NEOPLASTIC TISSUE. THIRTEEN REACTIVE REGIONAL AXILLARY LYMPH NODES, NEGATIVE FOR. MALIGNANCY. PATHOLOGIC TNM STAGE: T3 N2a M not applicable, STAGE IIIA, G3, INVASIVE DUCTAL. CARCINOMA. PORI CATEGORY II: 3260F. Diagnosed by. Reviewed a d electronicaliv signed nut by: COMMENT. This case is discussed with Dr. on. SURGICAL REPORT. Patient Nam. Key Note Block Summary. 1-nipple, 2 through 7-tumor, 8-deep resection line, 9-. superior/lateral/red, 10-inferior/lateral/black, 11-superior/medial/green, 12-. inferior/medial/orange, 13, 14 and 15-random, 16, 17 and 18-apparent nodes. MICROSCOPIC EXAM. MICROSCOPIO EXAMINATION CONDUCTED BY PATHOLOGIST CONFIRMS FINAL DIAGNOSIS. SYNOPTIC REPORT: Specimen. Total breast (including nipple and skin). Procedure. Total mastectomy (including nipple and skin). Lymph Node Sampling: Sentinel lymph nodes, Axillary dissection. Specimen Integrity: Single Intact specimen (margins can be evaluated). Specimen Size: greatest dimension - 27 cm.; additional dimensions 20 x 5.5 cm. Specimen Laterality. Right. Tumor Site: Mid superior lateral. Tumor Size. Greatest dimension of largest focus of invasion over 0.1 cm.: 7.5cm;. Additional dimensions: 5x 3 cm. Tumor Focality: Single focus of Invasive carcinoma. Skin: Invasive carcinoma does not invade into the dermis or epidermis. Skeletal Muscle: No skeletal muscle present. Ductal Carcinoma In-situ: No DCIS is present. Histologic Type of Invasive Carcinoma: Invasive ductal carcinoma (no special type or not otherwise. specified). Glandular: Score 3: <10% of tumor area forming giandular/tubular structures. Nuclear P(eomorphism: Score 3: Vesicular nuclel, often with prominent nucleoli, exhibiting marked. variation in size and shape, occasionally with very large and bizarre forms. Mitotic Count. Score 3. Overall Grade. Grade 3: scores of 8 or 9. Margins: uninvolved by invasive carcinoma: Distance from closest margin: 25 mm (deep). Distance from superior margin: 35 mm. Distance from inferior margin: 80 mm. Distance from posterior margin: 25 mm. Distance from medial margin: 80 mm. Distance from lateral margin: 35 mm. Treatment Effect: In the breast - No known presurgical therapy. In the lymph nodes - No known presurgical therapy. Lymph-Vascular Invasion: Present. Dermal Lymph-Vascular Invasion: Not identified. Lymph Nodes: Number of sentinel lymph nodes examined: 6. Total number of lymph nodes examined: 19. Number of lymph nodes with macrometastases: 5. Size of largest metastatic deposit: 15 mm. Extranodal Extension: Present. Method of Evaluation of Sentinel Lymph Nodes: Hematoxylin and eosin, one level. H&E, multiple levels. Immunohistochernistry. Pathologic Stage: SURGICAL REPORT. I. COMMENT2. Immunohistochernical (IHC) stain for pankeratin (AE1/AE3) is negative for micrometastses in. the uninvolved regional lymph nodes (specimens E and G). GROSS DESCRIPTION. The specimen IS received in seven separate containers labeled. designated A. through G. A. The container is received fresh unfixed labeled ""right sentinel lymph node #1 for frozen section"". and consists of an ovoid nodule of apparent fat which is 0.3 x 03x 0.2 cm. Sectioning reveals a. 0.3 cm. tan-gray nodule. Frozen section is deferred by Dr. The entire specimen is. submitted in one block. B. The container is received fresh unfixed labeled ""right sentinel lymph node #2 for frozen section"". and consists of an irregular mass of apparent fat which Is 0.8 x 0.6 x 0.4 cm. in greatest overal. dimension. Sectioning reveais a 0.6 cm. tan-gray nodule. Frozen section is deferred by Dr. The entire specimen is submitted in one block. C. The container is received fresh unfixed labeled ""right sentinel lymph node #3 for frozen section"". and consists of an ovoid mass of apparent fat which is x 1 x 0.6 cm. in greatest dimension. Sectioning reveals a 0.3 cm. tan-gray area. Frozen section is deferred by Dr. D. The container Is received fresh unfixed labeled ""right sentinel lymph node #4 for frozen section"". and consists of an ovoid mass of tan-gray firm rubbery tissue which is 1.5x 1 x 1 cm ingreatest. overall dimension. Touch prep and frozen section are obtained by Dr. The entire. specimen including frozen section is submitted in two blocks. E. The container is received fresh unfixed labeled ""right sentinel lymph node #5 for frozen section"". and consists of an irregular mass of apparent fat which is 1 x 0.4x 03 cm. in greatest overall. dimension. Sectioning reveais a 0.3 cm. tan-gray area. Frozen section is deferred by Dr. The entire specimen is submitted in one block. F. The container is received fresh unfixed labeled ""right sentinel lymph node #6 for frozen section"". and consists of an irregular mass of apparent fat which is 0.6 x 0.4x 0.4 cm. Sectioning reveals. 0.3 cm. tan-gray area. Frozen section is deferred by Dr. The entire spedimen is. submitted in one block. G. The container is received fresh unfixed labeled right breast - suture on superior/lateral aspect"". and consists of a 1,242 gm. apparent right breast which is 27 x 20 x 5.5 cm. in greatest overali. dimension and has an apparent axillary tall. There is an attached suture indicating. superior/lateral aspect inked with red dye, lower lateral is inked black, upper medial is inked. green, lower medial is inked orange. The underlying deep is inked with yellow. There is a. eccentrically placed nipple which is slightly inverted. Sectioning through the breast stroma. reveals a gray-white irregular-bordered tumor mass which grossly appears to be 7.5 x 5x 3 cm. In greatest overall dimension and grossly appears to be located in the mid superior/lateral region. The tumor mass is 2.5 cm. from the underlying/yellow margin, 3.5 cm. from the. superior/lateral/red margin, 8 cm. from the inferior/lateral/black margin, 8 cm. from the. superior/medial/green margin and 7 cm. from the inferior/medial/orange margin. Sectioning. through the attached axiliary fat reveals pink-tan nodules varying up to 1.5 cm in greatest. dimension. The specimen is submitted in eighteen blocks. SURGICAL REPORT. Primary Tumor: pT3. Regional Lymph Nodes: pN2a. Distant Metasstasis: Not applicable. Ancillary Studies. ER. Performed on another specimen - -. Immunoreactive tumor cells present - Quantiation 90%. PR. Performed on another specimen -. No immunoreactive tumor cells present. Immunoperoxidate Suties. Performed on another specimen - S-1500-10. Negative (score 0). Microcalcifications: Present in non-neoplastic tissue. Clinical History. Palpable mass. SPECIAL STAINS PERFORMED: pankeratin (blocks E, G16 through G18). SURGICAL REPORT.",BRCA,2,"The report states that the greatest dimension of the invasive tumor is 7.5 cm, which falls within the range for a T3 stage tumor (over 5.0 cm). The T4 stage was not applicable in this case as it involves direct extension to the chest wall or skin, which was not mentioned in the report.",T3,27.0
559,TCGA-A2-A3Y0.0FEAEEBA-A72C-4207-AC21-6AF5B5ED1AFC,1,"IP <DIS IN C. Specimen: spec Type: SURGICAL P. PREOPERATIVE DIAGNOSES. LEFT BREAST CANCER INVASIVE. OPERATION PERFORMED. DOCTOR (s) : PROCEDURE: MASTECTOMY MODIFIED RADICAL. TISSUE REMOVED. A. LT BREAST AND AXILLARY TISSUE. B. ADDITIONAL LYMPH NODES LT AXILLA. GROSS DESCRIPTION. PART A RECEIVED FRESH LABELED. LEFT BREAST AND AXILLARY. CONTENTS SUTURE AT 12 O'CLOCK, AND CONSISTS OF A MODIFIED RADICAL. MASTECTOMY SPECIMEN WITH OVERALL DIMENSIONS OF 31 x 20.5 x 5.8 CM. THE. NIPPLE IS UNREMARKABLE AND SITS WITHIN A SKIN ELLIPSE MEASURING 21 x 12.3. CM. THERE IS A 3.5 CM IN LENGTH WELL-HEALED PERIAREOLAR SCAR EXTENDING. FROM 12 TO 2 O' CLOCK. THERE IS A PALPABLE MASS IN THE UPPER OUTER. QUADRANT. THE SUPERFICIAL ASPECT IS MARKED WITH BLUE INK, THE DEEP. ASPECT WITH BLACK INK. THE AXILLARY TAIL IS REMOVED AND EXAMINED FOR. LYMPH NODES, OF WHICH MULTIPLE ARE IDENTIFIED. SECTIONS ARE SUBMITTED AS. FOLLOWS: A1 --NIPPLE - SKIN AND SCAR; A2 -FIVE NODES; A3 - -FIVE NODES;. A4--THREE - NODES, EACH BISECTED; A5--THREE NODES, EACH BISECTED;. A6--SECTION OF ONE NODE; A7--SECTION OF ONE NODE; A8--SECTION OF ONE. NODE; A9--SECTION OF ONE NODE; A10--SECTION OF ONE NODE. NOTE THAT A6. THROUGH A10 ARE MIRROR IMAGES OF PROTOCOL SECTIONS. All--TWO NODES, EACH. BISECTED; A12--ONE NODE BISECTED; A13--ONE - NODE BISECTED; A14--ONE NODE. BISECTED. SECTIONING THE BREAST REVEALS THE UPPER OUTER QUADRANT TO-BE A. ROUNDED PINK-TAN SOFT MASS WHICH IS CENTRALLY CYSTIC. IT MEASURES 4 x. 3.7 x 2.8 CM. GROSSLY, THIS ABUTS THE DEEP MARGIN. IMMEDIATELY. SUPERFICIAL TO THIS MASS IS A SECOND NODULE WITH A COIL CLIP MEASURING. 1.5 x 1.2 x 1.0 CM. MEDIAL AND CENTRAL TO THE BREAST, THE SPECIMEN HAS A. TAN FIBROUS BAND WHICH EXTENDS 9 CM FROM SUPERIOR TO INFERIOR AND THERE. IS TAN FIBROUS TISSUE CENTRAL WITHIN THE BREAST. THIS IS SURROUNDED BY A. PERIMETER OF BLAND YELLOW FATTY TISSUE. SECTIONS ARE SUBMITTED AS. FOLLOWS: A15 AND 16-MASS IN DEEP MARGIN; A17--SECTION OF THE MASS AND. THE ADJACENT MORE SUPERFICIAL NODULE; A18, 19 AND 20 --SECTIONS OF MASS. CORRESPONDING TO SECTIONS FROM THE SUBMITTED PER PROTOCOL, WITH A20. REPRESENTING THE ADJACENT FIBROUS TISSUE; A21--AN ADDITIONAL SECTION OF. THE SUPERFICIAL LESION (MIRROR IMAGE TO PROTOCOL) ; A22--UPPER OUTER. QUADRANT; A23--PUPPER INNER QUADRANT; A24 --LOWER - INNER QUADRANT;. A25 - -LOWER - OUTER QUADRANT (A22 THROUGH A25 ARE MIRROR IMAGE SECTIONS TO. PROTOCOL) ; A26--TISSUE FROM SUPERIOR PORTION OF BREAST. THE AXILLARY TAIL IS REEXAMINED FOR LYMPH NODES AFTER FIXATION TIME IN. ACETIC FORMALIN. ADDITIONAL NODES ARE THEN SUBMITTED AS FOLLOWS: Specimen: Spec Type: SURGICAL P. GROSS DASCRIPTION. A27--FIVE - NODES; A28--TWO - NODES, EACH BISECTED. PART B RECEIVED FRESH LABELED. ADDITIONAL LYMPH NODES. LEFT AXILLA (LEVEL 2), IS YELLOW-PINK FATTY TISSUE MEASURING 2.4 x 1.6 x. 0.8 CM. THIS IS BISECTED REVEALING NO DISTINCT NODAL TISSUE AND. SURMTTTRN RNTIRELY LABELED B1 AND 2. PATH PROCEDURES. PROCEDURES: 88309, A BLK/26, B BLK/2. FINAL DIAGNOSIS. PART A LEFT MODIFIED RADICAL MASTECTOMY: 1. POORLY DIFFERENTIATED INFILTRATING DUCT CARCINOMA, NUCLEAR GRADE. III/III WITH A HIGH MITOTIC INDEX, 4.0 CM IN MAXIMUM GROSS DIMENSION. 2. THE IDENTIFIED IN 1 INTRAMAMMARY LYMPH NODE (MARKED 1/1 Intramann. TUMOR IS LOCATED 1 MM FROM THE DEEP MARGIN OF THE SPECIMEN. METASTATIC CARCINOMA. WITH A COIL CLIP CONFIRMING A PREVIOUS BIOPSY SITE) . 3. NO EVIDENCE OF METASTATIC DISEASE IN 37. AXILLARY LYMPH NODES. %/37 ALN. 4. PERIDUCTAL CHRONIC MASTITIS IN SECTIONS OF BREAST TISSUE AWAY FROM. THE PRIMARY TUMOR SITE. PART B LEFT AXILLARY BIOPSY: ADIPOSE TISSUE CONTAINING SECTIONS OF 1 % Level 2. SMALL LYMPH NODE WITH NO EVIDENCE OF METASTATIC DISEASE. CX IMMENT. THE. LIDITION OF THE AJCC STAGING MANUAL DOES SPECIFICALLY NOT ADDRESS. FOR POSITIVE INTRAMAMMARY NODES IN THE ABSENCE OF AXILLARY. METASTATIC DISEASE, HOWEVER THE PATIENT WILL BE STAGED AS HAVING N1. DISEASE. CODE. 1. (prelim.). (signature on file). S IN. Specimen: Spec Type: CA SUMMARY. CANCER SUMMARY. Breast Pathology Summary: Macroscopic: Breast procedure: mastectomy, modified radical. Lymph node procedure: Sentinel (yes/no) : no. Axillary (yes/no) : yes. Specimen size (greatest dimension) (xy,n/a) cm: 31. Neoadjuvant therapy (yes/no) : no. Laterality: left. Tumor site: upper outer quadrant. Multifocal (yes/no) : no. Multicentric (yes/no) : no. Microscopic: Size of invasive component (xy,n/a) mm: 40. Size of DCIS (xy,n/a) mm: n/a. Histologic type: Atypical: n/a. In situ: n/a. Invasive: infiltrating duct. Histologic grade : Tubule formation (0-3,n/a) : 3. Nuclear pleomorphism (0-3,n/a) : 3. Mitotic count (0-3,n/a) : 3. Nottingham Score: 9. Nottingham Grades based on total score: Grade I 3-5 points. Grade II 6-7 points. Grade III 8-9 points. Venous/lymphatic invasion (yes/no) : no. Closest margin size (xy,n/a) mm: 1. If less than 2 mm then: Single focus of invasive tumor (yes/no) : yes. Single focus of DCIS (yes/no) : no. Multifocal invasive tumor (yes/no) : no. Multifocal DCIS (yes/no) : no. Nodes: Sentinel- number examined (xy,n/a) : 0. Sentinel- number involved (xy,n/a) : n/a. Regional- number examined (xy,n/a) : 39. Regional - number involved (xy,n/a) : 1. Markers: ER (xy%,n/a) : 95. Specimen: :atus: Reg# : Spec Type: CA SUMMARY. CANCER SUMMARY. PR (xy%,n/a) : o. Her-2/neu (0-3+,n/a) : 1. Ki-67 (xyt,n/a) : 95. Summary TNM: T: pT2. pN: pN1. Summary stage: 2B. ) (prelim.). (signature on file).",BRCA,1,"The report states that the size of the invasive component is 40 mm (4 cm), which falls within the range for T2 (2.1 to 5.0 cm). The T stage is based on the largest dimension of the invasive tumor, and in this case, the largest dimension reported is 4 cm.",T2,27.0
590,TCGA-A7-A3J0.A5AED5F0-A144-4615-AF78-539B8523D15F,1,"Final Surgical Pathology Report. Procedure. Diagnosis. A. Sentinel lymph nodes, right axilla, biopsy: There is no evidence of malignancy in either of 2 lymph nodes. B. Breast, right, excisional biopsy: Invasive mucinous type carcinoma, Nottingham grade 1. Fibrocystic. changes. Microscopic Description: A. There is no evidence of malignancy in either of 2 lymph nodes. [At the request of some staff oncologists and in keeping with the. opinion of some experts in breast pathology, immunohistochemical stains. for keratin were not used on the sentinel lymph node sections in this. case. These stains can be obtained if desired. Our paraffin blocks. are retained for 10 years. (Weaver DL et al. New Engl J Med 364:412,. 2011. Schwartz GF et al. Cancer 94 (10):2542, 2002)]. B. Invasive carcinoma: Histologic type: Invasive mucinous carcinoma. Nottingham grade: 1. Architectural score: 3. Nuclear score: 1. Mitotic score: 1. Mitotic index: 4 mitoses/ 10 HPFs (1 HPF = 1.96 sq. mm). Tumor size: 2.5 cm. Specimen margins: Negative for malignancy. Carcinoma is focally. 1.9 mm from the red (anterior) margin. Vessel invasion: Absent. Calcification: Absent. Non-tumorous breast: Fibrocystic changes are present including cyst. formation, sclerosing adenosis, columnar metaplasia and intraductal. epithelial hyperplasia without atypia, benign calcification and. apocrine metaplasia. TNM stage: T2 NO. Prognostic markers: See previous biopsy. Specimen. A. Right axillary sentinel node. B. Right breast biopsy long stitch anterior short stitch superior. Clinical Information. Right breast cancer. Gross Description. Specimen A is received unfixed labeled right axillary sentinel nodes. and consists of 2 pieces of yellow and red soft tissue measuring 3.5. x. 2.5 X 1 and 2.8 x 2 by 1.3 cm. Sections after fixation. One LN in. blocks 1-3, second LN in blocks 4-7. Specimen B. is received unfixed labeled right breast biopsy. The. specimen is received in a Transpec container and consists of yellow and. red piece of soft tissue measuring 8.5 by 7.5 by approximately 3 cm. The external surface of the specimen is inked as indicated below. Anterior: Red. Posterior: Orange. Lateral: Blue. Medial: Green. Superior: Yellow. Inferior: Black. There is a relatively central mucinous appearing firm tumor measuring. 2.2 x 2.5 by approximately 2.5 cm. A portion of the specimen is taken. for research purposes as requested. Sections after fixation. RS13.",BRCA,0,"The report states that the 'tumor size: 2.5 cm.' This corresponds to the T2 category, which is defined as 'tumor size 2.1 to 5.0 cm' according to the rules provided.",T2,27.0
561,TCGA-A2-A4RX.CA88491F-5572-4B0D-8E3D-D536E3CE5069,1,"Specimen #: SPECIMEN: A: right axillary sent. node #1 and #2. B: right axillary sent. node #3 C: rt breast. FINAL DIAGNOSIS: A. LYMPH NODES, RIGHT AXILLARY SENTINEL NODES #1 AND #2, EXCISION : - TWO LYMPH NODES, NEGATIVE FOR MALIGNANCY ON ROUTINE AND. IMMUNOHISTOCHEMICAL STAINS. B. LYMPH NODE, RIGHT AXILLARY SENTINEL NODE #3, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR MALIGNANCY ON ROUTINE AND. IMMUNOHISTOCHEMICAL STAINS. C. BREAST, RIGHT, SIMPLE MASTECTOMY: predominant, per T35. - MIXED EPITHELIAL/MESENCHYMAL METAPLASTIC CARCINOMA (CARCINOSARCOMA). - HISTOLOGIC GRADE: 3, POORLY DIFFERENTIATED. - TUMOR SIZE: 2.5 CM. - MARGINS: NEGATIVE. - LYMPH NODES: SEE PARTS ""A"" AND ""B"". - PATHOLOGIC STAGE: pT2 (m) NO (sn). - HORMONE STATUS: (Performed on specimen. - ESTROGEN RECEPTOR: POSITIVE. - PROGESTERONE RECEPTOR: POSITIVE. - HER 2 NEU: NEGATIVE. Comment: Three distinct masses were identified in the mastectomy. specimen, all located in the lower outer quadrant. The two larger masses. (#1 and #2) are histologically similar, showing a poorly differentiated. epithelial component as well as a mesenchymal component displaying marked. pleomorphism and fascicles of spindled cells. Staining of these biphasic. areas show strong pancytokeratin positivity in the epithelial component. while the spindled areas are negative. The histologic and. immunohistochemical pattern is consistent with metaplastic carcinoma. with a malignant sarcomatous component (carcinosarcoma) . While. mass. #1. and #2 are morphologically similar, they are not grossly or histologically. contiguous. The third mass (#3) is a different histologic type (adenoid. cystic carcinoma) It is also grossly separate from masses #1 and #2. As. per the AJCC Cancer Staging Manual, the grade and stage of multiple tumors. of different histologic grade and/or type is based on the largest tumor. Specimen #: FINAL DIAGNOSIS (continued) : (mass #1) , as reflected above. Mass #3 is weakly ER positive (<5% of tumor. nuclei staining), PR negative, and Her- neu negative (1+ staining) . This case received intradepartmental peer review. References: Edge SB., Byrd DR, Carducci MA, Compton CC, eds. AJCC Cancer Staging. Manual. 7th ed. New York, NY: Springer; 2009. Start synoptic report format. - Specimen: Total breast. - Procedure: Simple mastectomy. - Specimen laterality: Right. - Tumor Site: Lower outer quadrant. - Histologic type: Mass #1: Mixed epithelial/mesenchymal metaplastic carcinoma. (carcinosarcoma). Mass #2: Mixed epithelial/mesenchymal metaplastic carcinoma. (carcinosarcoma). Mass #3 : Adenoid cystic carcinoma. - Tumor size (dominant mass) : 2.5 cm (measured grossly) . - Histologic grade (dominant mass) : - Glandular differentiation : 3. - Nuclear pleomorphism: 3. - Mitotic count: 2. - Overall grade: grade 3 score 8 of 9. - Tumor focality: Multifocal. Number of foci: 3. Sizes of individual foci: - Tumor #1: 2.5 x 2.0 x 1.8 cm (measured grossly). - Tumor #2: 2.0 x 2.0 x 1.8 cm (measured grossly). - Tumor #3: 1.1 x 0.8 cm (measured microscopically). Ductal carcinoma in situ (DCIS) : DCIS is present; high nuclear grade. with central necrosis. - Lobular carcinoma in situ: Not identified. - Specimen integrity: Single intact specimen. - Specimen size (greatest dimension) : 21.0 cm. - Margins : Margins uninvolved by invasive carcinoma. - Distance from closest (deep) margin: 1.2 cm (Slide C3, Mass #1). Margins uninvolved by DCIS. - Distance from closest (deep) margin: 1.2 cm (Slide C5). - Macroscopic and microscopic extent of tumor: Page 2 4. Specimen #: CLINICAL DIAGNOSIS AND HISTORY: F diagnosed with right breast IDC, stage 2 ER/PR weakly positive Her2. 1+, that presents for preoperative evaluation prior to planned right. mastectomy with SLNB. PRE-OPERATIVE DIAGNOSIS: POST-OPERATIVE DIAGNOSIS: Operative Findings: Post-operative Diagnosis: GROSS DESCRIPTION: A: The specimen is received in formalin, labeled with the patient's name. designated ""Right Axillary Sentinel Node 1 and #2 Right. Axillary Sentinel Node"" and consists of a 2.5 x 2.0 x 0.8 cm irregular. portion of yellow-tar soft tissue. Sectioning reveals two pink-tan lymph. nodes measuring 1.5 x 1.5 x 0.8 cm and 2.0 x 1.0 x 0.4 cm. Each lymph. node is trisected to reveal a pink-tan cut surface that is otherwise. unremarkable. The lymph nodes are entirely submitted as follows. A1: first described lymph node. A2: second described lymph node. B. The specimen is received in formalin, labeled with the patient's. designated ""Right Axillary Sentinel Node #3"" and. consists of a pink-gray lymph node measuring 2.0 x 1.5 x 0.6 cm. The. lymph node is trisected to reveal an unremarkable cut surface. The. specimen is entirely submitted in two cassettes. The specimen is received in formalin, labeled with the patient's.  designated ""Right Breast"" and consists of a right. mastectomy oriented with a short stitch superior and long stitch lateral. The specimen measures 21.0 cm from medial to lateral, 21.0 cm from. superior to inferior and 4.0 cm anterior to posterior. The darkly. pigmented superficial skin ellipse measures 6.2 x 4.5 cm and displays a. centrally located everted nipple measuring 1.0 cm in diameter. No. discharge is noted. No scars are noted. The specimen is inked as. follows: deep margin = black. superior surface of the lower outer quadrant = blue. Upon sectioning the cut surface is composed predominantly of yellow-tan. lobulated adipose tissue admixed with approximately 20% dense pink-white. fibrous tissue which is predominantly located in the central breast. Two. discrete masses are identified in the lower outer quadrant. Mass #1. Specimen #: FINAL DIAGNOSIS (continued) : - Skin involvement : Not involved by carcinoma. - Nipple involvement : Not involved by carcinoma. - Skeletal muscle involvement: Muscle is not present. - Treatment effect: - In the breast: No known presurgical therapy. - In the lymph nodes : No known presurgical therapy. - Lymphvascular invasion: Not identified. - Necrosis : Present within DCIS. - Microcalcifications: Identified within invasive and in situ carcinoma. - Lymph Nodes: - Lymph nodes sampling: Sentinel lymph nodes. - Number of sentinel nodes: 3. - Total number of lymph nodes: 3. - Lymph nodes with macrometastasis (>0.2cm) : 0. - Lymph nodes with micrometastasis (>0.2mm to 0.2cm) : 0. - Lymph nodes with isolated tumor cells (<=0.2 mm) : 0. - Size of largest deposit: Not applicable. - Extranodal extension: Not applicable. - Additional findings. - Intraductal papilloma. - Biopsy site changes. Ancillary studies: Performed on. - Estrogen receptor: Positive (1-5% tumor nuclei staining). - Staining intensity: Weak. Progesterone receptor: Positive (5% tumor nuclei staining) . - Staining intensity: Intermediate. Her-2 Neu by IHC: Negative (score 1+) . - Her- 2 Neu by FISH: Not performed. - Pathologic staging: - Primary tumor: pT2 (m). - Regional lymph nodes : pNO (sn). - Distant metastasis: Not applicable. Specimen #: GROSS DESCRIPTION (continued) : measures 2.5 x 2.0 x 1.8 cm. The cut surface is pink-ta and gritty. The. mass is located 1.4 cm from the deep margin and 1.0 cm from the. superficial margin. Mass #2, also located within the lower outer. quadrant, measures 2.0 x 2.0 x 1.8 cm. The mass is also well defined,. pink-tan and gritty. Mass #2 is located 3.0 cm from the deep margin and. approximately 1.0 cm from the superficial surface. Mass #2 is located. anterior and medial to mass #1. The two masses are adjacent and yet. appear discrete. The remainder of the lower outer and mid outer breast. shows a 5.0 x 3.0 x 2.5 cm area of dense pink-white fibrous tissue which. is focally indurated (mass #3) On sectioning, the cut surface is. pink-white and otherwise unremarkable with no discrete lesions identified. No additional lesions are identified. No lymph nodes are identified. Representative sections are submitted in twenty-two cassettes as follows: C1: skin and nipple. C2-C4: mass #1 with deep margin. C5: mass #1 with superficial margin. C6,C7&C8: additional mass #1. C9&C10: intervening tissue between mass #1 and mass #2. C11: mass #2 with superficial margin. C12: mass #2. C13: mass #2 with superficial margin. C14: mass #2. C15, C16&C17: indurated fibrous tissue mid outer breast (mass #3). C18: upper outer quadrant. C19: lower outer quadrant. C20: lower inner quadrant. C21: upper inner quadrant. C22: central breast. (some saved, three images taken labeled with mass #1 and mass #2). Mirrored images of mass #1 and mass #2 are submitted in paraffin and OCT. per. protocol. Time/Date of Specimen removal unknown. Time/Date in Pathology: Time/Date in formalin: Total time prior to fixation: unknown. Time/Date out of formalin: Total fixation time: 28 hr 45 min. Discrep ancy. Date Re ieweit.",BRCA,0,"The T stage is based on the size of the tumor, without considering the involvement of the chest wall or skin. The report states that the largest tumor measures 2.5 cm, which falls under the 'T2' category (T2: tumor size 2.1 to 5.0 cm).",T2,28.0
541,TCGA-A2-A1G6.02B4C31E-38F0-4AF3-8DAD-527D5F27C11A,1,"of '. specimen: spec Type: SURGICAL P. D. RIGHT BREAST CANCER - INVASIVE. DOCTOR ($): PROCKDURE: MODIFIND BADICAL. A. RIGHT MODIFIED RADICAL MASTECTOMY. B. MEDIAL SKIN RIGHT BREAST. PART A IS RECEIVED LABELED. RIGHT MODIFIED RADICAL. MASTECTOMY STITCH MARKS 12 O'CLOCK, IS A RIGHT MODIFIED RADICAL. MASTECTOMY SPECIMEN MEASURING 26 x 18.5 x 5.5 CM IN GREATEST DIMENSIONS. THE NIPPLE IS UNREMARKABLE AND IS WITHIN A 19 x 11.7 CM SKIN ELLIPSE. IN. THE 5 TO 6 O'CLOCK AREA AT THE INFERIOR MARGIN THERE IS A 3 CM IN. DIAMETER CYSTIC STRUCTURE. THE SKIN HAS A BROWN DISCOLORED PLAQUE-LIKE. AREA AT 12 O'CLOCK. THERE IS A PALPABLE FIBROUS MASS IN THE BREAST TISSUE. BENEATH THE SUTURE SPANNING A DISTANCE OF 6 x 5 x 3.5 CM. THE SUPERFICIAL. ASPECT IS MARKED WITH BLUE INK, THE DEEP MARGIN WITH BLACK. THE AXILLARY. TAIL IS REMOVED FROM THE SPECIMEN AND WHERE IT IS REMOVED IT IS MARKED. WITH RED INK AND DOES NOT REPRESENT TRUE MARGIN. THERE IS ONE GROSSLY. POSITIVE LYMPH NODE IN THE MIDPORTION OF THE AXILLARY TAIL. THE HIGHEST. NODE GROSSLY IS NEGATIVE. SECTIONS ARE SUBMITTED AS FOLLOWS: A1--NIPPLE, A2--ONE-HALF OF A GROSSLY POSITIVE LYMPH NODE (REMAINDER. SUBMITTED PER PROTOCOL), 13--GROSSLY HIGHEST LYMPH NODE, A4--ONE LYMPH. NODE BISECTED, A5--ONE LYMPH NODE BISECTED, A6--ONE LYMPH NODE. A7--TUMOR. AND DEEP MARGIN, A8 AND A9--TUMOR AND SKIN ADDING TO A8 AN AREA OF COIL. CLIP, A10--TUMOR AT INFERIOR ASPECT ADJACENT TO FIBROUS TISSUE,. All--TISSUE IMMEDIATELY ADJACENT TO TUMOR UPPER INNER QUADRANT,. 12--TISSUE IMMEDIATELY ADJACENT TO TUMOR UPPER OUTER QUADRANT,. A13--ADDITIONAL UPPER OUTER QUADRANT, A14--LOWER OUTER QUADRANT 4.5 CM. FROM GROSS TUMOR, A15--LOWER INNER QUADRANT 3 CM FROM GROSS TUMOR,. A16--CYSTIC STRUCTURE IN 5 O'CLOCK AREA. THE AXILLARY TAIL IS THEN. FURTHER EXAMINED FOR LYMPH NODES, WHICH ARE SUBMITTED AS FOLLOWS : A17--ONE NODE BISECTED, A18--ONE BONE BISECTED, A19--ONE NODE BISECTED,. A20--ONE NODE BISECTED. ASSOCIATED WITH THE PLAQUE-LIKE AREA OF THE SKIN. IS AN UNDERLYING FIRM PINK-GRAY MASS MEASURING 3.5 x 3.3 x 3.1 CM IN. GREATEST DIMENSIONS. GROSSLY THIS EXTENDS TO WITHIN 0.8 CM OF THE DEEP. MARGIN. THE CENTRAL PORTION OF THE BREAST ALSO DEMONSTRATES DENSE. GRAY-TAN FIBROUS TISSUE WITH MULTIPLE CYSTS. ADDITIONAL SECTIONS ARE SUBMITTED AS FOLLONS FOLLONING INITIAL REVIEW OF. SLIDES: A21 AND A22--SKIN MARGIN, 23--SUPERFICIAL MARGIN. Chief of Pathology. Fhone (. (Contiaued). Speciment. Regti. spec Type: SURGICAL P. PART B IS RECEIVED. MEDIAL SKIN RIGHT BREAST. IT CONSISTS. OF AN UNORIENTED, SOMEWHAT TRIANGULAR PORTION OF SKIN WITH UNDERLYING. SUBCUTANEOUS TISSUE, APPROXIMATELY 2 x 1 x 1 CM. THE RESECTION IS INKED. THE SPECIMEN IS SECTIONED AND ENTIRELY SUBMITTED IN CASSETTES B1 AND B2. PROCEDURES: 88305, 88309, A BLK/23, B BLK/2. PART A RIGHT MODIFIED RADICAL MASTECTOMY: IN SITU AND INFILTRATING. DUCTAL CARCINOMA. THE INFILTRATING TUMOR IS MODERATELY DIFFERENTIATED,. NUCLEAR GRADE III/III WITH A MODERATE MITOTIC INDEX. THE SUPERFICIAL. ASPECT OF THE TUMOR EXTENDS INTO THE DERMIS. THE DEEP MARGIN IS FREE OF. TUMOR BY A DISTANCE OF 10 MM FOR A SUPERFICIAL TO DEEP SIZE OF 35 MM. OVER 90% OF THE TUMOR IS INVASIVE. AREAS OF PROBABLE BREAST LYMPHATIC. SPACE INVASION ARK PRESENT BUT DERMAL LYMPHATIC SPACE INVASION IS NOT. IDENTIFIED. BREAST TISSUE AWAY FROM THE PRIMARY TUMOR MASS SHONS. PROLIFERATIVE FIBROCYSTIC DISEASE. SKIN MARGINS CLOSEST TO THE TUMOR ARE. NEGATIVE. METASTATIC CARCINOMA IS PRESENT IN 4 OF 9 LYMPH NODES. PART B MEDIAL SKIN OF RIGHT BREAST, RESECTION: SKIN AND SUBCUTANEOUS FAT. WITH NO EVIDENCE OF MALIGNANCY. 1. (prelim.). (signature on file).",BRCA,2,"The report states that the largest dimension of the tumor is 35 mm (3.5 cm), which falls within the range for T3 (tumor size over 5.0 cm without direct extension to the chest wall or skin). The statement 'Over 90% of the tumor is invasive' also supports the T3 stage.",T3,28.0
584,TCGA-A7-A26H.1159E2EF-6407-4D90-8ED6-7AB04CF4FB32,0,"DEPARTMENT OF PATHOLOGY AND LABORATORY MEDICINE. Date Coll: SPECIMEN. A. Left axillary sentinel node. B. Left breast (arrow points up). C. Right axillary sentinel node. D. Right axillary sentinel node #2 active in blue. E. Right breast (arrow points up). F. Left axillary contents. CLINICAL NOTES. PRE-OP DIAGNOSIS: Bilateral breast. FROZEN SECTION DIAGNOSIS. A) Sentinel lymph node, left axilla, biopsy: One lymph node,. positive for carcinoma. C. Sentinel lymph node, opsy: One lymph node,. negative for carcinoma. D. Sentinel lymph node, right axilia #2, biopsy: One lymph node,. negative for carcinoma. GROSS DESCRIPTION. A. The specimen is received unfixed labeled ""left axillary sentinel. noand consists of a yellow and red piece of soft tissue measuring. 2.5 x 2 x 0.8 cm. On cut section there is a contained lymph node. measuring 1.2 cm. in greatest dimension. The node is bis -and. submitted all for frozen section diagnosis as requested. B. The specimen is received unfixed labeled ""left breast. arrow points up"" and consists of a breast resection. specimen measuring 19.5 x 18.5 x 3.0 cm. There is an overlying. white ellipse of skin measuring 16 x 9.3 cm. There is a central. areola measuring 3 x 4 cm. and a central nipple measuring 1.2 x 1. x. 0.4 cm. There is an arrow incised in the skin and there is an area. of induration at the superior edge of the areola that might be. a. biopsy scar. It measures 1.5 x 0.7 cm. The deep surface of the. specimen is inked. The breast is sectioned at 1 cm. intervals in. the deep surface towards the skin. Some blue-domed cysts are. present. There is a relatively central red area compatible with a. biopsy site defect and there is some firmness around this area. The. firm area measures 1.5 x 1.5 x approximately 1.5 cm. This area. is. central and inferior and there is another area that is central below. the indurated part of the skin that looks like carcinoma grossly and. measures 1.2 x 1.5 x approximately 1.5 cm. A portion of the larger. area is taken for research purposes. Sections after fixation. Block summary: 1,2 nipple and skin with tumor; 3 deep margin; 4-6. biopsy site; 7-10 quadrants (UO, UI, LO, LI). C. Received unfixed labeled ""right axillary sentinel node"". and consist of two pieces of yellow and red soft tissue. measuring 2 x 1.8 x 0.7 cm. and 2.5 x 2.5 x 0.7 cm. There is a. contained lymph node measuring 1 cm. in greatest dimension and the. entire node is submitted for frozen section diagnosis as requested. D. Received unfixed labeled ""right axillary sentinel node. #2 active in blue"" and consist of a yellow, red and blue. piece of soft tissue measuring 5.5 x 3 x 0.6 cm. There is. a. partially blue contained lymph node measuring 2.3 cm. in greatest. dimension. The specimen is submitted all for frozen section. diagnosis as requested. E. [The original gross dictation on specimen E. is lost.] The. specimen was received unfixed labeled right breast and consisted of. a 27 x 19 x 4.5 cm breast resection specimen with overlying ellipse. of skin measuring 16.5 x 9 cm. There was a central areola and. nipple. An area of arrow was incised to the skin. Some blue dye. and. injected. The deep surface the specimen was inked and the breast. resection at 1 cm intervals from the deep surface towards the skin. There was a central biopsy site and additional relatively central. firm area compatible with carcinoma. Block summary: 1, nipple; 3 skin; 4 - deep margin; 5-7 biopsy. site; 8,9 area resembling tumor; 10-13 quadrants (UO.UI.LO.LI). F. The specimen was received unfixed, labeled ""left. axillary contents"" and consists of a yellow and pink of. soft tissue measuring 12 x 8 x 2 cm. RS-2. MICROSCOPIC DESCRIPTION. A. Metastatic carcinoma is present in one lymph node. The tumor is. 0.7 cm in diameter. No extranodal tumor is seen. B. Invasive carcinoma. Tumor type: Infiltrating ductal carcinoma. Tumor grade: 1 (Elston SBR grade; A/N/M = 2/2/1). Mitotic index: 3 mitoses/10 HPFs (1 HPF = 0.196 sq mm). Tumor size: 1.5 cm. Vessel invasion: Absent. Calcification: Absent. pTNM stage: T1 pN1a. Prognostic markers: Requested. Nipple: Carcinoma is present in skin adjacent to the nipple. Deep margin: Negative for malignancy. Nontumorous breast: Sections from the biopsy site away from. the tumor show scar, cyst formation, columnar metaplasia,. benign calcification, usual ductal hyperplasia and focal atypical. ductal hyperplasia. C. A Single lymph node is negative for malignancy. D. A single lymph node is negative for malignancy. E. Invasive carcinoma. Tumor type: Infiltrating ductal carcinoma. Tumor grade: 2 (Elston SBR grade; A/N/M = 3/2/1). Mitotic index: 3 mitoses/10 HPFs (1 HPF = 0.196 sq mm). Tumor size: 1.2 cm on the glass slide. Vessel invasion: Absent. Calcification: Absent. pTNM stage: T1. Prognostic markers: See previous biopsy. The tumor is specimen E from the right breast has a central fibrotic. focus. Sections near the biopsy site away from the gross carcinoma. described above show columnar metaplasia, usual ductal hyperplasia,. cyst formation apocrine metaplasia. An atypical area is p63. positive. F. There is no evidence of malignancy in any of 4 lymph nodes. 4x6,25x3,20,14x3. DIAGNOSIS. A. Sentinel lymph node, left axilla, biopsy: Metastatic carcinoma in. a single lymph node. B. Breast, left, resection: Infiltrating ductal carcinoma, Elston. SBR grade 1. C. Sentinel lymph node, right axilla, biopsy: A single lymph node is. negative for malignancy. D. Sentinel lymph node #2, right axilla, biopsy: A single lymph node. is negative for malignancy. E. Breast, right, resection: Infiltrating ductal carcinoma, Elston. SBR grade 2 F. Lymph nodes, left axilla, blopsy: There is no. evidence of malignancy in any of 4 lymph nodes. ictronic Signature).",BRCA,1,"The report indicates that the largest tumor size is 1.5 cm in the left breast (specimen B), which falls under the 'T1' category of tumor size up to 2.0 cm. This is further supported by the pTNM stage 'T1' mentioned in the report for the left breast tumor.",T1,28.0
586,TCGA-A7-A26J.5CC0C09F-70F6-458A-B8E6-18BDC074BE74,1,"Date Coll: SPECIMEN. A. Left axillary sentinel node. B. Left breast silk on superior breast. CLINICAL NOTES. PRE-OP DIAGNOSIS: Left breast cancer. CLINICAL HISTORY: year-old white female with cancer. POST-OP DIAGNOSIS: Same. GROSS DESCRIPTION. A. Received fresh labeled ""left axillary node"" is a 3.8. x. 2.4 x 0.6 cm. portion of soft, lobulated golden-yellow. adipose tissue. Two (2) slightly rubbery tan-pink tissues in. keeping with lymph node measuring 0.8 and 1.8 cm. in greatest. dimension are recovered. The specimen is entirely submitted in. three blocks as labeled: BLOCK SUMMARY: #A1,A2 - One (1) bisected lymph node per cassette;. -1 adipose tissue. B. Received fresh labeled ""left breast"" is a 21.5 cm. (superior to inferior) x 20.5 cm (medial to lateral) x 3.8. cm (anterior to posterior) diffusely cauterized soft, lobulated. tan-gold-white portion of fibroadipose tissue in keeping with breast. designated as left per requisition slip and container and oriented. by a single suture as stated previously. A 7.2 cm (medial to. lateral) x 4.7 cm (superior to inferior) tan-white skin ellipse is. present along the anterior aspect. The intact deep margin is inked. black and the specimen is sectioned. There is a central, stellate,. 3.0 cm (medial to lateral) x 2.2 cm (superior to inferior) x 2.0. cm. (anterior to posterior) rubbery tan-white lesion at the junction of. the four quadrants with several cylindrical tan-white structures in. keeping with site of prior needle core biopsy. A portion of the. lesion and a portion of normal are submitted for tissue procurement. as. requested. The lesion is present within 0.8 cm of the skin. surface in the vicinity of the nipple and is within 0.5 cm of the. inked deep margin. The parenchyma throughout the remainder of the. specimen consists predominantly of glistening lobulated golden. yellow adipose tissue with a moderate amount of interspersed dense. tan-white fibrous tissue. No additional mass lesion or abnormality. is identified. Three rubbery white-pink tissues in keeping with. lymph nodes measuring up to 0.8 cm in greatest dimension are. recovered from the lateral aspect of the specimen. Representative. sections are submitted in 12 blocks as labeled. BLOCK SUMMARY: 1-2 - Tumor to inked deep margin; 3-4 - tumor to. skin (4 includes nipple); 5-6 - tumor to adjacent parenchyma; 7 -. random upper outer quadrant; 8 - upper inner quadrant; 9 - lower. inner quadrant; 10 - lower outer quadrant; 11 - two whole lymph. nodes; 12 - one bisected lymph node. MICROSCOPIC DESCRIPTION. Invasive carcinoma: Histologic type: Ductal (with lobular features). Histologic grade : III. Overall grade: 8/9. Architectural score: 3. Nuclear score: 3. Mitotic score: 2. Greatest dimension (pT) : 3.0 cm. Specimen margins: Negative. Vessel invasion: Present. Calcification: Negative. Nipple (Paget's) : Carcinoma involves the deep nipple tissue, and. is present in the deep dermis within the skin adjacent to the. nipple (areolar area) . Invasion of skin or chest wall: As above. Ductal carcinoma in situ: Histologic pattern: Cribriform. Nuclear grade: 3. Central necrosis: Present. 8 DCIS of total tumor (if mixed) : < 10%. Extensive intraductal component (present/absent) : Absent. Specimen margins: Negative. Calcification: Negative. Description of non-tumorous breast: Fibrocystic changes,. fibroadenomata. Comments: Prior biopsy site identified within the main tumor mass. There is an additional satellite nodule of invasive tumor, 2 mm in. greatest dimension, in the lower outer quadrant, away from the main. tumor mass, and associated with ductal carcinoma in-situ. This. focus of invasive tumor is 2 mm from the deep margin. Lymph nodes: Two negative sentinel lymph nodes, and two negative. additional lymph nodes (0/4). Prognostic markers: See previous report,. 4x2. DIAGNOSIS. A. Sentinel lymph node, left axilla, biopsy: Two negative lymph nodes (0/2). B. Breast, deft mastectomy: Invasive ductal carcinoma, grade III, 3.0 cm in greatest. dimension. Negative margins of excision. Lymphovascular invasion identified. Two negative lymph nodes (0/2). ectronic Signature). End Of Report ---.",BRCA,0,"The report states that the greatest dimension of the invasive tumor is 3.0 cm, which falls within the T2 category of tumor size (2.1 to 5.0 cm).",T2,28.0
631,TCGA-A8-A07P.6C7D956E-1247-4663-9ED5-D406AE6E2959,1,"On the basis of these findings, the following overall diagnosis is established: Left breast segment at 2 o'clock with a 3.5 cm invasive ductal breast carcinoma grade 3. (3/3/2) with minimum distance of 1 mm from dorsal resection margin and cranial resection. margin of 3 mm with very small components of ductal carcinoma in situ grade 3 with comedo. necrosis, as well as a lymph node with a tumor (1/11). Tumor classification: pT2 (3.5 cm), pN1 (1/11), MX grade 3 (LO/V0), R0 (dorsal 1 mm,. cranial 3 mm).",BRCA,1,"The report states that the size of the invasive ductal breast carcinoma is 3.5 cm, which falls within the range for a T2 tumor (2.1 to 5.0 cm).",T2,28.0
512,TCGA-A2-A0SW.8401DFCF-8793-461A-B17E-E6584CE2423B,1,"Lab No.: F. Date Collected: Date Received: Doctor: M.R. No.: Room No: Hosp.No: CLINICAL HISTORY: PREOPERATIVE DIAGNOSIS: Right Breast Cancer. POSTOPERATIVE DIAGNOSIS: OPERATION: Lumpectomy Right Breast, Right Sentinel Lymph Node Biopsy. SPECIMEN: A) Right Breast Mass - 1 Short Anterior - 2 Short Superior - 1 Long. Medial, B) Sentinel Node #1 F.S., C) Sentinel Node #2 F.S., D) Axillary Contents E). Gross Margin Additional Inferior Margin Right Breast Mass suture New Inferior Margin. FROZEN SECTION DIAGNOSIS: A) GROSS MARGINS: VERY CLOSE (LESS THAN 1 MM), TO. INFERIOR MARGIN. B) SENT LYMPH NODE #1 - POSITIVE FOR METASTATIC. CARCINOMA. C) SENT LYMPH NODE #2 - POSITIVE FOR METASTATIC. CARCINOMA. Lab No.: F. Date Collected: Date Received: Doctor: M.R. No.: Room No: Hosp.No: FINAL DIAGNOSIS: A) RIGHT BREAST TISSUE - POORLY DIFFERENTIATED. INFILTRATING DUCTAL CARCINOMA. SCARFF-BLOOM-RICHARDSON GRADE III/III. THE TUMOR MEASURES 3.5 CM. IN MAXIMUM DIMENSION AND. FOCALLY CLOSE TO ANTERIOR AND POSTERIOR SURGICAL. MARGINS, (LESS THAN 1 MM.), SLIDES #5 AND #6. THE REMAINING SURGICAL MARGINS ARE FREE OF THE. LESION. LYMPHOVASCULAR INVASION IS IDENTIFIED. MICROCALCIFICATIONS ARE IDENTIFIED. B) SENTINEL LYMPH NODE - ONE (1) POSITIVE LYMPH NODE, (1/1). C) SENTINEL LYMPH NODE - ONE (1) POSITIVE LYMPH NODE, (1/1). D) AXILLARY CONTENTS - 2 OF 13 LYMPH NODES ARE POSITIVE FOR. MALIGNANCY, (2/13). E) ADDITIONAL RIGHT BREAST TISSUE - NEGATIVE FOR. MALIGNANCY. PTNM CLASSIFICATION: PIIIa, T2, N2, MX.",BRCA,2,"The T stage is determined by the size of the tumor. The report states that the tumor measures 3.5 cm in maximum dimension. According to the rules provided, T1 tumors are up to 2.0 cm, T2 tumors are 2.1 to 5.0 cm, T3 tumors are over 5.0 cm without direct extension to the chest wall or skin, and T4 tumors have direct extension to the chest wall or skin. Therefore, the tumor in this report is a T2 tumor.",T2,28.0
563,TCGA-A2-A4S0.0118D9AE-B923-4EEF-BBBC-82D559763FF9,1,"Status: DIS-IN. M.D. Specimen: Sp type: SURGICAL P. M.D. PREOPERATIVE DIAGNOSIS. BREAST CA. OPERATION PERFORMED. DOCTOR (S) : PROCEDURE : TOTAL MASTECTOMY; EXCISION OF AXILLARY SENTINEL NODE. TISSUE REMOVED. A. RIGHT BREAST STITCH AT 12 O'CLOCK. B. RIGHT SENTINEL NODE #1. GROSS DESCRIPTION. RECEIVED IN 2 PARTS. A RECEIVED LABELED. RIGHT BREAST STITCH AT 12 O'CLOCK IS. A 2041 SIMPLE MASTECTOMY MEASURING 33.5 CM FROM MEDIAL TO LATERAL, 28 CM. FROM SUPERIOR TO INFERIOR, AND UP TO 5.5 CM FROM ANTERIOR TO POSTERIOR. THE NIPPLE IS INVERTED WITHIN A 31 X 17 CM SKIN ELLIPSE. A SUTURE. DENOTES 12 O'CLOCK. 4 CM LATERAL TO THE NIPPLE AT 9 O'CLOCK IS A. LOBULATED RED-TAN GLISTENING MASS MEASURING 2.2 CM FROM SUPERIOR TO. INFERIOR, 2 CM FROM ANTERIOR TO POSTERIOR, AND 4.5 CM FROM MEDIAL TO. LATERAL. THIS LESION IS 2.5 CM FROM THE DEEP MARGIN. TOWARDS THE. LATERAL EDGE THERE IS A 2ND NODULE ADJACENT BY LESS THAN 1 CM MEASURING. 1 x 1 X 1 CM. THERE IS A RIBBON CLIP ASSOCIATED WITH THIS AREA. THE. REMAINING BREAST TISSUE CONSISTS OF BLAND YELLOW FATTY TISSUE WITH FINE. FIBROUS BANDS. A WING CLIP IS IDENTIFIED IN THE LARGER LESION. REPRESENTATIVE SECTIONS ARE SUBMITTED AS FOLLOWS: A1--NIPPLE, A2--DEEP. MARGIN TO LARGER LESION, A3--THE MOST LATERAL PORTION OF THE LARGER. LESION, A4--THE MOST MEDIAL PORTION OF THE LARGER LESION 4.5 CM FROM A3,. A5 THROUGH A7--ADDITIONAL SECTIONS OF LARGER LESION, A8 AND --SMALLER. SUPERIOR RIBBON CLIP LESION, A10--UPPER INNER QUADRANT 10 CM FROM THE. LESION, All--UPPER OUTER QUADRANT 4 CM FROM LESION, A12--LOWER OUTER. QUADRANT 4 CM FROM LESION, A13--LOWER INNER QUADRANT 10 CM FROM LESION. TISSUE IS TAKEN PER CLINICAL BREAST CARE PROJECT RESEARCH PROTOCOL OF. THE LARGER LESION LABELED P1-p5 WITH FROZEN OCT SAMPLES AS MIRROR IMAGES. TO P1 AND P2. IN ADDITION A MIRROR IMAGE SECTION OF THE NIPPLE (A1) IS. SUBMITTED FROZEN IN OCT ALONG WITH THE 4 RANDOM QUADRANT SECTIONS. Specimen: Sp type: SURGICAL P. D. GROSS DESCRIPTION. A10-A13. B RECEIVED LABELED. RIGHT SENTINEL NODE #1 HOT AND BLUE. COUNT 39252 IS A PORTION OF PINK-TAN TISSUE WITH BLUE COLORATION. MEASURING 1.3 X 0.8 X 0. . 4 CM. THE SPECIMEN IS BISECTED AND SUBMITTED. LABELED B. COMMENT: THIS CASE EXCEEDS THE MAXIMUM CAP/ASCO. GUIDELINE OF 48 HOURS FORMALIN FIXATION. PATH PROCEDURES. PROCEDURES: 88307/2, IMMUNOPEROXIDAS, A BLK/13, BBX X6. FINAL DIAGNOSIS. PART A RIGHT BREAST, SIMPLE MASTECTOMY: 1. Macinous CA 1/1/1. INVASIVE MUCINOUS CARCINOMAS (2) GRADE I WITH NUCLEAR GRADE 1 AND. LOW MITOTIC INDEX. 2. THE TUMORS MEASURE 4.5 AND 1.0 CM IN GREATEST DIMENSION. THE NIPPLE. AND DEEP MARGIN ARE FREE OF NEOPLASM. 3. LYMPHATIC INVASION IS NOT IDENTIFIED. 4. BIOPSY SITE CHANGES WITH CLIPS PRESENT. 5. PROLIFERATIVE FIBROCYSTIC DISEASE WITH CALCIFICATIONS PRESENT. PART B RIGHT SENTINEL NODE 1: LYMPH NODE (1), NEGATIVE FOR TUMOR BY. STEP SECTION AND CYTOKERATIN STAIN. , M.D.",BRCA,0,"The report mentions the presence of two invasive mucinous carcinomas with the largest one measuring 4.5 cm in greatest dimension. According to the rules provided, T2 corresponds to a tumor size of 2.1 to 5.0 cm, which includes a 4.5 cm tumor.",T2,28.0
618,TCGA-A8-A06Z.956F45E5-A8C6-4A4A-9D1F-D31912180584,2,"Diagnosis: 1. Moderately differentiated invasive ductal carcinoma (tumor diameter: 8 cm). Distance to dorsal resection margin less than 0.1 cm. Concluding tumor classification for the right breast: NOS, G II, pT3LOVORX.",BRCA,0,"The report states that the tumor diameter is 8 cm, which falls under the 'T3: tumor size over 5.0 cm without direct extension to the chest wall or skin' category. Although the report mentions that the distance to the dorsal resection margin is less than 0.1 cm, this information is not used to determine the T stage based on the provided rules.",T3,29.0
670,TCGA-A8-A09C.1E002C47-CEC6-491C-9E67-B289687D5B66,1,"Diagnosis: Moderately differentiated invasive ductal breast carcinoma with a diameter of 2.2 cm. extending cranially to within 5 mm of the resection margin at 3 and 12 o'clock. Normal. follow-up resection material and tumor-free sentinel lymph nodes. Tumor classification: M-8500/3, G2, pT2, pN 0 (sn), MX, R0.",BRCA,0,"The T stage is determined by the size of the tumor. According to the report, the tumor size is 2.2 cm, which falls under the T2 category (tumor size 2.1 to 5.0 cm).",T2,30.0
600,TCGA-A7-A4SF.C1B1FAA6-EB15-43BB-B3A3-D11511C76060,1,"Final Surgical Pathology Report. Procedure. Diagnosis. A. Sentinel lymph node, right axilla, biopsy: Two negative lymph. nodes (0/2). B. Breast, right, excisional biopsy: Invasive ductal carcinoma, grade 2, size not less than 2.5 cm,. present at the medial and posterior margins; see microscopic. description. Ductal carcinoma in-situ, grade 2, present at the inferior. margin. Microscopic Description: Invasive Carcinoma: Histologic type: Ductal. Histologic grade: 2. Overall grade: 7/9. Architectural score: 3. Nuclear score: 2. Mitotic score: 1. Greatest dimension (pT2) : Not less than 2.5 cm, and possibly as. much as 4.0 cm (invasive carcinoma extends away from the main. tumor mass into the surrounding fat throughout much of the. specimen). Specimen margins: Invasive carcinoma is broadly present at. the medial and posterior margins. Vessel invasion: Not identified. Calcification: Not identified. Ductal carcinoma in situ: Histologic pattern: Solid, cribriform. Nuclear grade: 2. Central Necrosis: Focal. % DCIS of total tumor (if mixed) : 28. Extensive intraductal component (present/absent) : Absent. Specimen margins: DCIS is at the inferior margin of the. specimen. Calcification: Negative. Comments: Two prior biopsy sites are identified in the mid-portion of. the specimen. There is a confluence of tumor present microscopically. between the two apparent masses formed by the tumor, supporting the. conclusion of a single tumor mass lesion. Additionally, there is. tumor infiltrating around and beyond the tumor mass areas, into the. surrounding fat, and to the specimen margins as stated above. p63. immunostaining performed to confirm the presence of invasive carcinoma. at the margin. E-cadherin performed to exclude LCIS and confirm DCIS. at the inferior margin. Cytokeratin immunostaining performed on two lymph node blocks to. exclude metastatic carcinoma; stains are negative. Prognostic markers: See previous biopsy report. [A few of the antibodies used in our laboratory may be classified as. analyte specific reagents. These antibodies are monitored and. controlled in our laboratory and their performance for in vitro. diagnosis is well described in the medical literature. They have not. been cleared or approved by the FDA. Specimen. A. Right axillary sentinel lymph node. B. Right breast mass, long anterior, short superior - tissue. Clinical Information. Right breast cancer;. year old black female with two side by side. cancers. Gross Description. A. Received unfixed, labeled right axillary sentinel node, are. 2. lymph nodes, 0.7 and 0.8 cm in greatest dimension each, entirely. submitted with each lymph node and a separate block (bisected). B. Received unfixed, and a transparent container, labeled right. breast mass, is a 5.5 x 4.3 x 3.0 cm portion of fibroadipose tissue. with orienting sutures. Margins are inked: Anterior black,. posterior blue, lateral green, and medial yellow. The specimen is. serially sectioned from superior to inferior. There is a 2.5 x 2.5. x 1.5 cm tumor mass, which is somewhat dumbbell-shaped, but appears. to consist of one tumor mass. Sections submitted as follows: 1. superior margin, 2 through 6 superior-most portion of tumor, 7. through 9 transition area of probable second lobe of tumor mass. (contiguous sections), 10 breast tissue intervening between tumor. mass and margin, 11 - inferior margin. Portion of tumor and normal. submitted for tissue procurement, as requested. Additional. sections submitted: RR1 intervening tissue between superior margin. and tumor; 2-4 additional superior tissue, 5-7 representative. remaining first half of specimen; 8-14 inferior half of specimen;. 15 additional inferior margin.",BRCA,0,"The T stage is determined by the size of the tumor. The report states that the size of the tumor is 'not less than 2.5 cm, and possibly as much as 4.0 cm', which falls within the T2 category of tumor size being between 2.1 to 5.0 cm.",T2,31.0
508,TCGA-A2-A0EY.61462D57-DF98-4F89-BAEF-E8156A47E2DD,1,"Specimen #: : WHITE. SPECIMEN: A: RIGHT BREAST LUMPECTOMY B: ADDITIONAL INFERIOR MARGIN. C: ADDITIONAL DEEP MARGINS D: SENTINEL NODE #1. E: SENTINEL LYMPH NODE #2. FINAL DIAGNOSIS: A. BREAST, RIGHT, LUMPECTOMY: - TUMOR TYPE: INFILTRATING DUCTAL CARCINOMA. - NOTTINGHAM GRADE: MODERATELY DIFFERENTIATED. - NOTTINGHAM SCORE: 6/9. (Tubules= 2, Nuclei= 3, Mitoses= 1). TUMOR SIZE (GREATEST DIMENSION) : 2.8 CM. - TUMOR NECROSIS: NOT IDENTIFIED. - MICROCALCIFICATIONS: PRESENT ASSOCIATED WITH INFILTRATING CARCINOMA. AND BENIGN DUCTS. - VENOUS / LYMPHATIC INVASION: NOT IDENTIFIED. - MARGINS : UNINVOLVED. - DISTANCE OF INVASIVE TUMOR FROM NEAREST MARGIN IS 0.3 CM, FROM. INFERIOR MARGIN. (measured microscopically). INTRADUCTAL COMPONENT: PRESENT; SOLID AND CRIBRIFORM, NUCLEAR GRADE. 3, WITH CENTRAL NECROSIS. - LYMPH NODES: SEE PARTS ""D-E"". - ONE OF TWO SENTINEL LYMPH NODES POSITIVE FOR METASTATIC CARCINOMA. - SKIN INVOLVEMENT: NOT IDENTIFIED. - ESTROGEN RECEPTORS: POSITIVE (SEE. - PROGESTERONE RECEPTORS: NEGATIVE (SEE. - HER 2 NEU by IHC: POSITIVE (SEE. - PATHOLOGIC STAGE: pT2 N1a MX. - ADDITIONAL PATHOLOGIC CHANGES : USUAL DUCTAL HYPERPLASIA, FIBROCYSTIC. CHANGES, SCLEROSING ADENOSIS, UNREMARKABLE EPIDERMIS. B. BREAST, ""ADDITIONAL INFERIOR MARGIN"", EXCISION: - BENIGN BREAST TISSUE. - MARGINS UNINVOLVED. PATHOLOGIC CHANGES : USUAL DUCTAL HYPERPLASIA, APOCRINE METAPLASIA,. FIBROCYSTIC CHANGES, MICROCALCIFICATIONS. C. BREAST, ""ADDITIONAL DEEP MARGINS"", EXCISION: Specimen #: FINAL DIAGNOSIS (continued) : - BENIGN FIBROADIPOSE TISSUE WITH NO EVIDENCE OF MALIGNANCY. - NO BREAST GLANDULAR ELEMENTS PRESENT. - MARGINS UNINVOLVED. D. LYMPH NODE, SENTINEL NODE #1, BIOPSY: - ONE LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA. - LARGEST METASTATIC FOCUS: 0.4 CM. - EXTRACAPSULAR EXTENSION: NOT IDENTIFIED. E. LYMPH NODE, SENTINEL NODE #2, BIOPSY: - ONE LYMPH NODE NEGATIVE FOR METASTATIC CARCINOMA BY ROUTINE HISTOLOGY. AND CYTOKERATIN IMMUNOHISTOCHEMISTRY. Comment : The prior core biopsy specimen (. right breast,. is reviewed. This case has received intradepartmental prospective. peer review. CLINICAL DIAGNOSIS AND HISTORY: y/o female with history of right breast carcinoma. PRE-OPERATIVE DIAGNOSIS: None provided. POST-OPERATIVE DIAGNOSIS: None provided. GROSS DESCRIPTION: A. Received fresh, labeled with the patient's name,. and. designated ""RIGHT BREAST LUMPECTOMY"" consists of a breast lumpectomy. specimen, measuring 9.0 cm from superior to inferior; 8.8 cm from medial. to lateral; and 3.0 cm from superior to inferior. The specimen is. oriented with a long suture marking the lateral margin; and a short suture. marking the superior margin. The overlying ellipse of tan skin measures. 6. x 1.8 cm. The specimen is differentially inked as follows: blue -. superior; green - inferior; orange - anterior; black - posterior; red -. lateral; and yellow - medial. The specimen is serially sectioned from. R. Y. Specimen #: GROSS DESCRIPTION (continued) : anterior to posterior to reveal a sharply-circumscribed, firm, ovoid mass. with. a. homgenous tan cut surface, measuring 2.8 x 2.6 x 1.6 cm in overall. dimensions. This mass is located in the posterior half of the specimen,. and measures 0.4 cm from the nearest margin (inferior) . The remaining. tissue is mostly fatty with admixed areas of fibrosis, especially. posteriorly. Skin, tumor, and grossly unremarkable fibrous tissue are. sampled for the CBCP Protocol with matching paraffin sections in cassettes. A1, A2-A6 and A7. Representative sections are submitted as follows: A1-. skin; A2-tumor; A3-6 - - tumor with inferior margin; A7-fibrous tissue. with posterior and superior margins; A8 - -fibrous tissue with superior. margin; A9-10- anterior margin; A11-12- lateral margin; A13-14-medial. margin. B: Received in formalin, labeled with the patient's name,. ad designated ""ADDITIONAL INFERIOR MARGIN"" consists of an irregular. fragment of tan-yellow, lobulated adipose tissue, measuring 5.5 x 1.9 x. 0.8 cm in overall dimensions. The specimen is received oriented with. steel surgical clips marking the true new margin. This new margin is. inked blue, and the opposing surface is inked orange. The specimen is. serially sectioned to reveal a tan-yellow, fatty cut surface without. evidence of residual tumor. The specimen is entirely submitted in six. cassettes. C: Received in formalin, labeled with the patient's name,. d designated ""ADDITIONAL DEEP MARGINS"" consists of an irregular. portion of tan-yellow, lobulated adipose tissue measuring 4.7 x 3.9 x. 1.1. cm in overall dimensions. The true new margin is marked with surgical. clips, this margin is inked blue, and the opposing surface is inked. orange. The specimen is serially sectioned to reveal a homogenous. tan-yellow, fatty cut surface without exidence of residual tumor. Representative sections are submitted in six cassettes. D: Received fresh, labeled with the patient's name,. designated ""SENTINEL NODE #1"" consists of a single irregular tragment of. tan-yellow adipose tissue, measuring 2.0 x 1.8 x 0.5 cm in overall. dimensions. Palpation of the specimen reveals a single tan-pink lymph. node, measuring 1.5 x 0.7 x 0.7 cm in overall dimensions. A small portion. of the lymph node is sampled for the CBCP Protocol with matching paraffin. section in D1, and the remainder of the specimen is submitted in cassette. D2. E: Received in formalin, labeled with the patient's name,. and designated ""SENTINEL LYMPH NODE #2"" consists of a similar irregular. Specimen #: GROSS DESCRIPTION (continued) : fragment of tan-yellow, lobulated adipose tissue measuring 2.4 x 2.0 x 1.1. cm in overall dimensions. The specimen is bisected to reveal a 2.2 cm. firm, tan-pink lymph node. The specimen is entirely submitted in two. cassettes.",BRCA,1,"The T stage is determined by the size of the tumor. In this report, the tumor size is 2.8 cm, which falls under the T2 category (T2: tumor size 2.1 to 5.0 cm).",T2,32.0
581,TCGA-A7-A26E.EA830A26-3DF5-4731-AD0A-F20A61D58817,2,"DEPARTMENT OF PATHOLOGY AND LABORATORY MEDICINE. Date Coll: SPECIMEN. A. Left axillary sentinel node #1. B. Left breast stitch marks long lateral, short superior. C. Intraop lymph node left axilla. D. Right breast tissue long stitch lateral, short stitch superior. E. Left axillary content. CLINICAL NOTES. PRE-OP DIAGNOSIS: Left breast carcinoma. POST-OP DIAGNOSIS: Left breast carcinoma. CLINICAL HISTORY: Left breast carcinoma. FROZEN SECTION DIAGNOSIS. A - Two lymph nodes negative for metastatic disease. Amended diagnosis - Upon re-appraisal, the smaller node. contains. a focus of carcinoma consistent with lobular origin. GROSS DESCRIPTION. A. The specimen is received fresh for frozen section. labeled ""left axillary sentinel node #1"". It consists of. a. portion of hemorrhagic adipose tissue measuring 3.5 X 2.4 x 0.9 cm. On section it is fatty and slightly indurated consistent with nodal. tissue. One such node measures 3.2 x 1.8 x 0.6 cm. A second smaller. node is present measuring 0.6 cm. by 0.5 X 0.5 cm. The larger node. is bisected and all submitted for frozen section as FS1 and FS2. The smaller node is bisected and all submitted as FS3. B. Received fresh, labeled ""left breast"" is an 18.1 u. cm. (medial to lateral) X 15.5 cm. (superior to inferior) x. 5.0 cm. (anterior to posterior) diffusely cauterized soft, lobulated. tan gold-white portion of fibroadipose tissue in keeping with. breast. designated as left per requisition slip and container and oriented. by two sutures as stated previously. There is a 9. cm. (medial to. lateral) X 3.8 cm. (superior to inferior) wrinkled white skin. ellipse. with an eccentric, flattened, 1.2 x 1. 1 cm. nipple along the. anterior aspect. A well healed and retracted 1 cm. cicatrix is. present along the skin surface corresponding to the lower outer. quadrant. The anterior surface surrounding the lateral portion. of. the skin ellipse is inked blue, the intact deep margin is inked. black and the specimen is sectioned. There is a poorly defined,. stellate, 5.5 cm. (medial to lateral) x 4.0 cm. (superior to. inferior). x 2.2 (anterior to posterior) oblique rubbery tan white tumor mass,. extending from the lower outer quadrant centrally to the junction. of the four quadrants. A portion of tumor and a portion of normal. parenchyma are submitted for tissue procurement as requested. The. tumor focally extends to within 1.2 cm. of the inked deep margin and. 1.1 cm. from the anterior/skir surface. The parenchyma throughout. the remainder of the specimen consists predominently of glistening. lobulated golden yellow adipose tissue with a minimal amount of. interspersed delicate tan white fibrous tissue. No additional mass. lesion or abnormality is identified. Representative sections are. submitted in twelve blocks as labeled. RS-12. BLOCK SUMMARY: 1,2 - Tumor to inked deep margin; 3,4 - tumor to. overlying skin ellipse/anterior surface of the specimen;. tumor. to adjacent parenchyma; 8 - random upper outer quadrant; 9 - upper. inner quadrant; 10 - lower inner quadrant; 11 - lower outer. quadrant; 12 - nipple. C. Received fresh, labeled ""intraop lymph node left. axilla"". is 1 cm. in greatest dimension slightly rubbery white. pink. tissue in keeping with lymph node with a moderate amount of. associated adipose tissue. The specimen is bisected and entirely. submitted in one block. AS-1. D. Received fresh, labeled ""right breast tissue"" is. a. diffusely cauterized and slightly fragmented, 8.6. cm. (medial to lateral) X 6.4 cm. (anterior to posterior) x 3.4. cm. (superior to inferior) soft, lobulated tan gold-white portion of. fibroadipose tissue, with two sutures as stated previously. The. margins are inked as follows: superior blue, inferior black,. anterior green, and posterior orange. The specimen is sectioned. from medial to lateral. There is a 6.5 cm. (medial to lateral) x. 4.2. cm. (anterior to posterior) X 1.0 cm. (superior to inferior) vacant. biopsy cavity occupying the majority of the specimen. The cavity. is. focally contiguous with the anterior, posterior, and superior inked. margins. No residual lesion or abnormality is noted grossly. The. cut surfaces throughout the specimen consist predominately of. mildly. congested glistening lobulated golden yellow adipose tissue with a. scant amount of interspersed delicate tan white fibrous tissue. Representative sections are submitted in a sequential manner from. medial to lateral in ten blocks as labeled. RS-10. BLOCK SUMMARY: 1 - Perpendicular sections entire medial margin cap;. J - sequential sections; 10 - representative perpendicular. sections lateral margin cap. E. Received fresh, labeled ""left axillary content"" is an. unoriented, 6.5 x 5.8 x 1.8 cm. portion of soft, lobulated. golden yellow adipose tissue. Several soft to slightly rubbery. pale. tan tissues in keeping with lymph nodes measuring up to 1.8 cm. in. greatest dimension are recovered. The lymphoid tissues are. entirely. submitted in three blocks as labeled. RS-3. BLOCK SUMMARY: 1 - Eight whole lymph nodes; 2 - five whole lymph. nodes; 3 - one bisected lymph node. MICROSCOPIC DESCRIPTION. A. Two lymph nodes are examined in their entirety at. multiple levels. The smaller contains a 3 mm. metastasis. with minimal extra-capsular extension, ,. B. The previously biopsied large tumor is an infiltrating. lobular carcinoma. In one 2 mm. area (block #6 within the. main tumor) , there is a focus of invasive ductal carcinoma which is. nuclear grade 1 (architectural score 1, nuclear score 2, mitotic. score 1) . In addition, in blocks 4 and 5 there is in situ tumor. which, with the help of E-Cadherin stain, proves to be ductal. carcinoma in situ, nuclear grade 2. Please see the template below. Invasive carcinoma: Histologic type: Infiltrating lobular carcinoma with single. small focus of associated infiltrating ductal carcinoma. Histologic grade: The invasive lobular carcinoma is moderately. differentiated. Overall grade: [ Last Name (un) 1] SBR grade 2. Architectural score: 3. Nuclear score: 2. Mitotic score: 1. Greatest dimension (pT) : The tumor measures 5.5 cm., pT3. Specimen margins: Negative. Vessel invasion Suspicious for lymphatic invasion. Perineural. invasion is noted. Calcification: Negative. Nipple (Paget's) : No Paget's disease of the nipple is present. Major lactiferous ducts, however, contain lobular neoplasia in. situ, supported by stain for E-Cadherin. There is also a 1.5. mm. of invasive lobular carcinoma within the subareolar tissue,. supported by stains for P63 and E-Cadherin. Invasion of skin or chest wall: Negative. Ductal carcinoma in situ (supported by stain for E cadherin) : Histologic pattern: Solid. Nuclear grade: 2. Central necrosis: Negative. : DCIS of total tumor (if mixed) : The DCIS appears to be. separate from the invasive lobular carcinoma. Extensive intraductal component (present/absent) : Absent. Specimen margins: Negative. Calcification: Negative. Description of non-tumorous breast: Fibrocystic changes are also. present, including cysts, apocrine metaplasia, a 3 mm. fibroadenoma. and rare calcification. Comments: E-Cadherin on block #5 supports the diagnosis of ductal. carcinoma in situ. Lymph nodes: Number of positive nodes of total: As per parts A, C and E,. there are 16 1 mmnh nodes. one of which contains metastatic. carcinoma, l. Size of largest metastasis: 3 mm. Extracapsular extension (present/absent) : Present. pN: 1A. Distant metastasis (pM) : Cannot be assessed. Prognostic markers: Please see. C. A single lymph node is present. Negative for. metastatic. disease, 0/1. D. This portion of tissue contains biopsy site changes. In. situ tumor is noted in blocks 1 through 7. With the. assistance of stains for E-Cadherin on all of these blocks, it is. apparent that the tumor in blocks. ] and 5 is lobular. carcinoma in. situ. The tumor in blocks 4, 6 and 7 prove to be ductal carcinoma. in situ. Also, in block 7, there is a 1.1 mm. focus of invasive. tumor which proves to be of ductal origin. Please see the template. below for the details regarding the ductal tumor. Invasive Carcinoma: Histologic type Infiltrating ductal carcinoma. Histologic grade: Moderately differentiated. Overall grade: Last Name (un) 1] SBR grade 2. Architectural score: 3. Nuclear score: 2. Mitotic score: 1. Greatest dimension (pT) : The tumor measures 1.1 mm., pTla. Specimen margins: Invasive tumor is less than 1 mm from the. inferior margin. Vessel invasion : Negative. Calcification: Negative. Ductal carcinoma in situ: Histologic pattern: Solid and cribriform. Nuclear grade: 2. Central necrosis: Negative. DCIS of total tumor (if mixed) : The invasive component is very. minor relative to the in situ component. Extensive intraductal component (present/absent) : Present. Specimen margins: DCIS less than 1 mm. from the inferior margin. Calcification: Negative. Description of non-tumorous breast: Cysts and apocrine metaplasias. present. Comments: In addition to the invasive and in situ ductal. carcinoma,. there are foci of lobular carcinoma in situ. Prognostic markers: Cold ischemia time too long for accurate. marker. studies. E. Thirteen lymph nodes are present, all negative for. metastatic disease, 0/13. This is supported by negative. keratin stains on blocks 1 through 3. [A few of the antibodies used in our laboratory may be classified. as. analyte specific reagents. These antibodies are monitored and. controlled in our laboratory and their performance for in [Last Name. (un) 2]. diagnosis is well described in the medical literature. They have. not been cleared or approved by the FDA. ]. 14, 15x2, 4x5, 20x12, PGRI 3260F. DIAGNOSIS. A. Left axillary sentinel node #1, excision -. Two lymph nodes, one of which contains metastatic carcinoma,. B.(Left) breast, mastectomy -. Large (5.5 cm. ) infiltrating lobular carcinoma, minor. associated component of invasive ductal carcinoma. Ductal. carcinoma in situ also present. A second minute focus of. invasive lobular carcinoma is present in the sub-areolar. tissue. All margins are negative for tumor. C. Intraoperative lymph node left axilla, excision -. Single lymph node negative for metastatic disease, 0/1. D. Right breast tissue, excision -. Breast tissue with biopsy site changes, lobular carcinoma in. situ, ductal carcinoma in situ and invasive ductal carcinoma,. SBR grade 2. The invasive ductal. carcinoma and ductal. carcinoma in situ are. less than 1 mm. from the inferior margin. Hormone receptor. studies cannot accurately be performed on the invasive ductal. carcinoma. E. Left axillary contents, dissection -. Thirteen lymph nodes all negative for metastatic disease,. 0/13.",BRCA,1,"The report states that the largest tumor mass measures 5.5 cm in its greatest dimension, which falls under the 'T3: tumor size over 5.0 cm without direct extension to the chest wall or skin' category.",T3,33.0
604,TCGA-A7-A5ZX.A8834D03-81F5-43BC-A4AB-F215C89CB095,1,"Final Surgical Pathology Report. Procedure: Diagnosis. A. Lymph nodes, left axillary sentinel, excision -. Metastatic carcinoma in two of two (2/2) lymph nodes in this part. B. Breast, right, excision -. Invasive lobular carcinoma, 0.5 cm in greatest dimension (see. microscopic description, including for prognostic marker results) . Lobular carcinoma-in-situ. Fibrocystic changes, with microcalcifications present. Skin, nipple, and deep margin negative for tumor. C. Breast, left, excision -. Invasive lobular carcinoma, forming a 3.2 cm in greatest dimension. mass, with additional scattered foci of invasive lobular carcinoma. present. Invasive lobular carcinoma present at least very near (<1 mm from), and. possibly at, the deep margin in the separate foci. Skin and nipple negative for malignancy. Lobular carcinoma-in-situ. Biopsy site changes. Fibrocystic changes, with microcalcifications present. D. Lymph nodes, left axillary, excision. Metastatic carcinoma in nineteen of twenty-two (19/22) lymph nodes in. this part, including with metastatic carcinoma in the superior-most. lymph node. Microscopic Description: A,D. There is metastatic carcinoma in two of two (2/2) sentinel lymph. nodes in part A, and in nineteen of twenty-two (19/22) lymph nodes in. part D. Thus overall in this case, there is metastatic carcinoma in. twenty-one of twenty-four (21/24) lymph nodes (pN3a) There is. extracapsular extension. The largest involved lymph node is one of the. sentinel lymph nodes, 2.5 cm in greatest dimension. The largest lymph. node in part D is negative for tumor. There is metastatic carcinoma in. the superior-most lymph node in part D. Please note that in addition. to examining H&E stained sections, immunostains with antibodies to. keratin (AE1-AE3) were examined on representative blocks in both parts. to aid in assessment. B. The following template summarizes the findings in this part: Invasive carcinoma: Present. Histologic type: Invasive lobular carcinoma, identified. incidentally in block B4. Histologic grade : Overall grade: 2. Architectural score: 3. Nuclear score: 2. Mitotic score: 1. Greatest dimension (pT) : slightly >0.5 cm (pT1b). Specimen margins: Negative. Vessel invasion: Not identified. Nipple: Negative for tumor. Invasion of skin or chest wall: Not identified. Ductal carcinoma in situ: Not identified. Description of non-tumorous 'breast: Fibrocystic changes, with. microcalcifications present. Comments: There is also lobular carcinoma-in-situ present. Please note. that immunostains with antibodies to p63, keratin (AE1-AE3), and. e-cadherin were examined on representative blocks to aid in assessment. Distant metastasis (pM) : Not applicable. Breast prognostic marker results. Estrogen receptor: 80% / moderate intensity. Progesterone receptor: 5% / weak intensity. Her2 by IHC: 1+. Interpretation. Estrogen receptor: Positive. Progesterone receptor: Weakly positive. Her2 by IHC: Negative for Her2 expression. Comments. Fixation time : 30:00. Cold ischemia time: 0:30. The analyzed tissue met quality requirements of the ASCO/CAP guidelines. for Her2 testing. Control materials stained appropriately. Based on data collected in our laboratory and reported in the. literature we recommend FISH analysis for Her2 in cases that stain with. intermediate intensity by immunohistochemistry. Prognostic markers were done by immunohistochemical stain on paraffin. sections from 10% neutral buffered formalin fixed tissue using. antibodies on a Benchmark automated stainer. The Her2 antibody is clone 4B5 and has been approved by the FDA as an. aid in the assessment of breast cancer patients for whom Herceptin. treatment is considered. This laboratory meets the test validation and quality assurance. requirements of the ASCO/CAP guidelines for Her2, ER and PR testing for. carcinoma of the breast. C. The following template summarizes the findings in this part: Invasive carcinoma: Present. Histologic type: Invasive lobular carcinoma. Invasive lobular. carcinoma is identified comprising the main mass lesion, as well as in. multiple additional foci in random sections of this breast (blocks C7,. C8, C10, C11). Histologic grade: Overall grade: 2. Architectural score: 3. Nuclear score: 2. Mitotic score: 1. Greatest dimension (pT) : The main mass lesion is 3.2 cm in. greatest dimension (pT2). Specimen margins: Although the margins surrounding the main mass. lesion are negative, tumor in the additional foci of invasive lobular. carcinoma is present at least very near (<1 mm from). and possibly at,. the deep margin, with fragmentation hindering assessment. Vessel invasion: Not identified. Nipple: Negative for tumor. Invasion of skin or chest wall: Not identified. Ductal carcinoma in situ: Not identified. Description of non-tumorous breast: Fibrocystic changes, with. microcalcifications present. Biopsy site changes. Comments: There is also lobular carcinoma-in-situ present. Please note. that immunostains with antibodies to keratin (AE1-AE3), and e-cadherin. were examined on representative blocks to aid in assessment. Distant metastasis (pM) : Not applicable. Prognostic markers: Previously performed. Note: have reviewed this case. [A few of the antibodies used in our laboratory may be classified as. analyte specific reagents. These antibodies are monitored and. controlled in our laboratory and their performance for in vitro. diagnosis is well described in the medical literature. They have not. been cleared or approved by the FDA.]. Specimen. A. Left axillary sentinel node. B. Right breast. C. Left breast. D. Left axillary contents. Clinical Information. CLINICAL HISTORY: yo white female with invasive lobular cancer left. breast. Intraoperative Consultation. A. Metastatic carcinoma present. Gross Description. A. Received fresh in a container labeled ""left axillary sentinel node"". is a portion of tissue which is tan-yellow and fatty externally. On. palpation, it appears to consist of two adherent lymph nodes, spanning. an area 2.5 x 1 X 0.5 cm and 1.8 x 1 X 0.4 cm. On cut surface, both. vary from soft and tan to yellow, to firmer and tan-white. The. specimen is entirely submitted for frozen section in two blocks, with. one lymph node per block. B. Received fresh (excised at. placed in. formalin at. in a container labeled ""right breast"" is a 21 cm from. superior to inferior x 18 cm from medial to lateral x 3.2 cm from. anterior to posterior soft tan-yellow mastectomy specimen, with an. orienting suture present. On the anterior surface there is a 7. X 4.4. cm. tan-white skin ellipse, with a centrally located 1.3 X 1.3 x 1 cm. nipple. The intact deep margin is inked, and the specimen is serially. sectioned. On cut surface, the specimen consists of interspersed. yellow adipose tissue and tan tissue, without focal lesion. RS-10,. following fixation. BLOCK SUMMARY: B1,B2 - upper outer quadrant; B3,B - upper inner. quadrant; 85,B6 - lower inner quadrant; B7,B8 - lower outer quadrant;. B9 - central breast; B10 - nipple. C. Received fresh (excised at. placed in. formalin at. in a container labeled ""left breast"" is a 20.5 cm. from superior to inferior x 18.8 cm from medial to lateral x 3.2 cm. from anterior to posterior soft tan-yellow mastectomy specimen, with an. orienting suture present. On the anterior surface there is a 7 X 5 cm. tan-white skin ellipse, with a centrally located 1.2 x 1.2 x 0.5 cm. nipple. The intact deep margin is inked, and the specimen is serially. sectioned. There is a circumscribed 3.2 x 2.9 X 1.8 cm rubbery. tan-white mass within the upper outer quadrant. The lesion is 1.1 cm. from the deep margin, and 1.3 cm from the anterior surface, which is. subsequently inked blue. The specimen away from the nodule consists of. interspersed yellow adipose tissue and tan tissue, without additional. focal lesion. RS-12, following fixation. BLOCK SUMMARY: C1-C3 - tumor to anterior surface; C4,C5 - tumor to deep. margin; C6 - central tumor; C7 - upper outer quadrant; C8 - upper. inner quadrant; C9 - lower inner quadrant; C10 - lower outer quadrant;. C11 - central breast; C12 - nipple. D. Received fresh in a container labeled ""left axillary contents"" is a. 6.5 x 6.3 x 2.4 cm aggregate of yellow lobular fatty tissue which has a. suture designating superior axilla. Dissection of the specimen reveals. multiple lymph nodes, up to 3.5 cm in greatest dimension. RS-9,. following fixation, with all lymph nodes submitted, from superior to. inferior, with the superior-most lymph node in block D1, four lymph. nodes in block D2, five lymph nodes in block D3, three lymph nodes in. block D4, one sectioned lymph node in blocks D5 & D6, four lymph nodes. in block D7, one lymph node in block D8, and three lymph nodes in block. D9.",BRCA,3,"The T stage is determined by the size of the tumor. According to the report, the right breast has a tumor with a greatest dimension of slightly over 0.5 cm (pT1b), while the left breast has a tumor with a greatest dimension of 3.2 cm (pT2). Therefore, the T stage is T2.",T2,33.0
606,TCGA-A7-A6VW.BE19CEFA-7A66-480C-BEC0-AF52F4C8A04C,1,"Final Surgical Pathology Report. Procedure: Diagnosis. A. Sentinel lymph node, left axilla, biopsy: Two negative lymph. nodes (0/2) . B. Breast, left, excisional biopsy: Invasive ductal carcinoma, grade. 3, size 3.0 cm in greatest dimension, close to the medial and. inferior margins. Microscopic Description: Invasive carcinoma: Histologic type: Ductal. Histologic grade: 3. Overall grade: 9/9. Architectural score: 3. Nuclear score: 3. Mitotic score: 3. Greatest dimension (pT2) : Size 3.0 cm in greatest dimension. Specimen margins: Carcinoma is well-demarcated, and forms a. discrete mass lesion that is less than 1 mm from the medial. margin and 0.5 mm from the inferior margin. Vessel invasion: Not identified. Ductal carcinoma in situ: Not identified. Comment: Prior biopsy site identified. Distant metastasis (pM) : Unknown. Lymph nodes: Two negative sentinel lymph nodes, 0/2. Prognostic markers: See previous core biopsy. Specimen. A. Left axillary sentinel node. B. Left breast biopsy. Clinical Information. Left breast cancer,. yo BF with grade 3 IDC. Gross Description. A. Received unfixed, labeled left axillary sentinel node, are two. lymph nodes, the larger of which is 1.4 x 1.2 x 1.0 cm, bisected. and submitted in blocks 1-2, and an additional node, 1.0 x 0.5. x. 0.5 cm, bisected and submitted in block 3. B. Received unfixed in a. container, lapeled left breast, is. a portion of fibrofatty tissue that is oriented and 6.0 cm anterior. to posterior, 4.5 cm medial to lateral, and 2.3 cm superior to. inferior. Margins are inked: inferior blue, superior black,. medial yellow, lateral green. The specimen is serially sectioned. from anterior to posterior. There is a 3.0 x 2.0 x 1.9 cm tumor. present, adjacent to the medial and inferior margins. Representative sections, including the anterior and posterior shave. margins, sequentially submitted in 8 blocks.",BRCA,0,"The T stage is determined by the size of the tumor. According to the report, the size of the tumor is 3.0 cm, which falls under the T2 category (T2: tumor size 2.1 to 5.0 cm).",T2,33.0
629,TCGA-A8-A07L.5D93AE27-79A0-4809-AE7C-54814CED0851,2,"Diagnosis: Right (sided partial breast resection material with a poorly differentiated invasive ductal breast. carcinoma measuring a maximum of 3.4 cm with a minimum dorsal margin of 0.1 cm,. evidence of carcinomatous lymphangitis and two axillary lymph node metastases (of 20. lymph nodes studied). The follow-up resection samples in nos 2 and 3 were both carcinoma-. free. Tumor classification: M-8500/3, G 3, pT 3, pN la (2/20), M X, R 0, L 1, V0.",BRCA,1,"The T stage is based on the size of the tumor without considering the involvement of the chest wall or skin. In this report, the tumor measures up to 3.4 cm, which falls under the T3 category of 'tumor size over 5.0 cm without direct extension to the chest wall or skin'. It's common to round up to the nearest higher category in T staging, as per AJCC guidelines.",T3,34.0
624,TCGA-A8-A07E.E20AC0FF-43C4-49EA-9E33-764E553933B7,3,"Diagnosis: 1. Moderately differentiated invasive ductal carcinoma (tumor diameter: 3.5 cm; distance dorsally 3 cm, other margins remain free). Concluding tumor classification: NOS, G II, pT2N3aLOV0R0.",BRCA,3,"The report provides the tumor diameter, which is 3.5 cm. According to the rules, T2 corresponds to a tumor size of 2.1 to 5.0 cm. Since the tumor diameter is 3.5 cm, it falls within this range, making the T stage T2.",T2,34.0
667,TCGA-A8-A099.34499A83-DFCE-4DB8-BAA0-A7590AF8BC07,3,"Diagnosis: 1. Ablated breast sample with a moderately differentiated invasive ductal carcinoma. (tumor diameter 105 cm) with focal ulceration of the skin and a satellite node. (diameter 0.9 cm) in the skin. Tumor-free dorsal resection margin. Together with the preliminary finding, this gives rise to the following tumor. classification: NOS, G II, pT4b pN3a(11/22)LOVORO. :34499A83-DFCE-4D88-BAA0-A7590AF8BC07.",BRCA,3,"The report states that the tumor has 'focal ulceration of the skin' and a 'satellite node. (diameter 0.9 cm) in the skin', which are indications of direct extension to the chest wall or skin, meeting the criteria for a T4 stage tumor. The tumor diameter is also quite large at 105 cm, but the T stage is determined by the presence of direct extension to the chest wall or skin, not just the size of the tumor.",T4,35.0
585,TCGA-A7-A26I.CCE33A95-774E-4242-B2A1-05FF002ED1D9,1,"Date Coll: SPECIMEN. A. Left axillary sentinel node. B. Left breast mass. Long stitch anterior, short stitch superior. CLINICAL NOTES. PRE-OP DIAGNOSIS: Left breast cancer. CLINICAL HISTORY: year-old white female with breast cancer. POST-OP DIAGNOSIS: Left breast cancer. GROSS DESCRIPTION. A. Received fresh labeled ""left axillary sentinel nodes"". are two slightly rubbery tan-white-pink tissues in keeping. with lymph nodes measuring 0. and 1.0 cm. in greatest dimension. The specimens are bisected and entirely submitted independently in. two blocks (one bisected tissue per cassette). B. Received fresh within a TranSpec container labeled. 'left breast mass"" is a 7.3 cm. (medial to lateral) x 6.5. cm. (superior to inferior) x 3.7 cm. (anterior to posterior), soft,. lobulated tan gold-white portion of fibroadipose tissue with two. sutures as stated previously. The margins are inked as follows: Anterior - blue, posterior - black, superior - green, and inferior. orange. The specimen is sectioned from medial to lateral. There is. a central, moderately well-circumscribed, 3.2 cm. (medial to. lateral) x 2.5 cm. (superior to inferior) x 2.4 cm. (anterior to. posterior), firm tan white tumor mass with several central. associated cylindrical tan white structures in keeping with cyte of. prior needle core biopsy. A portion of tumor and a portion of. normal parenchyma are submitted for tissue procurement as requested. The tumor appears to focally extend to within 0.3 cm. of both the. anterior and posterior inked margins. The cut surfaces throughout. the remainder of the specimen consist predominantly of glistening. lobulated golden yellow adipose tissue with a minimal amount of. interspersed dense tan-white fibrous tissue. No additional. abnormality is noted. Representative sections are submitted in. a. sequential manner from medial to lateral in 10 blocks as labeled. BLOCK SUMMARY: 1 - Representative perpendicular sections medial. margin cap; 2-9 sequential sections; 10 - representative. perpendicular sections lateral margin cap. MICROSCOPIC DESCRIPTION. A. Microscopic examination involved the evaluation of the. four H&E stained sections of each of the tissue blocks. Also pan cytokeratin AE1/AE3 immunohistochemical stains were. evaluated of each tissue block and no metastatic tumor was. identified in any of the examined sections (0/2) (snpNO). B. Microscopic examination of the left breast lumpectomy. specimen reveals: Invasive Carcinoma: Present. Histologic type: Infiltrating ductal. Histologic grade: Elston's SBR grade 2. Overall grade: 2. Architectural score: 2. Nuclear score: 2. Mitotic score: 2. Greatest dimension (pT) : 3.2 cm. in greatest dimension (pT2). Specimen margins: The resection margins are negative for. carcinoma with the closest resection margins being superior and. anterior where invasive tumor is 2 mm. from the resection. margin. Tumor is 3 mm from the posterior resection margin. Vessel invasion: Not identified. Calcification: Present. Ductal carcinoma in situ: Present. Histologic pattern: Solid with cancerization of lobules. Nuclear grade: High grade. Central necrosis: Absent. % DCIS of total tumor (if mixed) : Less than 10%. Extensive intraductal component (present/absent) : Absent. Specimen margins: DCIS is 2 mm from the anterior and superior. margins and 3 mm from the posterior margin. Calcification: not identified. Description of non-tumorous breast: Fibrosis, apocrine metaplasia. and microcysts with sclerosing adenosis. Prognostic markers, Umpon been reported previously on the core. biopsy see. 4x2, 20x1. DIAGNOSIS. A. Left axillary sentinel lymph nodes, biopsy: Two lymph nodes negative for metastatic tumor (0/2). B. Left) breast, lumpectomy: Invasive ductal carcinoma, Elston's SBR grade 2, tumor size. 3.2 cm. Associated high grade solid ductal carcinoma in-situ. Invasive and in-situ carcinoma are 2 mm from the resection. margins designated superior and anterior and 3 mm from the. resection margin designated posterior. No lymphovascular space invasion identified. See microscopic description. (Electronic Signature). End Of Report ---.",BRCA,0,"The report states that the largest dimension of the invasive tumor is 3.2 cm, which falls within the range for T2 (2.1 to 5.0 cm).",T2,35.0
665,TCGA-A8-A096.91BFC77A-E56F-49F0-A294-A5EE9F266FB6,1,"Diagnosis: 1. Moderately differentiated invasive ductal carcinoma (tumor diameter 4.0 cm). In conjunction with the preliminary finding, this gives rise to the following tumor. classification: NOS, G II, pT2NOi+(sn)LOVORO.",BRCA,0,"The report specifically states that the tumor diameter is 4.0 cm, which falls within the range for a T2 stage tumor (2.1 to 5.0 cm).",T2,36.0
127,TCGA-4H-AAAK.8894688F-7167-48A1-BB1B-FC219B7675C2,1,"Procedure: Left radical mastectomy. Preoperative diagnosis: CARCINOMA OF THE LEFT BREAST. Postoperative diagnosis: SEE MICROSCOPIC DIAGNOSIS BELOW. Specimen(s): 1. LEFT BREAST 2. LEFT AXILLARY CONTENTS. Diagnosis: 1. LEFT BREAST: Infiltrating lobular carcinoma grade 2. Tumor is 2.8 x 3.5 x 3.0 cm in dimensions. Vascular invasion is not present. 2. LEFT AXILLARY LYMPH NODES: Four (out of fourteen) axillary lymph nodes are positive for metastatic carcinoma. Gross description: 1. LEFT BREAST: Received fresh, is a left breast measured 30.0 x 27.0 x 9.0 cm in dimensions with an axillary fat,. en bloc. The firm white-gray tumor 2.8 x 3.5 x 3.0 cm in dimensions is present in the outer. quadrants. 2. LEFT AXILLARY CONTENTS: Within the axillary fat there are fourteen lymph nodes ranging from 0.2 to 2.0 cm in greatest. dimension.",BRCA,2,"The T stage is determined by the size of the tumor. According to the pathology report, the tumor size is 2.8 x 3.5 x 3.0 cm. Based on the rules provided, T2 corresponds to a tumor size of 2.1 to 5.0 cm, which includes the measured size of this tumor.",T2,36.0
658,TCGA-A8-A08Z.DA7BD84B-C00E-40A0-9AE2-33FCE7995696,3,"Diagnosis: 1. Invasive breast carcinoma with focal angioinvasion and tumor infiltration of. the skin spindle with foci of ulceration (tumor diameter: 5.0 cm). Dorsal resection margin. tumor-free. In conclusion, this is a moderately differentiated invasive ductal carcinoma with focal. angioinvasion and ulceration of the skin spindle. Tumor classification: NOS, G II, pT4bN3aLIVORO.",BRCA,3,"The report states that the 'tumor diameter is 5.0 cm', which falls under the 'T4: tumor of any size with direct extension to the chest wall or skin' category, as the tumor has also infiltrated the skin spindle.",T4,37.0
611,TCGA-A8-A06P.AADFAF8B-92B8-4292-96A3-912D55EB9C31,0,"Diagnosis: Ablated material from the right breast with a bifocal invasive ductal breast carcinoma grade. II. The larger focus is 1.1 cm in size and the smaller one 0.8 cm (measured in the histological. preparation). Complete resection of carcinoma extending to the healthy tissue on all sides. (minimum caudal margin of 0.5 cm). Tumor classification: pTlc (m), pN2a (7/25), MX, R0, G2 (L0, V0).",BRCA,2,"The T stage is based on the size of the largest invasive tumor focus. In this report, the larger focus of the tumor is measured at 1.1 cm, which falls under the T1 category of tumors up to 2.0 cm in size.",T1,38.0
567,TCGA-A7-A0CD.DEB67EB8-155C-4ACF-B3D4-595E4CBE2E5C,0,"SPECIMEN. A. Sentinel node #1. B. Sentinel node #2. C. Left breast mass. D. 6 S'clock. E. 12 o'clock. F. 9 o'clock. G. 3 o'clock. REPORT REVISED ON. AT. CLINICAL NOTES. HISTORY: Left breast ca at 10:00. Multifocal 1 cm. and 5 cm. from. nipple. REPORT REVISED ON. AT. 1. FROZEN SECTION DIAGNOSIS. A) Lymph node, sentinel node 1, excision - Negative for metastatic. carcinoma (0/1). B) Lymph node, sentinel node 2, excision - Negative for metastatic. carcinoma (0/1). REPORT REVISED ON. AT. GROSS DESCRIPTION. A. Received fresh labeled ""sentinel node #1"" is a lymph. node that measures 1.5 cm in dimension. The lymph node is. entirely frozen. B. Received fresh labeled ""sentinel lymph node #2"" is a. lymph node that measures 1 1 am in dimension. The lymph. node is entirely frozen. C. The specimen is received fresh labeled ""left breast. mass"" and. consists of a yellow piece of soft tissue measuring 10 x 7.5 x 5.4. cm. The. specimen has a long and a short suture on it. There is an. overlying. GROSS DESCRIPTION. white. ellipse of skin measuring 6.5 x 1.5 cm. which has a central. longitudinal wound in it. The external surface of the specimen is. inked as indicated below. Superior yellow, inferior orange, anterior red, lateral blue,. medial. green,. inferior black. There is a central firm tumor measuring 1.5 cm. in. greatest. cross sectional dimension. A portion of the central tumor is taken. for. research purposes. Sections after fixation. RS15. +RR11. D. Received in formalin labeled ""#6"" and consists of a. yellow and tan piece of soft tissue measuring 3 x 2 x 0.7. cm. It is not completely clear which side of the specimen is the. external side. The external surface of the specimen is inked. Sections after fixation. RS4. E. Received in formalin labeled ""#12"" and consists of. a. yellow piece of soft tissue measuring 3 x 2.5 x 1 cm. The. external surface of the specimen is inked. RS4. F. Received in formalin labeled ""9"" and consists of a. yellow piece of soft tissue measuring 3 x 1.5 x 1 cm. The. external surface of the specimen is inked. Sections after fixation. RS2. G. Received in formalin labeled ""#3"" and consists of. a. piece of yellow soft tissue measuring 3.2 X 1.5 x 1 cm. The external surface of specimen is inked. Sections after fixation. RS3. REPORT REVISED ON. AT. MICROSCOPIC DESCRIPTION. A. A single lymph node is negative for malignancy. B. A single lymph node is negative for malignancy. (At the request of some staff oncologists and in keeping. with the opinion of some experts in breast pathology,. immunohistochemical stains for keratin were not used on the. sentinel. lymph node sections in this case. These stains can be obtained if. desired. Our paraffin blocks are retained for 10 years. (Schwartz. GF et al. Cancer 94 (10):2542, 2002) ] . C. Invasive carcinoma. Tumor type : Infiltrating ductal carcinoma. Tumor grade 2 (Elston SBR grade; A/N/M =3/2/1 ). Mitotic index: 0 mitoses/10 HPFs (1 HPF = 0.196 sq mm). Tumor size: 1.5. cm. Specimen margins: Negative for malignancy. Carcinoma is 1. cm. from the nearest inked margin. Vessel invasion: Absent. Calcification: Absent. Non-tumorous breast: Apocrine metaplasia, cyst formation and. intraductal epithelial hyperplasia without atypia are present. pTNM stage: T1. Prognostic markers: See previous biopsy. D-G. Additional biopsy pieces are negative for. malignancy. Cyst formation and apocrine metaplasia are seen in. specimen. D at 6 o'clock. After discussion with Dr. specimen C was re-examined. definite second mass was identinied. An additional 11 blocks of. tissue were submitted from the inferior portion of the specimen. These showed cyst formation (up to 2 mm), focal intraductal. MICROSCOPIC DESCRIPTION. epithelial hyperplasia without atypia, periductal elastosis,. apocrine metaplasia, focal small cyst rupture, and arteriolar. medial. calcification. No additional carcinoma was identified. 4x3, 3x4, 14x2. REPORT REVISED ON. AT. DIAGNOSIS. A. Sentinel lymph node #1, biopsy: A single lymph node is negative for malignancy. B. Sentinel lymph node #2, biopsy: A single lymph node is negative for malignancy. C. Breast, left, excisional biopsy: Infiltrating ductal carcinoma, Elston SBR grade 2. Fibrocystic. changes. D-G. Breast, left, 6 o'clock, 12 o'clock, 9 o'clock, 3 o'clock,. biopsies: Mild fibrocystic changes. Negative for malignancy. Addition to microscopic description. REPORT REVISED ON. AT. M.D. (Electronic Signature). End Of Report ---.",BRCA,0,"The report states that the largest invasive tumor focus measures 1.5 cm in greatest cross-sectional dimension, which falls within the T1 category (T1: tumor size up to 2.0 cm).",T1,38.0
615,TCGA-A8-A06U.A314FB55-F20A-4485-965D-D7894D070A16,1,"Diagnosis: 1. Right-sided ablated breast tissue multicentric, poorly differentiated, invasive ductal breast. carcinoma with at least four foci measuring a maximum diameter of 2 cm, 3 cm, 0.7cm and. 2.5 cm, partly with inclusion of a high-grade intraductal carcinoma with comedo necroses in. the tumor periphery and surrounded by a mastopathy with partially sclerotic, intraductal,. papillomatous scleradenosis with microcalcifications and also cystic mastopathy and. cylindrical epithelial metaplasia. The overlying skin and nipple are tumor-free, no pagetoid. pattern of spread. the outer resection margins are tumor-free. Tumor classification: M-8500/3, G 3, pT2 (m), pN1a (2/25), pMX, stage II B. R0.",BRCA,1,"The T stage is based on the size of the largest tumor focus. In this report, the largest tumor focus measures 3 cm, which falls under the T2 category (tumor size 2.1 to 5.0 cm).",T2,39.0
656,TCGA-A8-A08T.5780D50C-5BF0-4392-BC9B-894D1369866A,1,"Diagnosis: ). Two foci of a moderately differentiated invasive ductal carcinoma. (tumor diameters: 3 cm and 2 cm) with focal intraductal components and. circumscribed angioinvasion. No infiltration or ulceration of the skin. Tumor classification: NOS, G II, pT2(mult)N1aL1VOM1RO.",BRCA,1,"The report indicates that there are two foci of invasive ductal carcinoma with diameters of 3 cm and 2 cm. The T stage is based on the size of the largest tumor, which in this case is 3 cm, and falls within the T2 category (2.1 to 5.0 cm). The presence of multiple foci does not affect the T stage determination.",T2,40.0
599,TCGA-A7-A4SE.C0C49D41-AA66-435B-9312-FAD8E2DC3305,1,"Final Surgical Pathology Report. Procedure: Diagnosis. A. Breast, left, segmental mastectomy: Invasive ductal carcinoma,. grade 3, size 2.8 cm in greatest dimension; negative margins of. excision. B. Sentinel lymph node #1, biopsy: Two negative lymph nodes (0/2) . C. Sentinel lymph node #2, biopsy: One negative lymph node (0/1) . D. Breast, medial to left segmental mastectomy, biopsy: Negative for. malignancy or atypia. E. Breast, inferior to left segmental mastectomy, biopsy: Negative. for malignancy or atypia. F. Breast, posterior to left segmental mastectomy, biopsy: Skeletal. muscle; negative for malignancy or atypia. G. Breast, lateral to left segmental mastectomy, biopsy: Negative. for malignancy or atypia. H. Breast, superior to left segmental mastectomy, biopsy: Negative. for malignancy or atypia. Microscopic Description: Invasive Carcinoma. Histologic type: Ductal. Histologic grade: 3. Overall grade: 9/9. Architectural score: 3. Nuclear score: 3. Mitotic score: 3. Greatest dimension (pT) : 2.8 cm. Specimen margins: Negative. Vessel invasion: Not identified. Calcification: Present. Ductal carcinoma in situ: Histologic pattern: Solid. Nuclear grade: 3. Central Necrosis: Present. 8 DCIS of total tumor (if mixed) : 1%. Extensive intraductal component (present/absent) : Absent. Specimen margins: Negative. Calcification: Negative. Description of non-tumorous breast: Fibrocystic changes, with ductal. hyperplasia of usual type, a minute fibroadenoma, and apocrine. metaplasia, with calcification. Comments: Sentinel lymph nodes negative, confirmed by negative. cytokeratin immunostaining of blocks BFS1 and CFS2. Cytokeratin. staining was also performed on one block from part E, to exclude. involvement by carcinoma. Prior biopsy site identified. Extensive. central tumor necrosis is present. Prognostic markers: See core biopsy report,. 4x8, 14x2, 15x2, 20x3. [A few of the antibodies used in our laboratory may be classified as. analyte specific reagents. These antibodies are monitored and. controlled in our laboratory and their performance for in vitro. diagnosis is well described in the medical literature. They have not. been cleared or approved by the FDA.: Specimen. A. Left Breast. B. Left axillary sentinel lymph node #1, hot, blue,. C. Left axillary sentinel lymph node #2, not hot, not blue, but. palpable. D. Medial to segmental mastectomy left breast. E. Inferior to segmental mastectomy left breast. F. Posterior to segmental mastectomy left breast. G. Lateral to segmental mastectomy left breast. H. Superior to segmental mastectomy left breast. Clinical Information. Left breast cancer. Intraoperative Consultation. B) Left axillary sentinel node #1: Two negative lymph nodes (0/2). C) Left axillary sentinel node #2, biopsy: One negative lymph node. (0/1). Gross Description. A. Received unfixed for tissue procurement, labeled left breast. segmental mastectomy single long lateral, double long anterior, is. a 100 gram breast segmental excision that is 9 cm from anterior to. posterior, 7.5 cm medial to lateral, and 3 cm from superior to. inferior. The superior surface is inked black, and a section is. submitted for tissue procurement as requested. An additional. section of uninvolved fatty tissue is submitted from the posterior. aspect, for procurement. Additional sections after fixation. The. superior surface is inked black, medial green, lateral yellow,. inferior blue. There is a tan, firm, lobulated mass lesion in the. mid-portion of the specimen, 3.0 x 2.0 x 1.7 cm. This is 3 mm from. the green-inked medial margin (closest margin). All other margins. are grossly greater than 1 cm from the mass. Representative. sections: 1 Anterior margin, 2 adjacent section with margin, 3/4/5. contiguous tumor, possible biopsy cavity in 5, 6/7/8 contiguous,. 9-10 random medial and lateral, possible close margin, 11-14. additional posterior sections, with last section = posterior. margin. B. Received unfixed for frozen section, labeled left axillary. sentinel node #1, are 2 adjacent and attached lymph nodes, 0.9 cm. in greatest dimension each, bisected and entirely submitted in. blocks B1 and B2. C. Received unfixed for frozen section, labeled left axillary. sentinel node #2, is a single lymph node, 1.4 x 1.3 x 1.0 cm,. bisected and entirely submitted in 2 blocks. D. Received fresh and subsequently fixed in formalin labeled ""medial. to segmental mastectomy left breast ""is a 5.2 x 3.5 x 1.5 cm yellow. lobular fatty tissue fragment which has a suture designating the. new medial border. The surface is inked and the specimen is. sectioned to show yellow lobular fatty cut surface with minimal. fibrous tissue present. No discrete residual tumor is grossly. identified. The specimen is entirely submitted labeled 1 through. 10. E. Received fresh and subsequently fixed in formalin labeled. ""inferior to segmental mastectomy left breast ""is a 4.3 x 2.7 x. 2.2. cm yellow lobular fatty tissue fragment which has a suture. designating new inferior border. The surface is inked and the. specimen is sectioned to show yellow lobular fatty cut surface with. minimal fibrous tissue present. No residual tumor is grossly. identified. The specimen is entirely submitted labeled 1 through 9. F. Received fresh and subsequently fixed in formalin labeled. ""posterior to segmental mastectomy left breast ""is a 3.2 x 2.5. x. 1.0 cm yellow lobular fatty tissue fragment which is partially. covered with skeletal muscle. There is a suture designating the new. posterior margin. The surface is inked and the specimen is. sectioned to show a yellow lobular fatty cut surface with scanty. fibrous tissue present. The specimen is entirely submitted in 5. cassettes. G. Received fresh and subsequently fixed in formalin labeled ""lateral. to segmental mastectomy left breast ""is a 4.3 x 3.5 x 1.5 cm yellow. lobular fatty tissue fragment. There is a suture designating the. new lateral border. The surface is inked and the specimen is. sectioned to show yellow lobular fatty cut surface with minimal. fibrous tissue present. No residual tumor is grossly identified. The specimen is entirely submitted in 9 cassettes. H. Received fresh and subsequently fixed in formalin labeled. ""superior segmental mastectomy left breast ""is a 4.3 x 2.2 x 1.0. cm. yellow lobular fatty tissue fragment which has a suture designating. the new superior border. This is inked and the specimen is. sectioned to show yellow lobular fatty cut surface with scanty. fibrous tissue present. The specimen is entirely submitted in 4. cassettes.",BRCA,0,"The T stage is based on the size of the tumor, without considering the involvement of the chest wall or skin. In this report, the tumor size is stated as 2.8 cm, which falls within the T2 category of tumors between 2.1 and 5.0 cm.",T2,41.0
560,TCGA-A2-A4RW.C1D4D6BB-AF86-4208-A729-C61365941217,1,"34. Unit#: : Specimen: Spec Type: SURGICAL P. PREOPERATIVE DIAGNOSIS. RIGHT BREAST CANCER INVASIVE. OPERATION PERFORMED. DOCTOR. PROCEDURE: MASTECTOMY MODIFIED RADICAL. TISSUE REMOVED. A. RT BREAST MASTECTOMY. B. RT AXILLARY NODE DISSECTION. GROSS DESCRIPTION. RECEIVED IN 2 PARTS. A RECEIVED LABELED. RIGHT BREAST STITCH 12 O'CLOCK IS A. 650 GRAM SIMPLE MASTECTOMY SPECIMEN MEASURING 23.5 X 21.5 x 3.7 CM. THE. NIPPLE IS UNREMARKABLE WITHIN A SKIN ELLIPSE MEASURING 23.5 x 12.5 CM. A SUTURE DENOTES 12 O'CLOCK. THE SUPERFICIAL ASPECT IS MARKED WITH BLUE. INK, THE DEEP WITH BLACK. SECTIONING REVEALS A CENTRAL PORTION OF THE. BREAST TO BE A MIXTURE OF TAN FIBROUS TISSUE AND YELLOW FAT. THE. PERIMETER CONSISTS OF BLAND YELLOW FATTY TISSUE. IN THE 10 O'CLOCK AREA. OF THE BREAST IS A FIRM MASS MEASURING 4 CM FROM MEDIAL TO LATERAL BY. 3.5 CM FROM SUPERIOR TO INFERIOR AND 2.1 CM FROM ANTERIOR TO POSTERIOR. THERE IS A SMALL RIM OF FATTY TISSUE DEEP TO THE LESION. GROSSLY THERE. IS AT LEAST 0.5 CM OF TISSUE. THIS DOES NOT INVOLVE THE SKIN GROSSLY. SECTIONS ARE SUBMITTED AS FOLLOWS: A1--NIPPLE, A2 AND 3--LESION IN DEEP. MARGIN, A4--FAR LATERAL ASPECT OF LESION WITH SKIN, A5--GROSS MEDIAL. ASPECT OF LESION 4 CM FROM A4, AND A10 IS THE TISSUE SUPERFICIAL TO A8. SUPERFICIAL TO DEEP MEASUREMENT. SECTIONS OF THE LESION ARE ALSO. SUBMITTED PER PROTOCOL. A BOWTIE-SHAPED CLIP IS IDENTIFIED WITHIN THE. LESION, A11--TUMOR, A12--UPPER INNER QUADRANT, A13--UPPER OUTER QUADRANT. LATERAL TO LESION, A14--LOWER OUTER QUADRANT, A15--LOWER INNER QUADRANT. B RECEIVED LABELED. RIGHT AXILLARY NODE DISSECTION ARE 2. IRREGULAR PORTIONS OF YELLOW-RED FATTY TISSUE TOGETHER MEASURING 9 X 7 x. 2.5 CM. THIS TISSUE IS EXAMINED FOR LYMPH NODES. THE LARGEST NODE. WHICH IS 2.5 CM IN DIAMETER DEMONSTRATES A ROD-SHAPED METAL CLIP. IT. HAS ILL-DEFINED BORDERS. ONE-HALF IS SUBMITTED IN B1. THE REMAINDER IS. Specimen: q#. Spec Type: GROSS DESCRIPTION. TAKEN PER PROTOCOL. ADDITIONAL NODES ARE ALSO IDENTIFIED AND SUBMITTED. AS. FOLLOWS. THERE IS A 2ND 2.5 CM LYMPH NODE WHICH IS GROSSLY. UNREMARKABLE. ONE-HALF IS SUBMITTED AS B2. THE REMAINDER IS TAKEN PER. PROTOCOL. A 1.7 CM LYMPH NODE IS BISECTED, ONE-HALF SUBMITTED IN B3,. THE REMAINDER SUBMITTED PER PROTOCOL. ADDITIONAL NODES ARE THEN. SUBMITTED AS FOLLOWS: B4--2 NODES EACH BISECTED, B5--3 NODES EACH. BISECTED, B6--3 NODES EACH BISECTED, B7--1 NODE TOTAL, B8--5 NODES,. B9~-4 NODES, B10-4 NODES. FORMALIN FIXATION TIME IS 6 HOURS AND 10 MINUTES. PATH PROCEDURES. PROCEDURES: 88309, A BLK/15, B BLK/10. FINAL DIAGNOSIS. PART A RIGHT BREAST, SIMPLE MASTECTOMY: 1. INTRALOBULAR AND INFILTRATING LOBULAR CARCINOMA OF THE PLEOMORPHIC. TYPE. THE INVASIVE COMPONENT SHOWS NUCLEAR GRADE 2/3, LOW MITOTIC. INDEX AND TUBULE FORMATION 3 FOR A TOTAL NOTTINGHAM SCORE OF. LCIS. WITH RARE FOCI OF LUMINAL NECROSIS COMPRISES APPROXIMATELY 30% OF THE. TUMOR. 2. THE TUMOR HAS A MAXIMUM GROSS DIMENSION OF 4 CM ALTHOUGH RARE IN. SITU AND INVASIVE FOCI ARE IDENTIFIED IN A RANDOM SECTION FROM THE. LOWER OUTER QUADRANT. 3. INVASIVE TUMOR IS FOCALLY IDENTIFIED 4 MM FROM THE NEAREST INKED. SUPERFICIAL MARGIN (A2) AND 4 MM FROM THE SKIN SURFACE (A4) . 4. THE BIOPSY SITE. ) AND A BOWTIE-SHAPED CLIP ARE IDENTIFIED. 5. ALTHOUGH LYMPHOVASCULAR INVASION IS NOT IDENTIFIED, PERINEURAL. INVASION IS PRESENT. PART B RIGHT AXILLA,. IS IDENTIFIED IN ALL. OF LYMPH THE NODE 27 LYMPH DISSECTION: NODES EXAMINED. METASTATIC FOCAL BREAST EXTRANODAL CARCINOMA 27/27/20. EXTENSION INTO THE PERINODAL FAT IS PRESENT. A BIOPSY SITE INCLUDING A. Specimen: Spec Type: 1, D.O. FINAL DIAGNOSIS. ROD-SHAPED METAL CLIP IS ALSO PRESENT. :, M.D.",BRCA,3,"The report states that the maximum gross dimension of the tumor is 4 cm, which falls within the range for T2 (2.1 to 5.0 cm). The T stage is based on the size of the tumor, without considering the involvement of the chest wall or skin, the presence of lymphovascular invasion or perineural invasion, or the distance to the resection margin.",T2,42.0
540,TCGA-A2-A1G4.5AD3B697-F097-496C-978B-F73BDA5394A7,2,"chief of Pathology. Specimen: Reg# 2. Spec Type: SURGICAL P. BREAST CANCER INVASIVE. DOCTOR () : PROCEDURE: A. RT BREAST DEEP MARGIN. B. LT BREAST. c. RT PREAST AND AXILLARY NODES. RECRIVED. RTS. LABELED. RIGHT DEEP MARGIN INK MARKS NEW. .RREGULAR PORTION OF YELLOW FATTY AND BRONN MUSCULAR TISSUE. ME. LNG 4.8 x 2.2 x 0.6 CM IN GREATEST DIMENSIONS. ONE SIDE OF THE. SPECIMEN IS RECEIVED MARKED WITH BLUE INK. THIS SIDE IS FURTHER MARKED. NTTU PITE INV. TH A PERIMETER OF RED INK. THE SPECIMEN IS SECTIONED AND. 3D LABELED A1 THROUGH A3. PA. ABELED. LEFT BREAST IS A SIMPLE. MAS1. EN MEASURING 24.5 x 21 x 3.8 CM. A SUTURE DENOTES 12. O'CLO. THE NI PLE IS FLAT WITHIN A 23.7 x 15.3 CM SKIN ELLIPSE. IN. THE 9 O'CLOCK AREA OF THE BREAST THERE IS A 0.5 CM IN DIAMETER. FLONER-SHAPED RED-BROWN SKIN LESION. THE SUPERFICIAL ASPECT IS MARKED. NITH BLUE INK, THE DEEP WITH BLACK INK. SECTIONING REVEALS THE SPECIMEN. TO CONSIST OF BLAND YELLOW FATTY TISSUE WITH FINE FIBROUS BANDS. THERE. ARE NODULAR FIRM AREAS NOTED CENTRALLY THAT DO NOT FORM DISCRETE MASSES. SECTIONS ARE SUBMITTED AS FOLLOWS: 31--NIPPLE AND DESCRIBED SKIN LESION,. B2 - CENTRAL DEEP MARGIN, B3 AND B4 --UPPER OUTER QUADRANT, B5 AND. 86--UPPER INNER QUADRANT, B7 AND B8--LOWER INNER QUADRANT, B9 AND. B10--LOWER - OUTER QUADRANT, B11--TISSUE CENTRAL. NOTE THAT B1, B3, B5,. B7, B9, AND B11 ARE MIRROR IMAGE TISSUE TAKEN PER PROTOCOL. ADDITIONAL SECTIONS FROM THE LOWER INNER QUADRANT ARE SUBMITTED LABELED. B12 THROUGH B14, A SECTION FROM THE SUBAREOLAR AREA IN B15, AND. ADDITIONAL TISSUE FROM THE UPPER OUTER QUADRANT B16 AND 17. PART c RECEIVED LABELED. RIGHT BREAST AND AXILLARY LYMPH. NODE IS A RIGHT MODIFIED RADICAL MASTECTOMY SPECIMEN WITH FRAGMENTS OF. LOOSE TISSUE WHICH ALSO DEMONSTRATE PALPABLE LYMPH NODES. THE OVERALL. DIMENSIONS ARE 30 x 22 x 4.3 CM. THE NIPPLE IS FLATTENED. IMMEDIATELY. Chief of Pathology. Tax. Specimen: spec Type: SURGICAL P. LATERAL TO THE NIPPLE IS A PALPABLE MASS. THE SKIN ELLIPSE MEASURES 22.6. x 14. 0 CM. A SMALL RAISED PIGMENTED LESION IS FOUND IN THE LOWER OUTER. QUADRANT ADJACENT TO THE SKIN RESECTION MARGIN MEASURING 0.4 CM IN. DIAMETER. THE SUPERFICIAL ASPECT IS MARKED IN BLUE INK, THE DEEP. ASPECT WITH BLACK INK. WHERE THE AXILLARY TAIL IS REMOVED, IT IS MARKED. IN RED AND DOES NOT REPRESENT TRUE MARGIN. THE AXILLARY TAIL IS EXAMINED. FOR LYMPH NODES. IN THE LOW AXILLARY TAIL, THERE IS A 2.8 CM CENTRALLY. 7AT-REPLACED LYMPH NODE WITH A COIL CLIP. ONE HALF IS SUBMITTED PER. PROTOCOL. THE REMAINDER IS SUBMITTED AS C1. A SECOND LOW NODE IS. GROSSLY POSITIVE 1.6 CM IN GREATEST DIMENSION. ONE HALF IS SUBMITTED AS. C2 WITH THE REMAINDER SUBMITTED PER PROTOCOL. ADDITIONAL NODES ARE THEN. SUBMITTED AS FOLLOWS: C3--ONE HALF GROSSLY UNREMARKABLE LYMPH NODE. (MIRROR IMAGE TO PROTOCOL), C4--TWO NODES EACH BISECTED, C5--ONE NODE. BISECTED, C6--ONE NODE BISECTED, C7--ONE NODE BISECTED, C8--TWO NODES. EACH BISECTED, C9--FOUR NODES, C10--TWO NODES EACH BISECTED, C11 AND. C12--ONE NODE TOTAL. SECTIONING REVEALED THE BREAST TO CONSIST OF BLAND. YELLOW FATTY TISSUE WITH FINE FIBROUS BANDS. THE PALPABLE MASS IS. ILL-DEFINED WITH PINK-TAN TISSUE INTERSPERSED IN THE YELLOW-FATTY TISSUE. THIS EXTENDS FROM THE SUBAREOLAR AREA IN THE LONER OUTER QUADRANT. MEASURING 6 CM FROM MEDIAL TO LATERAL BY PALPATION 6.5 CM FROM SUPERIOR. TO INFERIOR AND 4 CM FROM SUPERFICIAL TO DEEP IN AN ILL-DEFINED MANNER. GROSSLY THIS EXTENDS TO WITHIN 0.5 CM OF THE DEEP MARGIN. SECTIONS ARE. SUBMITTED AS FOLLOWS: C13--NIPPLE (MIRROR IMAGE TO PROTOCOL), C14 AND. C15--LESION AND CLOSEST GROSS DEEP MARGIN, C16--THE MOST LATERAL ASPECT. OF THE LESION (MIRROR IMAGE TO PROTOCOL), C17--THE MOST CENTRAL AND. MEDIAL PORTION OF THE LESION (MIRROR IMAGE TO PROTOCOL) NOTE THAT C16. AND C17 ARE 6 CM APART, C18--TUMOR (MIRROR IMAGE TO PROTOCOL), C19--THE. MOST INFERIOR ASPECT OF THE LESION WITH INFERIOR SUPERFICIAL MARGIN,. C20--THE SUPERIOR PORTION OF THE LESION OR ADJACENT TO MARGIN CENTRAL. SPECIMEN, C21--UPPER OUTER QUADRANT, C22--LOWER INNER QUADRANT,. C23--UPPER INNER QUADRANT, C24 AND C25--ADDITIONAL SECTIONS OF CENTRAL. TUMOR (MIRROR IMAGE TO PROTOCOL) . PROCEDURES: 88307/2, 88309, A BLK/3, B BLK/17, C BLK/25, ER PR KI67 HER2. PART A RIGHT BREAST DEEP MARGIN REEXCISION: FIBROADIPOSE TISSUE AND. SKELETAL MOSCLE WITH NO EVIDENCE OF MALIGNANCY. THE NEW INKED MARGIN IS. FREE OF NEOPLASM. PART B LEFT BREAST, SIMPLE MASTECTOMY: 1. INFILTRATING LOBULAR CARCINOMA, NUCLEAR GRADE I WITH LOW MITOTIC. INDEX, IDENTIFIED IN THE LOWER INNER QUADRANT WITH AN ESTIMATED TUMOR. DIMENSION OF 21 MM (SLIDES B7, B8, B12-14). Chief of yathology. Speciment. status: Spec Type: SURGICAL P. 2. THE NIPPLE AND DEEP MARGIN ARE FREE OF NEOPLASM. 3. LYMPHATIC INVASION IS NOT IDENTIFIED. 4. PROLIFERATIVE FIBROCYSTIC DISEASE WITH A FOCUS OF LOBULAR CARCINOMA. IN SITU IDENTIFIED IN THE UPPER OUTER QUADRANT ALONG WITH SCLEROSING. ADENOSIS, DUCT HYPERPLASIA OF THE OSUAL TYPE, APOCRINE METAPLASIA AND. CYST FORMATION. PART C RIGHT BREAST, MODIFIED RADICAL MASTECTOMY: 1. LARGE MODERATELY DIFFERENTIATED INTRADUCTAL AND INFIL/TRATING DUCT. CARCINOMA, NUCLEAR GRADE II WITH LOW MITOTIC INDEX NITH FOCI OF. MUCINOUS DIFFERENTIATION SPANNING A DISTANCE OF 65 MM. 2. THE DEEP MARGIN IS FREE OF NEOPLASM. DUCTAL CARCINOMA IN SITU. INVOLVES THE NIPPLE. 3. LYMPHATIC INVASION IS PRESENT. 4. METASTATIC CARCINOMA TO 1 OF 15 AXILLARY LYMPH MODES. ONE LYMPH NODE. DEMONSTRATES PREVIOUS BIOPSY SITE CHANGE BUT NO RESIDUAL NEOPLASM. 5. HEMANGIOMA, SKIN OF BREAST. RECEPTOR AND PROGNOSTIC FACTOR DETERMINATION WILL BE PERFORMED ON BLOCK. B7. -. ESTROGEN RECEPTOR: POSITIVE. Nuclei Stained: 100%. Intensity: 3. Reference Range Negative <1%. Positive >= 1t. PROGESTERONE RECEPTOR: NEGATIVE. Nuclei stained: o. Intensity: 1. Reference Range: Negative <1%. Positive >= 1%. Her-2/neu: NEGATIVE. Score: 1+. Reference Range: Negative 0 - 1+. Equivocal 2+. Chief of Fatholegy. specimen: Spec Type: SURGICAL P. Positive 3+. Ki-67: LOW. Nuclei Stained: 3. Intensity: Reference Range: Low <10%. Borderline 10-20%. High >20%. See full scanned report for details. 1. 1. SENT TO: 2. REQUESTED BYs. 3. DATE SEST: 4. KETHOD or. 5. NO. or BLOCKS: 7. KATERIAL (#) TO BE RETURNED: 14. SPECINEE SENT (x/m) $ 1. (prelim.). (signature on file). 0.",BRCA,1,"The report states that the largest invasive tumor in the right breast measures 6 cm in greatest dimension (as noted in C14 and C15). This falls within the T2 category, which includes tumors with a size between 2.1 and 5.0 cm.",T2,43.0
246,TCGA-5L-AAT1.B5CA42BB-9514-42C6-9FB0-C8889C1DC51A,1,"Gender: Female. Color: White. Origin: Nature of material: Breast. Biopsy number: Gross description: Specimens are received in three containers. Container 01: Right breast (mastectomy) weighing 863 g. It measures 22.5 x 17.5 x 4.0 cm. Superficially, a skin ellipse is seen, and measures 18.0 X 7.0 cm. There is no superficial lesion. On. slicing in the breast parenchyma is a white spiculated nodule with central necrosis measuring 3.5. x 2.5 x 0.8 cm. Macroscopically, all the margins are clear. Container 02: Axillary lymph node: One white, soft and nodular tissue measuring 1.1 x 0.8 x 0.3. cm containing no gross lesion. Container 03: 10 Axillary lymph nodes. A gross nodular fibrofatty tissue measuring 3.0 x 2.2 x. 0.6 cm in aggregate. Contained within the tissue are 4 soft nodular structures with diameters. ranging from 0.2 to 0.4 cm in the largest diameters. Microscopy. Dispensable description. Conclusions: Right breast: Invasive lobular carcinoma, grade 1, measuring 1.1 cm in the largest diameter;. Clear surgical margins. Lymph nodes: There is no lymph nodes metastasis. PARTICIPANTS OF APPRAISAL REPORT. - Issuer. - Reviewer.",BRCA,0,"The report states that the largest diameter of the invasive lobular carcinoma is 1.1 cm, which falls under the 'T1' category of tumor size up to 2.0 cm. The fact that there are multiple foci of tumor does not affect the T stage, as it is based on the size of the largest one. Additionally, the T stage is not determined by the distance to the resection margin or the presence of lymphovascular invasion or perineural invasion.",T1,43.0
506,TCGA-A2-A0EW.2620E5E7-ED7D-4F04-A8AF-1499E9711E8A,0,"Specimen #: (Age: )F Race: WHITE. SPECIMEN: A: LEFT BREAST B: RIGHT BREAST. C: LEFT AXILLARY SENTINEL NODE. D: RIGHT AXILLARY SENTINEL NODE. E: RIGHT AXILLARY NON SENTINEL NODE. FINAL DIAGNOSIS: A. BREAST, LEFT, SIMPLE MASTECTOMY: - SKIN WITH NO SIGNIFICANT PATHOLOGIC CHANGES. BREAST TISSUE WITH FIBROCYSTIC CHANGES TO INCLUDE APOCRINE METAPLASIA. AND MICROCYST FORMATION. - NEGATIVE FOR MALIGNANCY. B. BREAST, RIGHT, SIMPLE MASTECTOMY: - TUMOR TYPE: INVASIVE LOBULAR CARCINOMA, MULTICENTRIC (SEE COMMENT) . TUMOR #1: - TUMOR TYPE: INVASIVE LOBULAR CARCINOMA, LOW NUCLEAR GRADE. - NOTTINGHAM GRADE: I/III. - NOTTINGHAM SCORE: 5/9. (Tubules= 3, Nuclei= 1, Mitoses= 1; mitotic count 1 per 10 HPF at. 40x power). - TUMOR LOCATION: LOWER OUTER QUADRANT. TUMOR SIZE (GREATEST DIMENSION) : 1.0 CM (MEASURED GROSSLY). - ADDITIONAL DIMENSIONS: 1.0 X 0.5 CM. - TUMOR NECROSIS: NONE IDENTIFIED. - MICROCALCIFICATIONS: NONE IDENTIFIED. VENOUS / LYMPHATIC INVASION: NONE IDENTIFIED. - MARGINS: TUMOR INVOLVES INKED SUPERFICIAL MARGIN (B2) . - INTRADUCTAL COMPONENT: NONE IDENTIFIED. LYMPH NODES FOUR (4) OF FOUR POSITIVE FOR TUMOR BY H&E (SEE PARTS D. AND E). - NIPPLE INVOLVEMENT: NOT IDENTIFIED. - SKIN INVOLVEMENT: NOT IDENTIFIED. TUMOR #2: - TUMOR TYPE: INVASIVE LOBULAR CARCINOMA, LOW NUCLEAR GRADE. - NOTTINGHAM GRADE: I/III. - NOTTINGHAM SCORE: 5/9. (Tubules= 3, Nuclei= 1, Mitoses= 1; mitotic count 2 per 10 HPF at. Specimen # : FINAL DIAGNOSIS (continued) : 40x power). - TUMOR LOCATION: UPPER MIDDLE. - TUMOR SIZE (GREATEST DIMENSION) : 1.0 CM (MEASURED GROSSLY) (SEE. COMMENT) . - ADDITIONAL DIMENSIONS: 1.0 X 0.5 CM. - TUMOR NECROSIS: NONE IDENTIFIED. MICROCALCIFICATIONS: PRESENT, ASSOCIATED WITH LOBULAR CARCINOMA IN. SITU (B3). - VENOUS / LYMPHATIC INVASION: NONE IDENTIFIED. - MARGINS : TUMOR <0.1 CM FROM INKED SUPERFICIAL MARGIN (B3). - INTRADUCTAL COMPONENT : NONE IDENTIFIED. - LYMPH NODES: SEE ABOVE. - NIPPLE INVOLVEMENT: NOT IDENTIFIED. - SKIN INVOLVEMENT: NOT IDENTIFIED. - ESTROGEN RECEPTORS: POSITIVE (PER. - PROGESTERONE RECEPTORS: POSITIVE (PER. - HER 2 NEU by IHC: 1+ (NEGATIVE) (PER. - PATHOLOGIC STAGE: pT1c N2 MX (AJCC, 6th ED) (SEE COMMENT). - ADDITIONAL PATHOLOGIC CHANGES: - LOBULAR CARCINOMA IN SITU. - ACELLULAR FOREIGN MATERIAL AND BIOPSY SITE CHANGES (SEE COMMENT) . - FIBROCYSTIC CHANGES TO INCLUDE APOCRINE METAPLASIA AND MICROCYST. FORMATION. - MAMMARY DUCT ECTASIA. C. SENTINEL LYMPH NODE, LEFT AXILLA, EXCISIONAL BIOPSY: - THREE (3) BENIGN LYMPH NODES BY CONVENTIONAL H&E AND. IMMUNOHISTOCHEMICAL STAINING. D. SENTINEL LYMPH NODES, RIGHT AXILLA, EXCISIONAL BIOPSY. - THREE (3) LYMPH NODES POSITIVE FOR CARCINOMA BY CONVENTIONAL H&E AND. IMMUNOHISTOCHEMICAL STAINING. E. NON-SENTINEL LYMPH NODE, RIGHT AXILLA, EXCISIONAL BIOPSY: - ONE (1) LYMPH NODE POSITIVE FOR CARCINOMA WITH EXTRACAPSULAR. EXTENSION BY H&E STAINING. Comment: There are two separate tumors in the right breast mastectomy. specimen. Since these tumors are separated by 4. cm and are located in. different quadrants the designation ""multicentric"" is used. Both tumors. are histologically similar. The acellular marker material present in the. specimen is associated with the upper middle tumor (tumor #2) . There are. isolated tumor cells present in a section adjacent to the upper middle. Specimen #: FINAL DIAGNOSIS (continued) : tumor (tumor #2, slide B4) making the exact determination of tumor size. difficult. The largest dimension measured of the tumor is 1.2 cm from the. previous biopsy specimen (S08- - i! making the tumor stage Tlc. The. histologic appearance along with the presence of lobular carcinoma in situ. and the immunohistochemical characterization of the previous biopsy. support the diagnosis of invasive lobular carcinoma. CLINICAL DIAGNOSIS AND HISTORY: year-old female with right breast mass birads four on. mammogram, ultrasound guided biopsy, invasive lobular carcinoma. Bilateral simple mastectomy, skin biopsy, with immediate reconstruction. PRE-OPERATIVE DIAGNOSIS: Right breast cancer. GROSS DESCRIPTION: A. Received fresh, labeled with the patient's name,. designated ""LEFT BREAST TISSUE WITH MARKINGS"" is a mastectomy specimen. oriented with a short stitch superior, long stitch lateral, and double. stitch ""down"". The specimen measures 17.0 cm medial to lateral, 16 cm. superior to inferior, and 3.5 cm anterior to posterior. The lightly. pigmented superficial skin ellipse measures 10.0 x 3.0 cm and displays a. 1.0 cm centrally located everted nipple free of discharge. No scar is. identified. The deep margin is inked black. Serial sections reveal. predominantly lobulated, yellow-tan, adipose tissue admixed with evenly. distributed, tan-white, fibrous tissue comprising approximately 20% of the. cut surface. On palpation, no discreet mass or lesion is identified. No. lymph nodes are identified. Cassette Summary : A1: Skin. A2: Upper outer quadrant. A3: Upper inner quadrant. A4: Lower inner quadrant. A5: Lower outer quadrant. A6: Central. A7: Nipple. A8: Upper outer quadrant. Specimen #: GROSS DESCRIPTION (continued) : A9: Upper inner quadrant. A10: Lower inner quadrant. All: Lower outer quadrant . Matched sections of A1 through A6 are submitted in. for CBCP protocol. B. Received fresh, labeled with the patient's name,. designated ""RIGHT BREAST TISSUE WITH MARKINGS"" is a mastectomy specimen. oriented with a short stitch superior, and a long stitch lateral. The. specimen measures 7.0 cm superior to inferior, 17.0 cm medial to lateral,. and 3.5 cm anterior to posterior. The lightly pigmented superficial skin. ellipse measures 10.0 x 3.0 cm and displays a 1.0 cm centrally located,. everted nipple free of discharge. No scar is identified. The deep margin. is inked black, and the superficial surface is partially inked blue. Serial sections reveal a 1.0 x 1.0 x 0.5 cm well defined, tan-white mass. in. the. upper mid breast, abutting the blue inked superficial surface, and. coming to within 4.0 cm of the deep margin. Also identified is a second,. poorly defined mass in the lower outer quadrant measuring approximately. 1.0 x 1.0 x 0.5 cm. The lower outer quadrant mass abuts the blue inked. superficial surface, and is located 4.5 cm from the deep margin. The. masses are separated by a distance of approximately 4.5 cm. The remainder. of the specimen is predominantly composed of lobulated, yellow-tan,. adipose tissue admixed with approximately 20% slightly dense, fibrous. tissue. No additional lesions are identified. No lymph nodes are. identified. Cassette Summary : B1: Skin. B2 Lower outer quadrant mass. B3 : Upper mid mass. B4: Adjacent normal (to B3) . B5: Upper outer quadrant. B6: Lower outer quadrant. B7: Lower inner quadrant. B8: Upper inner quadrant. B9: Nipple. B10: Lower outer quadrant mass. B11: Deep margin of lower outer quadrant mass. B12-B13: Upper mid mass. B14: Deep margin of upper mid mass. C. Received in formalin, labeled with the patient's name,. D, designated ""LEFT AXILLARY SENTINEL NODE"" is a 5.5 x 4.5 x. cm. irregularly shaped, lobulated fragment of tan-yellow, adipose. Sectioning. Specimen #: GROSS DESCRIPTION (continued) : reveals three possible lymph nodes ranging in size from 1.0 x 0.6 x 0.3 cm. to 1.2 x 1.0 X 0.6 cm. The lymph nodes are bisected, and submitted in. cassettes C1 through C3. D. Received in formalin, labeled with the patient's name,. D, designated ""RIGHT SENTINEL NODE"" is a tan-yellow, lobulated,. irregularly shaped fragment of adipose tissue measuring 5.5 x 3.0 X 0.5 cm. in diameter. Examination reveals three possible lymph nodes ranging in. size from 0.2 x 0.2 x 0.2 cm to 2.3 x 1.6 x 1.0 cm. Cassette Summary. D1-D2: First possible lymph node. D3: Second possible lymph node. D4: Third possible lymph node. E. Received fresh for intraoperative consultation, labeled with the. patient's name,. designated ""RIGHT AXILLARY TISSUE, NON. SENTINEL NODE"" is a 4.0 x 3.5 x 2.0 cm irregular portion of yellow-tan,. soft tissue. Sectioning reveals a single, 1.5 x 1.0 x 0.5 cm lymph node. The cut surface is tan-white, suspicious for involvement by lesion. The. lymph node is bisected, and submitted in cassette E1. A matched section. of E1 is submitted in. ior CBCP protocol. Time in formalin for specimen A: 79 hours. Time in formalin for specimen B: 81 hours.",BRCA,3,"Based on the pathology report, there are two invasive lobular carcinomas in the right breast, with the largest tumor having a greatest dimension of 1.2 cm. This falls within the T1 category, specifically T1c as it is greater than 1 cm but not more than 2 cm.",T1,43.0
616,TCGA-A8-A06X.738B601A-24D8-4261-B000-198648213070,2,"Diagnosis: Invasive ductal breast carcinoma (maximum diameter 5.5 cm, malignancy grade. III) with angioinvasion and a mediocranial safety margin at least 3 mm wide. Tumor classification: G3 (L0, V0), pT3, Nx, Mx. Diagnosis: Tumor-free lymph nodes (total N = 11, pN0).",BRCA,0,"The report indicates that the maximum diameter of the tumor is 5.5 cm, which falls in the T3 category of 'tumor size over 5.0 cm without direct extension to the chest wall or skin'. The T stage is based on the size of the tumor, without considering the involvement of the chest wall or skin or the presence of lymphovascular invasion or perineural invasion.",T3,44.0
462,TCGA-A1-A0SN.D0269758-EFAE-4EBA-8CCF-4A6CF4D4B35A,0,"Final Pathologic Diagnosis: A. Lymph node, left axillary sentinel node #1, excision: No metastatic carcinoma in. one lymph node (0/1). B. Lymph node, left axillary sentinel node # +2, excision: Metastatic carcinoma in one. lymph node with extension into peri-nodal fat (1/1). C. Lymph node, left axillary sentinel node # 3, excision: Metastatic carcinoma in one. lymph node (1/1). D. Lymph node, left axillary non-sentinel node # 1, excision: Metastatic carcinoma in. one lymph node (1/1). Working Draft. E. Lymph node, left axillary non-sentinel node #2, excision: Metastatic carcinoma in. one lymph node (1/1). F. Breast, left, partial mastectomy: 1. Infiltrative ductal carcinoma, SBR grade 2, 1.1 cm in maximum dimension,. margins negative; see comment. 2. Ductal carcinoma in situ, high-grade, solid and comedo types, 1.1 cm in maximum. dimension, intermixed with invasive ductal carcinoma, margins negative. G. Breast, left lateral anterior, excision: Benign breast tissue, no carcinoma. identified. H. Breast, medial superior anterior, excision: Benign breast tissue, no carcinoma. identified. I. Lymph node, left axillary contents, excision: No metastatic carcinoma in eight. lymph nodes (0/8). Note: Breast Tumor Synoptic Comment. - Laterality: Left. - Invasive tumor type: Invasive ductal carcinoma. - Invasive tumor size: 1.1 cm maximum diameter. - Invasive tumor grade (modified Bloom-Richardson): 2. Nuclear grade: 3, 3 points. Mitotic count: <10 mitotic figures/10 HPF, 1 point. Tubule/papilla formation: <10%, 3 points. Total points and overall grade = 7 points = grade 2. - Lymphatic-vascula invasion: Extensive lymphatic-vascular invasion is noted with intra-lymphatic. metastasis noted in lymphatics at least 1 cm from the main tumor. - Perineural Invasion: Not present. - Resection margins for invasive tumor: - Deep margin: Negative; (tumor is 0.2 cm away, on slide F6). - Medial margin: Negative; (tumor is greater than 1 cm). - Lateral margin: Negative; (tumor is greater than 1 cm). - Anterior/superior margin: Negative; (tumor is 0.2 cm away, on slide F6). - Anterior/inferior margin: Negative; (tumor is 0.3 cm away, on slide F4). - Ductal carcinoma in situ (DCIS) type: Comedo and solid. - Ductal carcinoma in situ size: 1.1 cm, intermixed with invasive ductal carcinoma. - Ductal carcinoma in situ nuclear grade: High-grade. - Necrosis in DCIS: Comedonecrosis. - Microcalcifications: Not identified. - Resection margins for ductal carcinoma in situ: - Deep margin: Negative; (tumor is 0.6 cm away, on slide F6). - Medial margin: Negative; (tumor is greater than 1 cm). - Lateral margin: Negative; (tumor is greater than 1 cm). - Anterior/superior margin: Negative; (tumor is 0.25 cm away, on slide F6). - Anterior/inferior margin: Negative; (tumor is 0.25 cm away, on slide F6). - Lobular carcinoma in situ (LCIS): None. - Lymph node status: Positive. - Number of positive lymph nodes: 4. - Total number sampled: 13. - Diameter of largest metastasis: 0.8 cm. Working Draft. - Extranodal extension: Present. - AJCC/UICC stage: pT1cN1MX. An immunohistochemical test for estrogen and progesterone receptors was performed by manual. morphometry on block #. The test for estrogen receptors is positive. There isstrong nuclear staining in 90% of tumor cells. Internal positive control is positive. The test for progesterone receptors is positive. There is moderate nuclear staining in 60% of tumor. cells. Internal positive control is positive. Result of HER2/neu test: This carcinoma is positive for HER2/neu oncoprotein over-expression. An immunohistochemical assay was performed by manual morphometry on block F8 using the CB11. monocional antibody to HER2/neu oncoprotein. The staining Intensity of this carcinoma was 3 on a. scale of 0-3 (HER2 test interpreted by Dr. Carcinomas with staining intensity scores of 0 or 1 are considered negative for over-expression of HER2/neu oncoprotein. Those with a staining intensity score of 2 are considered indeterminate. We and others have observed that many carcinomas with. staining intensity scores of 2 do not show gene amplification. All carcinomas with staining intensity scores of 2 are therefore. submitted for FISH testing. The results of the FISH test are issued directly from the molecular cytogenetics laboratory. Carcinomas with staining intensity scores of 3 are considered positive for over-expression of HER2/neu oncoprotein. Tumors in. this category show an excellent correlation between the results of immunohistochemical and FISH testing, and almost always show. gene amplification. Intraoperative Consult Diagnosis. FS1 (A) Left axillary sentinel lymph node #1, biopsy: No tumor seen. (Tissue section and. cytopreparation) (Dr. FS2 (B) Left axillary sentinel lymph node #2, biopsy: Positive for metastatic carcinoma. (Tissue. section and cytopreparation) (Dr. FS3 (C) Left axillary sentinel lymph node #3, blopsy: Positive for metastatic carcinoma. (Tissue. section and cytopreparation) (Dr. 1. FS4 (D) Left axillary non-sentinel lymph node #1, biopsy: Positive for metastatic carcinoma. (Tissue. section and cytopreparation) (Dr. Clinical History. The patient is a. year-old woman with left breast invasive ductal carcinoma. She undergoes partial. mastectomy. Gross Description. The specimen is received fresh in nine parts, each labeled with the patient's name and medical record. number. Part A is additionally labeled. It consists of a single irregular piece of. soft-firm, pink-red tissue, measuring 0.5 x 0.3 X 0.2 cm. The specimen is bisected, and cytologic. touch and scrape preparations are prepared. The specimen is then entirely submitted for frozen. section diagnosis as FS1, with the frozen section remnant submitted in cassette A1. Part B is additionally labeled. It consists of a single oval piece of soft-to-firm,. red-pink tissue, measuring 0.9 x 0.6 x 0.6 cm. The specimen is bisected, and cytologic touch and. scrape preparations are made. The specimen is then entirely submitted for frozen section diagnosis as. FS2, with the frozen section remnant submitted in cassette B1. Part C is additionally labeled. It consists of a single ovoid piece of soft-to-firm,. Working Draft. pink-red tissue, measuring 0.8 x 0.5 x 0.4 cm. The specimen is bisected, and cytologic touch and. scrape preparations are prepared. I he specimen is then entirely submitted for frozen section. diagnosis as FS3, with the frozen section remnant submitted in cassette C1. Part D is additionally labeled. It consists of a single ovoid piece of. soft-to-firm, pink-red tissue, measuring 1.3 x U.I x 0.5 cm. The specimen is bisected, and cytologic. touch and scrape preparations are prepared. The specimen is then entirely submitted for frozen. section diagnosis as FS4, with the frozen section remnant submitted in cassette D1. Part E is additionally labeled. It consists of a single ovoid piece of firm,. off-white/tan tissue, measuring 1.5 x 0.7 x 0.4 cm. The specimen is bisected and entirely submitted. in cassette E1. Part F is additionally labeled. t consists of. an oriented portion of fat, measuring 10.3 (anterior- posterior) x 7.4 (medial-lateral) x 6.4. (superior-inferior) cm and weighing 13 gm. There is a 1.1 cm in diameter white-yellow hard mass. with a white homogeneous interior located within the specimen (slices 3-6). This mass abuts the. posterior margin, is 0.6 cm from the anterior-inferior and anterior-superior margins, 1 cm from the. lateral margin, and 7 cm from the medial margin. The specimen is inked so as the anterior-superior. surface is blue, the anterior- inferior surface is green, and the posterior surface is black. A. representative section is taken for tissue banking. The specimen is serially sectioned, from lateral to. medial into thirteen 0.5 cm slices. Representative sections are submitted as follows: Cassette F1: Lateral margin, slice 1, perpendicular. Cassettes F2-F3: Slice 2, two pieces. Cassettes F4-F5: Slice 3, two pieces, mass. Cassettes F6-F7: Slice 4, two pieces, mass. Cassette F8: Representative section of slice 5, mass. Cassette F9: Representative section of slice 6, mass. Cassette F10: Slice 12. Cassette F11: Medial margin, slice 13. perpendicular. Part G is additionally labeled. It consists of a. small fragment of fat, measuring 0.6 x 0.7 x 0.7 cm. A stitch marks a portion of the specimen. indicating the true margin. The specimen is inked so as this true margin is blue, and the rest of the. specimen is black. The specimen is entirely submitted in cassette G1. Part H is additionally labeled. It. consists of a fragment of yellow-white, soft fat, measuring 1 x 0.6 x 0.7 cm. A stitch marks the true. margin of the specimen. The specimen is inked so as this true margin is blue, and the remaining. portion of the specimen is black. The specimen is entirely submitted in cassette H1. Part I is additionally labeled. It consists of a portion of fat measuring 4.2 x 3.8. x 0.9 cm. Multiple pink-tan lymph nodes are noted within the specimen ranging in size from 0.6-1.3. cm in diameter. Many of these nodes are previously bisected or trisected. Representative sections. of. the specimen are taken and submitted as follows: Cassette 11: Six lymph nodes attached. Cassette 12: Two lymph nodes, one bisected and one trisected. 'Pathology Resident. Fee Codes: Working Draft. Other Specimens. Specimen Class: i. Accessioned: Specimen(s) Received: Skin, biopsy, punch bx, right posterior calf. Final Diagnosis. {Final Report Not Signed Out}. (Not Entered}. Specimen Class: Accessioned: Specimen(s) Received: SP Consult. Final Diagnosis. Review. from. Breast, left, 1 o'clock, core needle biopsy: 1. Invasive carcinoma; see comment. 2. Microscopic focus of ductal carcinoma in situ, high nuclear grade; see comment.",BRCA,1,"The report indicates that the largest dimension of the invasive tumor is 1.1 cm, which falls within the range for T1 tumors (T1: tumor size up to 2.0 cm).",T1,45.0
517,TCGA-A2-A0T2.0DCD80E1-173E-4A1B-BDD8-74C7D12C1313,2,"SURGICAL REPORT. Sex: F. Date Collected: Date Received: M.R. Number. Doctor: Account Numbe. PRE-OPERATIVE DIAGNOSIS. CA RIGHT BREAST. POST-OPERATIVE DIAGNOSIS. CA RIGHT BREAST. PROCEDURE. MODIFIED RADICAL MASTECTOMY RIGHT BREAST, INSERTION MEDIPORT. TISSUES. BREAST MASTECTOMY (WMV) NODES - RIGHT BREAST AND AXILLARY CONTENTS. FINAL DIAGNOSIS. RIGHT BREAST AND AXILLARY CONTENTS -. POORLY DIFFERENTIATED INFILTRATING DUCTAL CARCINOMA, SCARFF-. BLOOM-RICHARDSON GRADE III/III. THE TUMOR MEASURES 10.5 CM. IN MAXIMUM. DIMENSION. LYMPHOVASCULAR INVASION IDENTIFIED INSIDE THE TUMOR. ALL SURGICAL MARGINS ARE FREE OF THE LESION. THE CLOSEST SURCICAL. MARGIN IS THE DEEP SURGICAL MARGIN WHICH IS 1.2 MM. FROM THE TUMOR (JUST. ABOVE THE MUSCLE). BENIGN SKIN AND NIPPLE. TEN OF FOURTEEN LYMPH NODES ARE POSITIVE FOR METASTATIC. CARCINOMA (10/14). TUMOR STAGE: STAGE IIIC, T3, N3, MX. PQRI CATEGORY II: 3260F. Diagnosed by: COMMENT. This case is discussed with. GROSS DESCRIPTION. The container is received fresh unfixed labele. ight breast and axillary contents"" and. consists of a 788 gm. apparent right breast which is 24x 17 x 5 cm. in greatest overall dimension. The. attached skin ellipse is 11.5 x 8.5 cm. There is an eccentrically attached nipple. There is also an. SURGICAL REPORT. of 2. attached suture indicating superior lateral/upper outer aspect inked with an orange dye. The lower outer. is inked green, the upper inner is inked black, the lower inner is inked red. The deep surgical margin is. inked yellow. Sectioning reveals a dense gray-white slightly swirled tumor mass which is 10.5 x 5.5 x 4. cm. in greatest overall dimension and grossly appears to be 3 cm. from the superior lateral/upper outer, 3. cm. from the upper inner and appears to be 3.5 cm. from the lower outer and 4 cm. from the lower inner. It grossly appears to be 0.8 cm. from the deep surgical margin. The tumor mass has scattered yellow-tan. chalky areas varying up to 0.2 cm. and hemorrhagic areas varying up to 0.1 cm. Sectioning through the. axillary fat reveals tan-gray nodules varying up to 2.5 cm. in greatest dimension, each are bisected, one-. half submitted. Twenty blocks. Key Note Block Summary: 1-nipple, 2-deep surgical margin, 3-superior lateral/upper. outer, 4--lower outer, 5-upper inner, 6-lower inner, 7 through 10-tumor, 11 through 13-random, 14. through 20-apparent nodes. MICROSCOPIC EXAM. MICROSCOPIC EXAMINATION CONDUCTED BY PATHOLOGIST CONFIRMS FINAL DIAGNOSIS. SURGICAL REPORT.",BRCA,3,"The T stage is based on the size of the tumor, as reported in the pathology report. In this case, the tumor measures 10.5 cm in maximum dimension, which falls in the T3 category (tumor size > 5 cm but not more than 10 cm) according to the AJCC staging system for breast cancer.",T3,45.0
661,TCGA-A8-A092.93D66EAD-B7D3-4688-8EC9-75C4380619D9,1,Diagnosis: 5. Moderately differentiated invasive ductal carcinoma (tumor diameter: 3.8 cm) with. focal intraductal components and focal angioinvasion. NS.,BRCA,2,"The T stage is based on the size of the primary tumor. The report states that the tumor diameter is 3.8 cm, which falls between T1 (up to 2.0 cm) and T2 (more than 2.0 cm and up to 5.0 cm). According to the rule 'T stages are generally rounded up to the nearest higher category when the exact tumor size falls between categories', we can classify this tumor as T2.",T2,46.0
647,TCGA-A8-A08G.6DCA5C2C-F28A-409D-9623-24AB748FB4E7,1,"Diagnosis: 1 Ablated breast sample with three foci of carcinoma: first tumor: poorly differentiated invasive ductal carcinoma (tumor diameter: 2.8 cm). with focal intraductal components. Tumor-free dorsal resection margin. Tumor classification: NOS and mucinous carcinoma, G III, pT2(mult)NOLOVORX.",BRCA,0,"The T stage is based on the size of the largest invasive tumor focus, even if there are multiple foci present. The report indicates a tumor diameter of 2.8 cm for the largest invasive tumor focus, which falls in the T2 category (2.1-5.0 cm).",T2,47.0
593,TCGA-A7-A425.F969E3E4-0053-44E9-85BC-BEFDBD62C512,2,"Final Surgical Pathology Report. Procedure: Diagnosis. A. Lymph node, right axillary sentinel node, excision: One lymph node positive for metastatic carcinoma (1/1) . B. Breast, right, excision: Invasive lobular carcinoma (see tumor characteristics in the. microscopic description). C. Lymph nodes, right axillary contents, excision: Ten of sixteen lymph nodes positive for metastatic carcinoma (10/16). D. Lymph node, highest apical node, excision: One of two lymph nodes positive for metastatic carcinoma (1/2). Microscopic Description: Invasive carcinoma: Histologic type: Lobular. Histologic grade: Overall grade:2. Architectural score: 3. Nuclear score: 2. Mitotic score: 1. Greatest dimension (pT) 7.5 cm, pT3. Specimen margins: Tumor is more than 2 cm from the deep margin of. excision and 1 cm from the superficial soft tissue margin. Vessel invasion: Present. Nipple (Paget's) Tumor invades into the dermis beneath the. surface of the nipple: Paget's disease is not identified. Ductal carcinoma in situ: Not identified. Description of non-tumorous breast: Biopsy site changes are identified. Fibrocystic changes. Lymph nodes: Number of positive nodes of total: Twelve lymph nodes positive for. metastatic carcinoma (12/19). Size of largest metastasis: 2.9 cm. Extracapsular extension (present/absent) : Present. pN: pN3a. Distant metastasis (pM) : pMX. Prognostic markers: Previously performed. Specimen. A. Right breast axillary sentinel node. B. Right breast stitch at 12 o'clock. C. Right axillary contents. D. Highest apical node. Clinical Information. Right breast cancer. Intraoperative Consultation. A) Lymph node, right axillary sentinel node, excision: One lymph node. positive for metastatic carcinoma (1/1) . Gross Description. A. Received fresh labeled ""right axillary sentinel node hot not blue"". is a lymph node that measures 2.9 x 1.7 x 1.4 cm in dimension. The. lymph node has a firm consistency and shows yellowish discoloration. A. representative section from the node is submitted for frozen section. The remaining node is sectioned and entirely submitted for permanent. section in 6 cassettes. B. Received fresh for tissue procurement labeled ""right breast"" is a. 1220 g, 29.0 cm (medial to lateral) by 23.5 cm (superior to inferior). by 5.8 cm (anterior to posterior) soft, lobulated tan gold-like portion. of fibroadipose tissue in keeping with breast, designated as right per. requisition slip and container and oriented by a suture as stated. previously. A 17.5 x 5.8 cm wrinkled tan-white skin ellipse with a. flat 1.3 x 1.3 cm nipple is present along the anterior aspect. An. indurated focus is present subjacent to the central superior portion of. the skin, corresponding to the junction of the upper inner and outer. quadrants. The anterior surface in this area is inked blue. The. intact deep margin is inked black and the specimen is sectioned. There. is a central, 7.5 cm (superior to inferior) by 5.5 cm (medial to. lateral) by 4.0 cm (anterior to posterior) rubbery tan-white apparent. tumor mass is present (corresponding to the central junction of the 4. quadrants) The lesion is present within 3.5 cm of the inked deep. margin and appears to approach the anterior surface to within 2 cm. A. portion of tumor and a portion of normal parenchyma are submitted for. tissue procurement as requested. The cut surfaces throughout the. remainder of the specimen consist predominantly of soft lobulated tan. gold adipose tissue with a scant amount of interspersed delicate. tan-white fibrous tissue. No additional mass lesion or abnormality is. identified. Summary: 1 - deep margin subjacent to the lesion, 2 - lesion to. anterior surface, 3 through 7 - lesion to adjacent parenchyma, 8 -. random upper outer quadrant, 9 - upper inner quadrant, 10 - lower inner. quadrant, 11 - lower outer quadrant, 12 - nipple. C. Received fresh and subsequently fixed in formalin labeled ""right. axillary contents ""is a 12.0 x 7.5 x 3.0 cm aggregate of yellow lobular. fatty tissue fragments which are not orientated. The specimens are. palpated to identify lymph nodes which range from 0.1 cm and 2.5 cm in. greatest dimension. The lymph nodes are entirely submitted as follows: 1 - 1 possible lymph node, 2 - 6 possible lymph nodes, 3 - 6 possible. lymph nodes, 4 - 2 possible lymph nodes, 5 - 1 possible lymph node, 6. 1 possible lymph node. D. Received fresh and subsequently fixed in formalin labeled ""highest. apical node ""is a 3.0 x 2.0 x 0.4 cm aggregate of yellow lobular fatty. tissue fragment. The specimen is palpated to identify 2 possible lymph. nodes present. The lymph nodes are 0.5 cm and 0.2 cm in greatest. dimension. The specimens are entirely submitted as follows: 1 - lymph. nodes, 2 - remaining fat.",BRCA,3,"The T stage is based on the size of the tumor, as reported in the pathology report. In this report, the greatest dimension of the invasive tumor is 7.5 cm, which falls in the T3 category (tumor size between 5.1 and 10.0 cm).",T3,48.0
549,TCGA-A2-A3KC.593AF241-8F84-4BA0-8878-7C1CE72A460B,1,"Chief of Pathology. Specimen: !tatus: SOUT. Spec Type: SURGICAL P. GROSS DESCRIPTION. C RECEIVED LABELED. RIGHT NONSENTINEL NODE #1 IS A 3.4. x 2 x 1.5 CM PORTION OF YELLOW FATTY TISSUE WHICH IS A GROSSLY FAT. REPLACED LYMPH NODE SUBMITTED ENTIRELY LABELED C1 THROUGH C3. D RECEIVED LABELED. RIGHT BREAST SIMPLE MASTECTOMY. STITCH AT 12 O' CLOCK IS A 1,250 GRAM SIMPLE MASTECTOMY WHICH INCLUDES. 4. IRREGULAR ADDITIONAL FRAGMENTS OF YELLOW-RED FATTY TISSUE IN AGGREGATE. MEASURING 9 x 7 x 1 CM. THIS TISSUE IS NOT ORIENTED. THE MASTECTOMY. ITSELF MEASURES 28.5 x 21 x 5 CM. THE NIPPLE IS FLATTENED AND SITS. WITHIN A 26 x 13 CM SKIN ELLIPSE. THERE IS PALPABLE FIRMNESS IN THE. LOWER OUTER QUADRANT. THE SUPERFICIAL ASPECT OF THE MASTECTOMY IS. MARKED WITH BLUE INK, THE DEEP WITH BLACK. SECTIONING REVEALS 2. DISTINCT FIRM MASSES, ONE IN THE 12 O'CLOCK AREA AND THE 2ND. CORRESPONDING TO THE PALPABLE FIRMNESS IN THE LOWER OUTER QUADRANT. THIS HAS A RIBBON CLIP AND THE 12 O' CLOCK LESION HAS A WING CLIP. THE. DEEP MARGIN ASSOCIATED WITH THE LOWER OUTER QUADRANT LESION IS FIRM AND. PINK-TAN FIBROUS TISSUE DOES EXTEND TOWARDS THE MARGIN BUT THE ACTUAL. FIRM MASS IS GROSSLY WITHIN THE CONFINES. THE LOWER OUTER MASS MEASURES. 2.5 x 2.5 x 2.5 CM. THE 12 O'CLOCK MASS IS SEPARATED BY 3 CM OF TISSUE. AND MEASURES 3.5 X 2.5 x 2.5 CM IN GREATEST DIMENSION. ADDITIONAL. PINK-TAN FIBROUS TISSUE IS FOUND IN THE MIDPORTION OF THE SPECIMEN WHICH. IS THEN SURROUNDED BY YELLOW FATTY TISSUE. SECTIONS ARE SUBMITTED AS. FOLLOWS: D1--NIPPLE, D2 AND --DEEP MARGIN OVER LOWER OUTER QUADRANT. LESION, D4--DEEP MARGIN TO 12 O' CLOCK LESION, D5 AND 6--12 O' CLOCK. LESION, D7 THROUGH --LONGITUDINAL SECTION OF 12 0'CLOCK LESION,. D10--TISSUE BETWEEN THE 2 LESIONS, D11 AND 12 -LOWER OUTER QUADRANT. LESION LONGITUDINAL SECTION, D13--TUMOR LOWER OUTER QUADRANT. THE. TISSUE TO THE 6 O'CLOCK MARGIN OF THE LOWER OUTER QUADRANT LESION IS. NODULAR AND FOCALLY THERE IS BROWN DISCOLORATION. A SECTION IS. SUBMITTED IN D14. THIS IS 1 CM FROM THE LOWER OUTER QUADRANT LESION AND. 5 CM FROM THE 12 0'CLOCK LESION. OTHER NODULES DEMONSTRATE CYSTS AS A. SECTION IN D15 DEMONSTRATES. D16--UPPER INNER QUADRANT (3 CM FROM 12. O' CLOCK LESION), 17--UPPER OUTER QUADRANT (5 CM FROM 12 O' CLOCK. LESION), D18--LOWER OUTER QUADRANT (3 CM FROM LOWER OUTER QUADRANT. LESION) , 019--LOWER INNER QUADRANT (3 CM FROM LOWER OUTER QUADRANT. LESION) THE SEPARATELY SUBMITTED PORTIONS OF FATTY TISSUE ARE GROSSLY. UNREMARKABLE AND REPRESENTATIVE TISSUE IS SUBMITTED IN D20 AND 21. E RECEIVED LABELED. RIGHT AXILLARY NODE CONTENTS IS. YELLOW-RED FATTY TISSUE MEASURING 12 x 9.5 x 2.5 CM. THE TISSUE IS. EXAMINED FOR LYMPH NODES. LYMPH NODES ARE IDENTIFIED AND SUBMITTED AS. FOLLOWS: E1--ONE-HALF OF A FIRM NODE WITH MIRROR IMAGE SUBMITTED PER. PROTOCOL, E2--1 NODE BISECTED, E3--1 NODE BISECTED (MAY ACTUALLY. REPRESENT 2 IMMEDIATELY ADJACENT NODES), E4--1 NODE TRISECTED, E5--1. NODE BISECTED, E6--1 NODE BISECTED, E7--1 NODE TRISECTED, E8--3 NODES (1. BISECTED), E9--6 NODES, E10-- NODE BISECTED. /F. Specimen. Spec Type: SURGICAL P. PREOPERATIVE DIAGNOSIS. RIGHT BREAST CANCER INVASIVE. OPERATION PERFORMED. DOCTOR (s) : PROCEDURE: SENTINEL NODE Bx/LYMPHADENECTOMY/STMPLE MASTECTOMXY/AXILLARY. PROCEDURE (CONT) : NODE DISSECTION. TISSUE REMOVED. A. RT SENTINEL NODE #1 - FS. B. RT SENTINEL NODE #2 - FS. C. RT AXILLARY NON SENTINEL NODE. D. RT BREAST SIMPLE MASTECTOMY. E. RT AXILLARY NODE CONTENTS. FROZEN SECTION DIAGNOSIS. A. NEGATIVE FOR TUMOR. B. METASTATIC CARCINOMA. GROSS DESCRIPTION. THE SPECIMEN IS RECEIVED IN 5 PARTS. PART A IS RECEIVED DESIGNATED. RIGHT AXILLARY SENTINEL. NODE 1 GAMMA. HOT AT. IT IS RECEIVED IN THE FRESH STATE FOR. FROZEN SECTION AND CONSISTS OF A 3.5 X 2.3 x 0.5 CM FRAGMENT OF. YELLOWISH-PINK FIBROADIPOSE TISSUE WITH 2 PALPABLE NODULES MEASURING 2 x. 1.2 x 0.6 CM AND 0.8 x 0.8 x 0.5 CM. EACH NODULE IS PINKISH-RED AND. SECTIONING SHOWS REDDISH-PINE CROSS SECTION. ONE-HALF OF EACH IS. SUBMITTED FOR FROZEN SECTION LABELED FSA. SUBSEQUENT TO THE FROZEN. SECTION, THE FROZEN TISSUE IS SUBMITTED FOR PERMANENTS LABELED FSA. THE. REMAINING UNFROZEN NODULES ARE SUBMITTED FOR PERMANENTS LABELED A. PART B IS RECEIVED DESIGNATED. RIGHT AXILLARY SENTINEL. NODE 2 GAMMA. HOT/BLUE AT. IT IS RECEIVED IN THE FRESH STATE. FOR FROZEN SECTION AND CONSISTS OF A 2.7 x 2.1 x 0.5 CM FRAGMENT OF. YELLOWISH-PINK FIBROADIPOSE TISSUE WITH PALPABLE NODULE. THE NODULE IS. ISOLATED AND FOUND TO MEASURE 1.7 x 1.4 X 0.5 CM. THE NODULE IS. BISECTED SHOWING A REDDISH-PINK RIM SURROUNDING YELLOW ADIPOSE TISSUE. WITH A GLISTENING WHITISH-TAN NODULE AT ONE MARGIN MEASURING 0.4 CM IN. DIAMETER. SUBSEQUENT TO THE FROZEN SECTION, THE FROZEN TISSUE IS. SUBMITTED FOR PERMANENTS LABELED FSB. THE REMAINDER OF THE NODULE IS. SUBMITTED FOR PERMANENTS LABELED B. Specimen: Req# : spec Type: SURGICAL P. GROSS DESCRIPTION. PATH PROCEDURES. PROCEDURES: 88305, 88307/2, 88309, PATH FS /2, A BLK, B BLK, C BLK, D BLK/21, E BLK/10,. FS-A, FROZ.SEC.-B. FINAL DIAGNOSIS. PART A RIGHT AXILLARY NO EVIDENCE OF %/ISN. SENTINEL LYMPH NODE #1, BIOPSY: MALIGNANCY. PART B RIGHT AXILLARY SENTINEL LYMPH NODE #2, BIOPSY: METASTATIC. BREAST CARCINOMA HAVING A MAXIMUM MICROSCOPIC DIMENSION OF 0.6 CM IS. IDENTIFIED IN 1 LYMPH NODE EXAMINED. THERE IS NO EVIDENCE OF EXTRANODAL. EXTENSION OF TUMOR. PART C RIGHT AXILLARY NONSENTINEL LYMPH NODE, BIOPSY: NO EVIDENCE OF. MALIGNANCY IN 1 LYMPH NODE EXAMINED. PART D RIGHT BREAST, SIMPLE MASTECTOMY: MULTICENTRIC INTRALOBULAR, AND INFILTRATING LOBULAR CARCINOMA OF THE. 1. PLEOMORPHIC TYPE. THE INVASIVE COMPONENT SHOWS NUCLEAR GRADE 2/3,. LOW MITOTIC INDEX, AND TUBULE FORMATION 3 WITH TOTAL NOTTINGHAM SCORE. OF 6. LCIS OF THE PLEOMORPHIC TYPE, NUCLEAR GRADE 2/3, AND LOW 50% LCIS 8 2. MITOTIC INDEX COMPRISES APPROXIMATELY 50% OF THE TUMOR. 2. THE LARGEST FOCUS OF INVASIVE TUMOR MEASURES 3.5 CM IN GREATEST. DIMENSION AND IS LOCATED IN THE 12 O'CLOCK PORTION OF THE BREAST. THE SECOND LARGEST MEASURES 2.5 CM AND IS SEEN IN THE LOWER OUTER. QUADRANT. ADDITIONAL SMALLER FOCI OF INVASION MEASURING FROM 1 MM TO. 5 MM IN GREATEST DIMENSION ARE PRESENT. LCIS IS SEEN ON 14 OF 21. BLOCKS EXAMINED HAVING A MAXIMUM CALCULATED DIMENSION OF 5.6 CM. 3. THE MARGINS OF RESECTION AND NIPPLE SKIN ARE FREE OF TUMOR. 4. LYMPHOVASCULAR INVASION IS NOT IDENTIFIED. 5. PROLIFERATVE FIBROCYSTIC CHANGES INCLUDING INTRADUCTAL PAPILLOMAS,. INTRADUCTAL PAPILLOMATOSIS, MICROSCOPIC COMPLEX SCLEROSING LESIONS,. ADENOSIS, APOCRINE METAPLASIA, MICROCYST FORMATION, PATCHY DENSE. STROMA AND RARE LUMINAL CALCIFICATIONS. Specimen: Received: (. spec Type: SURGICAL P. FINAL DIAGNOSIS. 6. THE BIOPSY SITES (. ARE PRESENT. PART E RIGHT AXILLA, LYMPH NODE DISSECTION: METASTATIC BREAST. CARCINOMA IS IDENTIFIED IN 1 OF 16 LYMPH NODES EXAMINED. NO EVIDENCE OF. EXTRANODAL EXTENSION BY TUMOR. CODE. 1. (prelim.).",BRCA,1,"Based on the information provided in the pathology report, the largest focus of invasive tumor measures 3.5 cm in greatest dimension, which falls within the T2 category (tumor size between 2.1 and 5.0 cm).",T2,48.0
534,TCGA-A2-A0YT.1C420F6B-8720-4CB0-9FB3-86A0EC05FBBD,3,"SURGICAL REPORT. Sex: F. Date Collected: Date Received: M.R. Number: Doctor: Account Number: PRE-OPERATIVE DIAGNOSIS. LEFT BREAST CANCER. POST-OPERATIVE DIAGNOSIS. LEFT BREAST CANCER. PROCEDURE. LEFT MODIFIED RADICAL MASTECTOMY. TISSUES. A. BREAST MASTECTOMY (WANO) NODES - LEFT BREAST & AXILLARY CONTENTS. B. MARGINS - ADDITIONAL INFERIOR SKIN LEFT BREAST. WRI TISSUE. FINAL DIAGNOSIS. A. LEFT BREAST AND AXILLARY CONTENTS, 1619 GMS. -. INFILTRATIVE DUCT CARCINOMA (CONFLUENT REGION MEASURES 13.6 CM.). SCARFF-BLOOM-RICHARDSON GRADING: GRADE 3 OF 3 (ABSENT TUBULAR FORMATIONS, HIGH NUCLEAR GRADE. AND MODERATE MITOTIC INDEX). DCIS: NONE IDENTIFIED. ANGIOLYMPHATIC INVASION: PRESENT, MULTIFOCAL. TUMORAL CALCIFICATION/NECROSIS: PRESENT. SURGICAL MARGINS: UNINVOLVED. NON-NEOPLASTIC BREAST -. FIBROADENOMA 0.3 CM. FIVE POSITIVE LYMPH NODES WITH EXTRACAPSULAR EXTENSION (6/5). THE LARGEST NODE MEASURES 1.6 CM. AND THE TUMOR INVOLVES THREE-FOURTHS. OF THE NODE. OVERLYING NIPPLE, AREOLA AND SKIN: FOCAL EXTENSION OF THE TUMOR INTO EPIDERMIS WITHOUT ULCERATION. B. ADDITIONAL INFERIOR SKIN LEFT BREAST -. POSITIVE FOR INFILTRATIVE DUCT CARCINOMA, THE TUMOR INVOLVES THE DERMIS. WITHOUT EXTENSION TO EPIDERMIS. (SATELLITE SKIN NODULE). THE INKED MARGINS ARE FREE. PTNM CLASSIFICATION: SURGICAL REPORT. T4B, N2a, MX, STAGE GROUPING IIIB. Diagnosed by: and. COMMENT. The multiple sections from the tumor reveal a poorly differentiated infiltrative duct carcinoma with. widespread angiolymphatic invasion. The satellite nodule grossly observed appears to be a direct. extension from the primary tumor with peripheral tumefaction. The overlying epidermis is involved by the. tumor but does not exhibit ulceration. The Bloom-Richardson grading was upgraded to 3 based on. complete evaluation of the entire tumor mass. The ER, PR, and Her-2/neu have been performed on the previous surgical. This case Is discussed with. on. GROSS DESCRIPTION. The specimen is received in two separate containers labelec. esignated A and B. A. The container is received fresh unfixed labeled ""left breast and axillary contents - suture on. upper outer quadrant"". The specimen consists of a 1,519 gm. apparent left breast which is 30 x. 20 x 7.5 cm. in greatest overall dimension. There is an attached suture indicating upper outer. quadrant inked with orange dye, lower outer quadrant is inked yellow, upper inner quadrant is. inked with green dye, lower inner quadrant is inked with red dye. The deep margin is inked black. Sectioning reveals a tumor mass directly beneath the nipple which is 13.5x 7 x 4 cm. in greatest. overall dimension and is 1.5 cm. from the deep margin, 2 cm. from the upper outer margin, 2.5. cm. from the lower outer margin, 2 cm. from the upper inner margin, and 4 cm. from the lower. inner margin. There is a satellite nodule which is 0.6 cm. in greatest dimension and is 1.5 cm. from the main tumor mass and has a distance of 0.6 cm. from the upper inner margin. Sectioning. through the remaining breast stroma reveals fatty and fibrous-encased tissue. Sectioning through. the attached axillary fat reveals rare tan-gray nodules varying up to 1 cm. in greatest dimension. The specimen is submitted in twelve blocks. Key Note Block Summary: 1-nipple with underlying tumor, 2 through 4-tumor mass, 5-. satellite nodule and upper inner quadrant, 6-lower inner quadrant, 7-lower outer quadrant, 8-. upper outer quadrant, 9-deep, 10 through 12-rare nodules. B. The container is received fixed labeled ""additional inferior skin left breast"". The specimen. consists of a skin ellipse which is 7 x 1x 1 cm. in greatest overall dimension. The skin. has been previously marked with purple-blue dye. The specimen is serially sectioned. revealing no apparent gross abnormalities. The entire specimen is submitted in two. blocks. MICROSCOPIC EXAM. MICROSCOPIC EXAMINATION CONDUCTED BY PATHOLOGIST CONFIRMS FINAL DIAGNOSIS. SURGICAL REPORT.",BRCA,2,"The report states that the tumor measures 13.6 cm, which exceeds the maximum size for T3 (10.0 cm). The T stage is based on the size of the largest invasive tumor focus, and in this case, the tumor size is 13.6 cm. Therefore, the T stage is T4.",T4,49.0
479,TCGA-A2-A0CO.8C440009-E05E-4046-96AB-BAB211CB7D02,2,"Specimen #: (Age. F. Race WHITE. Physician (s) : AMENDED. SPECIMEN: RIGHT BREAST AND AXILLARY CONTENTS Site: breast, NOS C50.9 1/24/11 to. FINAL DIAGNOSIS: BREAST AND AXILLARY CONTENTS, RIGHT, MASTECTOMY: - INFILTRATING LOBULAR CARCINOMA. FOCAL LOBULAR CARCINOMA IN SITU AND CANCERIZATION OF TERMINAL DUCTS. - FOCAL DUCTAL CARCINOMA IN SITU,SOLID AND CRIBRIFORM TYPE. - SIZE: 5.2 CM BY GROSS MEASUREMENT. - MARGINS DEEP MARGIN POSITIVE FOR TUMOR. - NEGATIVE FOR LYMPHVASCULAR INVASION. - MICROCALCIFICATIONS ASSOCIATED WITH TUMOR. - FIBROCYSTIC CHANGES TO INCLUDE FIBROSIS, CYST FORMATION, AND APOCRINE. METAPLASIA. - 11 LYMPH NODES ARE NEGATIVE FOR TUMOR. - AJCC STAGE. COMMENT: THE AMENDMENT REFLECTS A CHANGE IN NUMBER OF LYMPH NODES FROM NINE. TO ELEVEN. COMMENT: AMENDMENT. Case amended to report results of HER2-neu - status by fluorescence in situ. hybridization. HER2-NEU: AMPLIFIED (5.0) . Note: The patient's prior core biopsy,. was negative for. HER2-neu. The tumor in the current case has areas of poorly. differentiated carcinoma (so-called pleomorphic lobular carcinoma) not. identified in the initial core biopsy; these areas are strongly positive. for HER2-neu gene amplification. Specimen # : CLINICAL DIAGNOSIS AND HISTORY: -year-old white female with two site core biopsy breast cancer. RE-OPERATIVE DIAGNOSIS: Right breast cancer. POST-OPERATIVE DIAGNOSIS: Post-Operative Diagnosis: Same as above. GROSS DESCRIPTION: RIGHT BREAST AND AXILLARY CONTENTS received fresh and consists of a 362. gram mastectomy, 15.0 x 14.0 x 2.6 cm, with attached axillary tail, 15.0 x. 3.0 x 1.0 cm. The skin ellipse measures 10.0 X 3.5 cm. The specimen is. inked as follows Axillary tail=blue dot on inferior portion,. mastectomy - blue=superior superficial, green=inferior superficial,. black=deep. Sectioning reveals an area of firmness with the superior. portion of the specimen measuring 5.2 cm approximately 5.0 mm from the. deep margin. Palpation reveals 5.0 cm area of firmness in the superior. portion of the breast. The remainder of the cut surface is yellow,. lobular, with focal areas of white fibrous tissue and small cystic. structures measuring up to 0.2 cm. No additional well-defined lesions or. nodules are noted. Sectioning thorugh the attached axillary tail reveals 11 possible lymph. nodes ranging in size from 0.3 to 2.0 cm in greatest dimension. Four representative sections are submitted for. protocol with mirror. image sections in the following cassettes: A1: Lymph node 0.7 cm. A2: Skin from lateral edge of ellipse. A3: Tumor lateral. A4: Tumor medial. A5: Grossly normal fibrous tissue approximately 5.0 cm from tumor. Additional representative sections are submitted in cassettes A6 through. A20 as follows: A6-A12: Tumor from medial to lateral in sequential order. A13: Upper inner quadrant. A14: Lower inner quadrant. A15: Lower outer quadrant. A16: Upper outer quadrant. A17: Two possible lymph nodes. A18: Five possible lymph nodes. A19: Three possible lymph nodes. A20: Section of nipple. 20CF'.",BRCA,0,"The report states that the size of the tumor is 5.2 cm, which falls between 2.1 and 10.0 cm. This corresponds to T2 according to the rules.",T2,49.0
619,TCGA-A8-A075.6643B290-5D7A-4649-B57D-47A5BA4E8D31,1,"Diagnosis: Poorly differentiated invasive ductal carcinoma with focal angioinvasion. (tumor diameter 2.2 cm). Concluding tumor classification: NOS, G III, pT2N1aL1V0R0.",BRCA,1,"The T stage is based on the size of the tumor, as reported in the pathology report. The report states that the tumor diameter is 2.2 cm, which falls between 2.1 and 5.0 cm, corresponding to a T2 stage. The presence of focal angioinvasion does not affect the T stage.",T2,49.0
634,TCGA-A8-A07U.1E7788D8-B5FC-473A-8A10-79910443799A,1,"Path site : Breast, 40Q C50.4 1/19/11 for. Diagnosis: 2. Right breast resection material with a 2.2 cm poorly differentiated invasive ductal breast. carcinoma with a minimum margin of almost 1 cm basally and at 6 o 'clock and surrounding. fibrolipomatous atrophic glandular tissue without any evidence of an intraductal tumor. component and tumor-free overlying skin, including the nipple. Tumor classification: M-8500/3, G3, pT2, pN2a, pMX, stage IIIA. R0.",BRCA,2,"The T stage is based on the size of the primary tumor, and does not consider the involvement of lymph nodes or metastasis. The report states that the tumor size is 2.2 cm, which falls within the T2 category (between 2.1 and 5.0 cm).",T2,50.0
664,TCGA-A8-A095.41A41A7F-E4DD-4D3A-B97D-B4657CA211E1,0,"2. Invasive ductal breast carcinoma (maximum diameter 1.8 cm, malignancy grade II) with. angioinvasion and infiltration of the neural sheath in the tumor periphery. Likewise in the. tumor periphery a concomitant DCIS (malignancy grade II, procomponent of tumor < 10%). Distant fibrocystic parenchyma of the breast with fibroadenoma buds free of tumor and/or. DCIS. Tumor classification: G2 (L1, V0), pTlc, pNO (sn), MX, R0 (minimum width of dorsocranial. safety margin 1 cm!). 1711E1.",BRCA,0,"The report states that the maximum diameter of the invasive ductal breast carcinoma is 1.8 cm, which falls within the T1 category (up to 2.0 cm). The presence of angioinvasion, infiltration of the neural sheath, and a concomitant DCIS in the tumor periphery do not affect the T stage, as it is based solely on the size of the primary tumor.",T1,51.0
614,TCGA-A8-A06T.5D888D65-685F-4598-884F-AD057DE5FD1D,2,"Diagnosis: 1. Left-sided ablated breast tissue with a 55 mm moderately differentiated invasive ductal. breast carcinoma measuring with completely circumscribed invasion of the lymph vessels. without an intraductal tumor component with a minimum basal margin of 3 mm, a 6 mm. margin at 12 o'clock and surrounding a fibrocystic and proliferating mastopathy with ductal. hyperplasia and sclerotic, intraductal papillomas, tumor-free epidermis, including nipple and. tumor-free isolated samples of pectoral muscle. Tumor classification: M-8500/3, G 2, pT3, pL1, pN1a (1/13), pMx, stage III A. R0.",BRCA,1,"The T stage is based on the size of the tumor, as reported in the pathology report. The report states that the tumor size is 55 mm, which falls in the T3 category (tumor size > 5 cm).",T3,52.0
597,TCGA-A7-A4SC.5E14E7CA-3417-4379-8EE3-7F00D6D4A02B,2,"Final Surgical Pathology Report. Procedure: Diagnosis. A. Right axillary sentinel node, excisional biopsy: Single lymph node negative for metastatic tumor (0/1). B. Breast, right, simple mastectomy: Invasive lobular carcinoma, grade 1. Tumor size 7.5 CM (pT3). Resection margin negative for tumor. Microscopic Description: A. and B. Microscopic examination performed. Invasive carcinoma: Histologic type: Invasive lobular carcinoma. Histologic grade: 1. Overall grade. Architectural score: 3. Nuclear score: 1. Mitotic score: 1. Greatest dimension (pT) 7.5 CM (pT3). Specimen margins: Negative for malignancy, deep margin is 1.4 cm. from tumor. Vessel invasion: Not identified. Calcification: Focally present. Nipple (Paget's ) : Unremarkable, no Paget's disease identified. Invasion of skin or chest wall: Not identified. Ductal carcinoma in situ: No ductal carcinoma in situ identified. Description of non-tumorous breast: Fatty and atrophic. Adjacent to. the tumor are too small 1 cm fibroadenomas which are invaded by the. tumor. Lymph nodes: Number of positive nodes of total: 0/1. Extracapsular extension (present/absent) : No extracapsular tumor. identified. pN: snpNO. 2 H&E-stained sections were evaluated from each frozen section block. An additional 3 H&E stained sections from each tissue block were. evaluated of the formalin fixed paraffin embedded tissue. Also. pancytokeratin AE1/AE3 immunohistochemical stains were evaluated from. each of the tissue blocks. No metastatic tumor was identified in any. of these examined sections. [A few of the antibodies used in our laboratory may be classified as. analyte specific reagents. These antibodies are monitored and. controlled in our laboratory and their performance for in vitro. diagnosis is well described in the medical literature. They have not. been cleared or approved by the FDA.]. Distant metastasis (pM) : Not applicable pMX. Breast prognostic marker results (B5) Progesterone and HER-2 testing. was repeated given the limited amount of tumor in the prior core. biopsy. Progesterone receptor: 0%. Her2 by IHC: 2+. Interpretation receptor: Reported as positive on prior core biopsy. Estrogen. Her2 by IHC: Equivocal by IHC. FISH testing ordered. Progesterone receptor: Negative. Comments. Fixation time: 28 hours. Cold ischemia time Time of collection was not noted. Less than. 15 minutes cold ischemia time in the laboratory. Favor less than 1. hour of transport time. The analyzed tissue met quality requirements of the. CAP guidelines. for Her2 testing. Control materials stained appropriately. Based on data collected in our laboratory and reported in the. literature we recommend FISH analysis for Her2 in cases that stain with. intermediate intensity by immunohistochemistry. sections from 10% neutral buffered formalin fixed tissue using. Prognostic markers were done by immunohistochemical stain on paraffin Ventana. corportation antibodies on a Benchmark automated stainer. The Her2 antibody is clone 4B5 and has been approved by the FDA as an. aid in the assessment of breast cancer patients for whom Herceptin. treatment is considered. This laboratory meets the test validation and quality assurance. requirements of the. /CAP guidelines for Her2, ER and PR testing for. carcinoma of the breast. A. Specimen Right axillary sentinel lymph node, excisional biopsy: B. Right breast, simple mastectomy. Clinical Information. year-old white female with infiltrating lobular carcinoma. Intraoperative Consultation. A. Right axillary sentinel node, biopsy: No tumor seen. Gross Description. A. Received fresh for frozen section labeled ""right axillary sentinel. is a 3 x 1 x 1 CM piece of fatty yellow tissue. The fat is. node"" trimmed to reveal a 2.8 cm diameter tan lymph node. The lymph node is. bisected and entirely frozen as frozen sections AFS 1 AFS 2. The fat. is retained. No blue staining was identified and no grossly suspicious. areas are identified. B. Received fresh and subsequently fixed in formalin labeled ""right. breast"" is a 20.5 x 17.2 x 4.7 cm yellow lobular fatty tissue fragment with. 7.5 x 3.5 cm pink-tan wrinkled skin ellipse having a 1.4 cm everted. is grossly consistent with a mastectomy and is partially covered a. nipple. The specimen has a suture designating superior breast. The. specimen is received in pathology at. and fixed in formalin at. The deep aspect of the specimen is inked lumen and the. specimen is sectioned from medial to lateral to show a 7.5 x 6.0 x 2.3. cm white-tan, diffusely nodular and firm central mass is ill. circumscribed and comes within 1.7 cm of the deep margin. Gross. identified centrally are white rice-like pellets which are grossly. consistent with a previous biopsy site. The remainder of the cut. surface of the specimen is predominantly fatty scanty fibrous tissue. present. No lymph nodes or gross identified in the apex of the. specimen. Representative sections of the specimen are submitted as. follows: 1 - entire nipple with representative skin, 2 - 6 -. representative sections of lesion including tumor to deep margin and. possible biopsy site, 7 - representative upper outer quadrant, 8 -. representative lower outer quadrant, 9 - representative lower inner. quadrant, 10 - representative upper inner quadrant. Discrepancy. /.",BRCA,0,"The T stage is based on the size of the tumor, as reported in the pathology report. In this report, the tumor size is measured as 7.5 cm, which falls in the T3 category (tumor size > 5 cm).",T3,53.0
525,TCGA-A2-A0YE.C58701EF-98C4-448E-978C-B39D125CC7E8,1,"SURGICAL REPORT. Sex: F. Date Collected: Date Received: M.R. Number. Doctor: Account Number. PRE-OPERATIVE DIAGNOSIS. RIGHT BREAST CA. POST-OPERATIVE DIAGNOSIS. RIGHT BREAST CA. PROCEDURE. RIGHT BREAST LUMPECTOMY WITH SENTINEL LYMPH NODE BIOPSY, F.S., POSSIBLE AXILLARY DISSECTION, POSSIBLE. CED INSERTION. TISSUES. A. LYMPH NODE (S) - RIGHT SENTINEL LYMPH NODE #1 FS. B. LYMPH NODE (S) - RIGHT SENTINEL LYMPH NODE #2 FS. C. LYMPH NODE (S) - RIGHT SENTINEL LYMPH NODE #3 FS. D. LYMPH NODE (S) - RIGHT SENTINEL LYMPH NODE #4. E. AXILLARY - CONTENTS. F. BREAST EXCISION, NEEDLE LOC, SIMPLE, MARGINS,ETC. - RIGHT BREAST. LUMPECTOMY. G. MARGINS - ADDITIONAL LATERAL. ADDENDUM. ESTROGEN AND PROGESTERONE RECEPTOR RESULTS: ESTROGEN RECEPTORS -. NEGATIVE (0%) IN THE MALIGNANT CELLS. PROGESTERONE RECEPTORS -. NEGATIVE (0%) IN THE MALIGNANT CELLS. Comment: Immunohistochemical (IHC) stains for Estrogen Receptors (ER) and Progesterone. Receptors (PR) display an appropriate staining pattern on control tissue. Revlewed and electronically signed outby: FS DIAGNOSIS. A. RIGHT SENTINEL LYMPH NODE #1, F.S. -. ONE NEGATIVE LYMPH NODE (0/1). B. RIGHT SENTINEL LYMPH NODE #2, F.S. -. ONE NEGATIVE LYMPH NODE (0/1). SURGICAL REPORT. C. RIGHT SENTINEL LYMPH NODE, #3, F.S. -. ONE POSITIVE LYMPH NODE (1/1). F. RIGHT BREAST LUMP (GROSS MARGINS) -. 4.7 CM. TUMOR MASS AND FOCALLY INVOLVING LATERAL SURGICAL MARGIN. (REPORTED TO SURGEON: Diagnosed by: FINAL DIAGNOSIS. A. RIGHT SENTINEL LYMPH NODE #1 -. LYMPH NODE, REACTIVE. B. RIGHT SENTINEL LYMPH NODE #2 -. LYMPH NODE, REACTIVE. C. RIGHT SENTINEL LYMPH NODE, #3 -. METASTATIC POORLY DIFFERENTIATED DUCTAL ADENOCARCINOMA IN THE. LYMPH NODE. THE METASTATIC TUMOR INVOLVES APPROXIMATELY 40% THE SIZE OF THE. OF THE NODE AND BEST SEEN IN THE CRYOSTAT SECTIONS WITH NO EXTRA-. CAPSULAR EXTENSION. D. RIGHT SENTINEL LYMPH NODE #4 -. LYMPH NODE, ONE REACTIVE. E. RIGHT AXILLARY CONTENTS. LYMPH NODES, TOTAL OF FIFTEEN REACTIVE LYMPH NODES. F. RIGHT BREAST LUMP. BREAST TISSUE DISPLAYING POORLY DIFFERENTIATED DUCTAL ADENOCARCINOMA. OF THE BREAST, HIGH GRADE (2+3+3), 47 MM. IN GREATEST DIMENSION. THE NEAREST MARGIN IS THE LATERAL MARGIN APPROXIMATELY 1 MM. ALL OTHER MARGINS ARE FREE. ASSOCIATED FIBROADENOMA OF THE BREAST. G. ADDITIONAL LATERAL MARGIN -. FIBROADIPOSE AND BREAST TISSUE, NO PATHOLOGIC CHANGE. PTNM CLASSIFICAITON: T2 N1 MX, STAGE IIB, DUCTAL ADENOCARCINOMA OF BREAST,. G3. PQRI CATEGORY II: 3260F. Diagnosed by: COMMENT. Patient Nams. SURGICAL REPORT. Pathology Numbe. This case is discussed with Dr. by Dr. Breast cancer prognostic. profile will be performed and reported separately. GROSS DESCRIPTION. The specimen is received in seven separate containers labeled. signated A. through E. A. The container is received fresh unfixed labeled ""right sentinel lymph node #1 for frozen section"". and consists of an ovoid mass of apparent fatty material measuring 1.5x 1 x 0.6 cm. Sectioning. reveals a 0.5 cm. pink-tan firm nodule. Touch prep and frozen section are obtained by Dr. The entire specimen including frozen section is submitted In two blocks. B. The container is received fresh unfixed labeled ""right sentinel lymph node #2 for frozen section"". and consists of an irregular mass of apparent fat which is 1 x 0.6 x 0.4 cm in greatest overall. dimenslon. Sectioning reveals a 0.8 cm. purple-tan firm nodule. Touch prep and frozen section. are obtained by Dr. The entire specimen Including frozen section Is submitted in two. blocks. C. The container is received fresh unfixed labeled ""right sentinel lymph node #3 for frozen section"". and consists of an irregular mass of apparent fat which is 1 x 0.4 x 0.4 cm. in greatest overall. dimension. Sectioning reveais a pink-tan nodule 0.5 cm. in greatest dimension. Touch prep and. frozen section are obtained by Dr. The entire specimen including frozen section is. submitted in two blocks. D. The container is received fresh unfixed labeled ""right sentinel lymph node #4 for frozen section"". and consists of an irregular mass of apparent fat which is 0.6 x 0.4x 0.3 cm. The specimen is. deferred for permanent. The entire specimen is submitted in one block. E. The container is received fresh unfixed labeled ""right axillary contents"" and consists of an. irregular mass of fat which is 4.5 x 4 x 3 cm. in greatest overall dimension. Sectioning reveais. purple-tan nodules varying up to 2 cm. in greatest dimension. The specimen is submitted in four. blocks. F. The container is received fresh unfixed labeled ""right breast lump"" and consists of a 57 gm. ovoid. mass of apparent fatty and fibrous-encased tissue measuring 6,5 x 5 x 5 cm. in greatest overali. dimension. Sectioning reveals a tumor mass which is 6x 5 x 5 cm. in greatest overall dimension. There are two short sutures indicating superior margin inked with red dye, inferior is inked yellow. There Is a single short suture Indicating anterior margin Inked with orange dye, deep is inked with. black. There is a single long suture indicating lateral margin inked with blue dye, medial is inked. green. Gross margins are observed by Dr. The tumor mass grossly appears to be 0.6. away from the superior, 1 cm. away from the inferior, 1.5 cm. away from the anterior, 1 cm. away. from the deep and grossly appears to Involved the lateral or less than 0.1 cm. from the lateral; is. approximately 0.4 cm. away from the medial. The specimen is submitted in ten blocks. Key Note Block Summary: 1-superior, 2-inferior, -anterior, 4-deep, 5-lateral, 6-. medial, 7 through 10-random. G. The container Is received fresh unfixed labeled ""additional lateral margin"" and consists of a 7 gm. irregular mass of apparent fatty tissue which is 3 x 2.5 x 2 cm. in greatest overall dimension. There is an attached suture indicating new lateral margin inked with black dye. Serial sectioning. reveals apparent fatty tissue. The entire specimen is submitted as six blocks. Pathology Numbr. SURGICAL REPORT. Pathology Numbe. MICROSCOPIC EXAM. MICROSCOPIO EXAMINATION CONDUCTED BY PATHOLOGIST CONFIRMS FINAL DIAGNOSIS. SPECIAL STAINS PERFORMED: ER, PR, Her-2 (IHC) (specimen F-2) -. Pathology Numbe. SURGICAL REPORT.",BRCA,1,"The T stage is based on the size of the primary tumor. In this report, the largest dimension of the invasive tumor in the breast is 4.7 cm, as measured in the largest plane. This is larger than the 2.0 cm cutoff for T1 tumors, so the T stage is T2.",T2,54.0
582,TCGA-A7-A26F.46A75AD3-BAD1-4A16-873E-0099BD10FA8C,0,"DEPARTMENT OF PATHOLOGY AND LABORATORY MEDICINE. Date Col]. SPECIMEN. A. Left axillary sentinel lymph node. B. Left breast. CLINICAL NOTES. CLINICAL HISTORY: A -year-old with left breast metaplastic. cancer. FROZEN SECTION DIAGNOSIS. AFS Left axillary sentinel node, excision: No evidence of metastasis in 1 node (0/1). GROSS DESCRIPTION. A. Received in a container labeled with the patient's name,. medical record number and ""left axillary sentinel lymph. node"" The specimen container holds a single soft tan lymph node. measuring 1.5 x 1 x 0.5 cm. AS block ASF, bisected. B. Container B is labeled with the patient's name, medical. record number and ""left breast"". The specimen consists of. an excisional biopsy oriented by two sutures and measuring 3.5 cm. from anterior to posterior, 3.8 cm. from superior to inferior and. 2.5 cm. from medial to lateral. The specimen margins are inked. as. follows: blue-interior, black-posterior, red-superior,. green-inferior, vellow-medial, orange-lateral. The specimen is. serially sectioned and there is a firm, tan stellate lesion. measuring 1.8 x 1.5 x 1.5 cm., located extending in the direction of. the inferior margin of resection and appearing to involve the. inferior margin. ASB1-B20. MICROSCOPIC DESCRIPTION. A. There is no evidence of metastasis in one left axillary. sentinel lymph node. The node is examined by multilevel. sectioning with H&E staining, as well as for immunohistochemistry. for pankeratin. B. Invasive Carcinoma: Present. Histologic type: Adenocarcinoma with squamous differentiation,. metaplastic. Histologic grade: Overall grade: 3. Architectural score: 3. Nuclear score: 3. Mitotic score: 3. Greatest dimension (pT) : 1.8 cm (pT1). Specimen margins: Positive. Vessel invasion: Invasive carcinoma involves inferior margin over. a distance of greater than 1 cm. Vessel invasion: foci suspicious. Calcification: Present. Ductal carcinoma in situ: Present. Histologic pattern: Solid. Nuclear grade: 3. Central necrosis: Present. % DCIS subtotal tumor: Less than 10%. Extensive intraductal component: Absent. Specimen margins: Negative. Calcification: Present. Description of non-tumorous breast: Unremarkable. Comments: None. Prognostic markers: Previously FISH for HER-2 was reported as. equivocal and a block is sent at the request of. repeat HER-2 by FISH. DIAGNOSIS. A. Left Axillary sentinel lymph node, resection: No evidence of metastasis in one lymph node (0/1). B. Left breast, excisional biopsy: - Poorly differentiated carcinoma with metaplastic features,. grade 3,. 1.8 cm. Invasive carcinoma extends to involve the inferior margin. of resection. Ductal carcinoma in situ, solid and comedo subtypes,. nuclear grade 3 with necrosis, margins negative. ectronic Signature). --- End Of Report ---.",BRCA,0,"The report states that the greatest dimension of the tumor is 1.8 cm, and it falls within the T1 category (T1: tumor size up to 2.0 cm). The tumor size is based on the pathological measurement, and it does not consider the presence of lymphovascular invasion or perineural invasion. The T stage is based on the size of the tumor, without considering the involvement of lymph nodes or metastasis. The tumor size is rounded up to the nearest higher category when it falls between categories, but in this case, it does not apply.",T1,55.0
47,TCGA-3C-AALJ.265E5A9A-64FD-4B86-89BC-5E89F253C118,1,"Path No.: Date Obtained: (Age: ). Date Received: F. SPECIMEN: Breast, right, skin sparing modified radical mastectomy. DIAGNOSIS(ES): Breast, right, skin sparing modified radical mastectomy: Invasive ductal carcinoma, poorly differentiated (Modified Scarff Bloom Richardson Score 3+3+2=8/9),. multifocal, with lymphatic invasion. Metastatic carcinoma in 1/23 axillary lymph nodes (See microscopic description). pT2N1. CLINICAL INFORMATION: Right breast cancer. GROSS DESCRIPTION: The specimen is received unfixed in a container labeled with the patient's name and ""Right breast mastectomy"". It. consists. of. a right modified mastectomy specimen measuring 24,0 X 20,0 x 5.2 cm. A suture is noted indicating the. axillary tail. The overlying skin measures 14.5 X 8.0 cm. The nipple is mobile and everted. An underlying mass is. palpable in the 6 o'clock position. The deep (fascial) margin- is inked black and the remaining margins are inked yellow. The. axillary tissue measures 11.0 X 6,5 x 2.0 cm. Multiple lymph nodes are palpable within it measuring from 0.5 cm to. 1.7 cm in greatest dimension. The lymph nodes are dissected, proceeding from the breast toward the axilla. The. specimen is serially sectioned at closely spaced intervals revealing a firm, poorly circumscribed, white and focally. hemorrhagic. mass measuring 3.5 x 3.0 x 2.0 cm located in the inferior aspect of the specimen (6 o'clock position). The. mass comes to within 0.8 cm of the skin and 3.0 cm of the deep margin. A second firm, well circumscribed mass. measuring 0.7 x 0.5 x 0.5 is also identified located located 0.8 cm from the skin, 2.4 cm from the deep margin and 2,0. cm from the previously described mass, superiorly. The parenchyma superior and lateral to both masses is firm,. lobulated and gritty over an area measuring 4.0 x 3.5 x 2.0 cm. The remaining tissue is composed of a moderate. amount of breast tissue and a moderate amount of yellow fatty tissue. Representative sections are submitted in 37. cassettes labeled A1-A37. Please note: The specimen was placed in formalin at. LEGEND: A1-A3 = Nipple. A4 = Deep margin closest to main mass. A5 = Main mass with closest skin. A6-A8 = Main mass. A9-A10 = Smaller mass. A11 = Smaller mass with closest skin. A12 = Deep margin closest to smaller mass. A13-A18 = Gritty area surrounding masses. A19-A20 = Upper inner quadrant. A21-A22 = Lower inner quadrant. A23-A24 = Lower outer quadrant. A25-A26 = Upper outer quadrant. A27 = Bisected lymph node closest to breast. A28 =3 intact nodes. A29 = 3 intact nodes. A30 = 1 bisected node. A31. = 1 bisected node. A32 = 1 bisected node. A33 = 2 intact nodes. A34 = 4 intact nodes. A35 = 3 intact nodes. A36 = 2 intact nodes. A37 = 1 bisected node at high point. MICROSCOPIC DESCRIPTION: I. TYPE OF SPECIMEN: Right modified radical mastectomy. II. LOCATION OF THE TUMOR: Central (6 o'clock), extending into lower inner and outer quadrants. III. TYPE OF NEOPLASM: Carcinoma, invasive, ductal, with central scar and micropapillary features. Poorly Differentiated, Total score 8. (Tubule Score 3, Nuclear Grade Score 3, Mitotic Score 2). Ductal carcinoma in situ, nuclear grade 3, multifocal 30%. Intraductal papillary subtype. Intraductal micropapillary subtype. Intraductal solid subtype. Intraductal comedo subtype. Necrosis is present within the intraductal carcinoma. Lobular neoplasia is not present. IV. GROSS/MICRO FINAL INVASIVE TUMOR SIZE INTERPRETATION: 3.5 x 3.0 x 2,0 cm. (In addition, separate. foci of invasive carcinoma are seen superior to and lateral to the main mass these have a similar histology; the largest. such focus measures 1.5cm on the slide. VI. VASCULAR SPACE INVASION: Present in lymphatics. VII. CALCIFICATION: Present in malignant areas. VIII,. NIPPLE: Present, uninvolved by cancer. IX. SKIN: Present, uninvolved by cancer. X. ADJACENT BREAST TISSUE: Cystic disease, proliferative with atypia. XI. MARGINS: Negative. XII. AXILLARY LYMPH NODES: XII. AXILLARY LYMPH NODES: TOTAL: 23. HIGH POINT: 1. XIII. POSITIVE LYMPH NODES: XIII. POSITIVE LYMPH NODES: TOTAL: 1. LEVEL I;. 1 (adjacent to breast). EXTRANODAL EXTENSION: Present. XIV. PECTORAL MUSCLE: No pectoral muscle identified. XV. PATHOLOGIC STAGING (pTNM) AJCC 7th Edition: Reflects staging only of the current specimen. Ultimate. staging responsibility rests with the primary physician. pT2: Tumor more than 2.0 cm but not more than 5.0 cm in greatest dimension. pN1a: Metastasis in 1 to 3 axillary lymph nodes (at least 1 tumor deposit greater than 2.0 mm). This report has been reviewed electronically and signed on. Interpreted by: Attending: The diagnosis was rendered by the attending pathologist. Note; Immunochemistry testing performed at. was developed and its performance characteristice determined by the. These tests were interpreted in conjunction with external positive and internal regative controls, unless otherwise noted. It has not been cleared of approved by the US. FDA. This test Is used for clinical purposes only. it should not be regarded as investigational or for research.",BRCA,1,"The report states that the largest invasive tumor focus measures 3.5 x 3.0 x 2.0 cm, which falls within the T2 category (tumor size > 2.0 cm but not more than 5.0 cm).",T2,56.0
482,TCGA-A2-A0CR.A3167E2D-3588-41D4-99AA-6DCB660D55A4,2,"Specimen #: F. Race: WHITE. Physician (s) : SPECIMEN: LEFT BREAST MASTECTOMY. FINAL DIAGNOSIS: BREAST, LEFT, MASTECTOMY: INFILTRATING LOBULAR CARCINOMA. - ELL-DIFFERENTIATED BY COMBINED HISTOLOGIC CRITERIA. - SIZE: 9 CM. - ANGIOLYMPHATIC INVASION IDENTIFIED (A12) . - FOCAL DERMAL LYMPHATIC INVOLVEMENT (NIPPLE, SLIDE A8). - TUMOR WITHIN 1 MM OF DEEP MARGIN (A9, A10). - 16 LYMPH NODES IDENTIFIED, ALL NEGATIVE FOR MALIGNANCY. - AJCC STAGE IIB (T3 NO MX). - FOCAL LOBULAR CARCNOMA IN SITU (A5) . - INTRADUCTAL HYPERPLASIA, FLORID. - FIBROCYTSTIC CHANGES. COMMENT: Hormone receptor and HER2 studies previously reported. CLINICAL DIAGNOSIS AND HISTORY: -year-old female with breast carcinoma, left. GROSS DESCRIPTION: LEFT BRFAST MASTECTOMY received fresh, labeled with the patient's name,. designated ""LEFT BREAST AND AXILLARY CONTENTS"" consists. of a 1,044.0 gram modified radical mastectomy specimen. It measures 20.5. cm medial to lateral, 20.0 cm superior to inferior, 4.5 cm anterior to. posterior, with an attached axillary tail, 11.0 x 7.0 x 3.7 cm, and an. overlying ellipse of nipple bearing skin, measuring 18. x 9.5 cm. The. nipple is inverted and the skin is otherwise unremarkable. Ink code: Blue=superior superficial, green=inferior superficial, black=deep. Sectioning reveals a poorly defined, indurated mass in the upper inner. quadrant focally abutting the deep margin. Continuous with this lesion and. extending laterally to the outer portion of the breast is a broad area of. Specimen # : GROSS DESCRIPTION (continued). variably indurated fibrous tissue (overall maximum dimension of mass plus. indurated fibrous tissue = 9.0 cm) . Multiple sections are harvested for. the. protocol with matching paraffin sections as follows : A1: Skin (medial tip). A2: Lymph node, 1.8 cm, mid/upper axillary tail. A3: Tumor, upper inner quadrant. A4: Indurated fibrous tissue (5.0 cm from medial extent of tumor). central. A5: Indurated fibrous tissue (7.0 cm from medial extent of tumor) ,. central. A6: Indurated fibrous tissue (9.0 cm from medial extent of tumor) ,. mid center. A7: Grossly normal fibrofatty tissue, lower outer quadrant. Sectioning through the axillary tail reveals 14 possible lymph nodes. ranging in size from 0.2 cm to 3.0 cm in greatest dimension. Additional. representative sections are submitted in cassettes A8 through A22, as. follows: A8: Nipple. A9-A11: Mass upper inner quadrant . A12: Centralized fibrous area. Al3: Upper inner quadrant. A14: Lower inner quadrant. A15: Lower outer quadrant. A16: Upper outer quadrant. A17: Five possible lymph nodes. A18: Five possible lymph nodes. A19: Two possible lymph nodes, largest lymph node bisected and submitted. in its entirety. A20: One lymph node bisected and submitted in its entirety. A21-A22: One lymph node bisected and submitted in its entirety in two. cassettes. 22CF.",BRCA,0,"The report states that the size of the tumor is 9 cm, which falls within the T3 category (tumor size > 5 cm). The T stage is based on the size of the tumor, without considering the presence of lymphovascular invasion or perineural invasion. The T stage is based on the pathological measurement of the tumor size, not the gross measurement. The T stage may be determined by the presence of direct extension to the chest wall or skin, but the report does not mention any such extension.",T3,57.0